Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
098fead86afa584c45f4f9018cd4c025dfe0f1856d901d5866075062eacc8720.png
simple
<table><tr><td></td><td>Intervention Group: FFS Beneficiaries (n=317)</td><td>Control Group: Non-FFS Participants (n=254)</td><td>Difference Between Groups</td><td><i>P</i> Value</td></tr><tr><td>Household Dietary Diversity Score<sup>a</sup></td><td></td><td></td><td></td><td></td></tr><tr><td>Baseline, mean (SD)</td><td>3.4 (1.4)</td><td>3.4 (1.5)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Endline, mean (SD)</td><td>5.6 (2.1)</td><td>4.8 (2.1)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Change over time,<sup>b</sup> adjusted<sup>c</sup> mean (CI)</td><td>2.1 (1.9 to 2.4)</td><td>1.4 (1.0 to 1.7)</td><td>0.9 (0.5 to 1.3)</td><td>&lt;.001</td></tr><tr><td>Achieved target at endline,<sup>c</sup> % (CI)</td><td>69.7 (63.6 to 75.9)</td><td>48.0 (40.6 to 55.3)</td><td>21.7 (12.3 to 31.1)</td><td>&lt;.001</td></tr><tr><td>Household Food Insecurity Access Scale</td><td></td><td></td><td></td><td></td></tr><tr><td>Baseline, mean (SD)</td><td>14.4 (4.6)</td><td>14.8 (5.3)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Endline, mean (SD)</td><td>5.7 (5.1)</td><td>10.1 (6.1)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Change over time,<sup>b</sup> adjusted<sup>c</sup> mean (CI)</td><td>&#8722;8.6 (&#8722;9.4 to &#8722;7.9)</td><td>&#8722;4.7 (&#8722;5.7 to &#8722;3.7)</td><td>&#8722;4.6 (&#8722;5.0 to &#8722;4.2)</td><td>&lt;.001</td></tr><tr><td>Improved a category<sup>c</sup> (baseline to endline), % (CI)</td><td>55.3 (48.8 to 61.9)</td><td>32.4 (24.6 to 40.3)</td><td>22.9 (12.7 to 33.1)</td><td>&lt;.001</td></tr></table>
f42a13e89a7204f7d90e8a14fe17fbb9fd8313a54d2cbe3b535a397a9c3a32fa.png
complex
<table><tr><td></td><td></td><td></td><td colspan="6">Risk of malnutrition</td></tr><tr><td></td><td></td><td></td><td colspan="3">Low <i>n</i> = 159</td><td colspan="3">High <i>n</i> = 65</td></tr><tr><td></td><td></td><td></td><td>Admission</td><td>In-hospital follow up</td><td>P</td><td>Admission</td><td>In-hospital follow up</td><td>P</td></tr><tr><td>HGS, kg</td><td>&#9794;</td><td>101</td><td>26.4 (9.64)</td><td>27.5 (9.63)</td><td>0.082</td><td>24.0 (9.34)</td><td>24.8 (8.69)</td><td>0.223</td></tr><tr><td></td><td>&#9792;</td><td>120</td><td>15.2 (5.44)</td><td>15.9 (5.24)</td><td>0.069</td><td>13.0 (4.65)</td><td>14.2 (4.94)</td><td>0.115</td></tr><tr><td>SMM, kg</td><td></td><td>179</td><td>25.7 (5.36)</td><td>25.6 (5.47)</td><td>0.455</td><td>24.5 (5.75)</td><td>24.8 (5.60)</td><td>0.270</td></tr><tr><td>ALM, kg</td><td></td><td>179</td><td>19.6 (4.77)</td><td>20.0 (4.87)</td><td>0.030</td><td>18.7 (5.19)</td><td>19.5 (5.30)</td><td>0.007</td></tr><tr><td>FFM, kg</td><td></td><td>179</td><td>48.1 (9.20)</td><td>48.2 (9.43)</td><td>0.678</td><td>46.2 (10.0)</td><td>47.1 (9.96)</td><td>0.088</td></tr><tr><td>SMI, kg/m<sup>2</sup></td><td>&#9794;</td><td>78</td><td>9.90 (1.21)</td><td>9.83 (1.23)</td><td>0.404</td><td>9.00 (1.65)</td><td>9.09 (1.65)</td><td>0.470</td></tr><tr><td></td><td>&#9792;</td><td>101</td><td>8.67 (1.18)</td><td>8.62 (1.33)</td><td>0.683</td><td>8.46 (1.27)</td><td>8.58 (1.07)</td><td>0.411</td></tr><tr><td>Relative SMM, %</td><td></td><td>179</td><td>36.6 (5.59)</td><td>36.3 (5.62)</td><td>0.380</td><td>36.8 (6.73)</td><td>37.4 (7.24)</td><td>0.128</td></tr><tr><td>Relative ALM, %</td><td></td><td>179</td><td>27.6 (4.37)</td><td>28.2 (4.82)</td><td>0.027</td><td>27.9 (5.54)</td><td>29.3 (6.81)</td><td>0.002</td></tr><tr><td>Relative FFM, %</td><td></td><td>179</td><td>68.5 (10.1)</td><td>68.6 (10.3)</td><td>0.800</td><td>69.7 (12.6)</td><td>71.3 (13.8)</td><td>0.038</td></tr></table>
50729b7881163654368954f8d66a99e2333ae5893fa86f877d73c91a8f6dfab1.png
complex
<table><tr><td> </td><td colspan="2">All (n = 198)</td><td colspan="2">Boys (n = 101)</td><td colspan="2">Girls (n = 97)</td></tr><tr><td>Symptoms presence</td><td>No (n = 148)</td><td>Yes (n = 50)</td><td>No (n = 82)</td><td>Yes (n = 19)</td><td>No (n = 66)</td><td>Yes (n = 31)</td></tr><tr><td>IgE (mg/dL)</td><td>127 &#177; 273</td><td>258 &#177; 483*</td><td>168 &#177; 319</td><td>321 &#177; 595*</td><td>75 &#177; 190</td><td>220 &#177; 405&#176;</td></tr><tr><td>Leptin (pg/mL)</td><td>7043 &#177; 6196</td><td>10280 &#177; 8184*</td><td>4595 &#177; 4902</td><td>4602 &#177; 5682</td><td>10084 &#177; 6317</td><td>13761 &#177; 7555*</td></tr><tr><td>Eosinophils (%)</td><td>2.9 &#177; 2.8</td><td>3.0 &#177; 1.7</td><td>3.6 &#177; 3.6</td><td>4.1 &#177; 1.9</td><td>2.2 &#177; 1.0</td><td>2.4 &#177; 1.2</td></tr><tr><td>Interleukin-2 (pg/mL)</td><td>12.7 &#177; 22.3</td><td>15.7 &#177; 28.4</td><td>9.5 &#177; 13.1</td><td>18.5 &#177; 42.7</td><td>16.7 &#177; 29.6</td><td>14.1 &#177; 14.7</td></tr><tr><td>Interleukin-4 (pg/mL)</td><td>185 &#177; 280</td><td>170 &#177; 237</td><td>204 &#177; 305</td><td>208 &#177; 254</td><td>159 &#177; 243</td><td>141 &#177; 225</td></tr><tr><td>Interleukin -5 (pg/mL)</td><td>3.2 &#177; 21.8</td><td>1.6 &#177; 1.5</td><td>1.2 &#177; 1.5</td><td>1.4 &#177; 1.2</td><td>5.5 &#177; 32.5</td><td>1.6 &#177; 1.8</td></tr><tr><td>Interleukin &#8722;10 (pg/mL)</td><td>65 &#177; 181</td><td>50 &#177; 89</td><td>32 &#177; 33</td><td>46 &#177; 61</td><td>108 &#177; 264</td><td>52 &#177; 103</td></tr></table>
2defc968fb40fa75239ed6840237d1ec99fd7b7ce0347238fe596381da96db79.png
complex
<table><tr><td></td><td colspan="6">Weighted percentage (95% CI)<sup>2</sup></td></tr><tr><td></td><td>1993</td><td>1995</td><td>1997</td><td>1999</td><td>2001</td><td>2003</td></tr><tr><td>All</td><td>15.7 (14.6 to 16.8)</td><td>16.0 (13.8 to 18.5)</td><td>17.6 (15.9 to 19.4)</td><td>16.0 (14.5 to 17.7)</td><td>15.8 (14.7 to 16.9)</td><td>18.3 (16.2 to 20.7)</td></tr><tr><td colspan="7">Gender</td></tr><tr><td> Girls</td><td>20.8 (19.1 to 22.6)</td><td>22.0 (18.2 to 26.4)</td><td>24.2 (21.2 to 27.6)</td><td>20.8 (18.3 to 23.4)</td><td>20.0 (18.2 to 21.9)</td><td>22.2 (19.3 to 25.3)</td></tr><tr><td> Boys</td><td>10.9 (9.8 to 12.0)</td><td>10.5 (9.2 to 11.8)</td><td>12.1 (11.1 to 13.2)</td><td>11.4 (9.4 to 13.7)</td><td>11.3 (10.3 to 12.4)</td><td>14.7 (12.7 to 16.8)</td></tr><tr><td colspan="7">School Grade</td></tr><tr><td> 9</td><td>9.5 (8.3 to 10.8)</td><td>12.3 (9.8 to 15.3)</td><td>13.3 (11.5 to 15.3)</td><td>12.0 (9.6 to 15.0)</td><td>11.2 (9.9 to 12.6)</td><td>14.6 (12.2 to 17.4)</td></tr><tr><td> 10</td><td>13.4 (11.8 to 15.3)</td><td>12.1 (9.8 to 14.8)</td><td>16.7 (14.7 to 18.9)</td><td>15.2 (12.1 to 18.9)</td><td>14.1 (12.5 to 15.8)</td><td>17.0 (14.8 to 19.4)</td></tr><tr><td> 11</td><td>17.2 (15.5 to 19.0)</td><td>18.7 (14.5 to 23.8)</td><td>17.9 (15.3 to 20.8)</td><td>19.3 (16.5 to 22.4)</td><td>18.9 (17.3 to 20.7)</td><td>20.2 (17.3 to 23.3)</td></tr><tr><td> 12</td><td>21.6 (19.2 to 24.2)</td><td>20.4 (16.9 to 24.4)</td><td>21.8 (17.8 to 26.3)</td><td>19.0 (15.2 to 22.2)</td><td>20.6 (18.2 to 23.3)</td><td>22.9 (19.6 to 26.7)</td></tr><tr><td colspan="7">Race</td></tr><tr><td> NHW<sup>3</sup></td><td>14.2 (13.0 to 15.6)</td><td>13.3 (11.3 to 15.7)</td><td>15.2 (13.0 to 17.7)</td><td>14.3 (13.0 to 15.8)</td><td>14.4 (13.1 to 15.9)</td><td>16.7 (13.9 to 20.0)</td></tr><tr><td> Black<sup>4</sup></td><td>22.3 (20.2 to 24.6)</td><td>25.1 (22.0 to 28.4)</td><td>26.0 (22.7 to 29.6)</td><td>24.5 (19.3 to 30.5)</td><td>19.8 (17.5 to 22.3)</td><td>23.8 (21.2 to 26.6)</td></tr><tr><td> HW<sup>5</sup></td><td>17.1 (15.2 to 19.1)</td><td>20.5 (16.6 to 25.0)</td><td>17.3 (14.5 to 20.6)</td><td>17.8 (14.7 to 21.4)</td><td>18.1 (16.4 to 19.9)</td><td>20.1 (17.8 to 22.6)</td></tr><tr><td> Other</td><td>15.2 (12.5 to 18.4)</td><td>16.5 (11.0 to 23.9)</td><td>20.8 (16.6 to 25.7)</td><td>14.9 (11.5 to 19.0)</td><td>17.8 (15.4 to 20.4)</td><td>18.5 (15.6 to 21.8)</td></tr></table>
a5d09237aec64fb54d7949ec9b35ce990de93a26f7acf7fe89d41e1a4f6014a0.png
simple
<table><tr><td> </td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td><i>p</i> value</td></tr><tr><td>M<sub>2</sub> oocyte counts</td><td>1.7 &#177; 0.9</td><td>1.7 &#177; 0.8</td><td>1.9 &#177; 1.0</td><td>0.461 </td></tr><tr><td>Fertilization rates (%)</td><td>82.3 &#177; 32.2</td><td>79.6 &#177; 33.4</td><td>64.4 &#177; 34.4<sup>a,b</sup></td><td>0.04</td></tr><tr><td>Embryo counts</td><td>1.5 &#177; 1.0</td><td>1.3 &#177; 0.8</td><td>1.5 &#177; 1.0</td><td>0.685 </td></tr><tr><td>Stimulation duration (days)</td><td>8.5 &#177; 2.5</td><td>8.6 &#177; 2.0</td><td>8.6 &#177; 3.1</td><td>0.977</td></tr><tr><td>Gonadotropin dose (units)</td><td>2993 &#177; 1212</td><td>2772 &#177; 844</td><td>2752.8 &#177; 1003</td><td>0.546</td></tr><tr><td>Clinical pregnancy rates (%)</td><td>33.3</td><td>25</td><td>15<sup>c</sup></td><td>0.02</td></tr><tr><td>Cycle cancellation rates (%)</td><td>16.6</td><td>17.3</td><td>20</td><td>0.732</td></tr></table>
fa2f45dd708eb27a141f66cda17651d4af989d09c515f19734e7ea40ae5209b4.png
complex
<table><tr><td colspan="8">Dose Intensity Rates (DSI) in percentage</td></tr><tr><td colspan="3">GEM Group (<i>n</i> = 9)</td><td colspan="5">CIS/GEM Group (<i>n</i> = 21)</td></tr><tr><td colspan="3"></td><td></td><td colspan="2">CIS</td><td colspan="2">GEM</td></tr><tr><td>Cycles</td><td>Median</td><td>IQR</td><td>Cycles</td><td>Median</td><td>IQR</td><td>Median</td><td>IQR</td></tr><tr><td>C1</td><td>100</td><td>(91.7&#8211;100)</td><td>C1</td><td>100</td><td>(100&#8211;100)</td><td>100</td><td>(100&#8211;100)</td></tr><tr><td>C2</td><td>100</td><td>(95&#8211;100)</td><td>C2</td><td>100</td><td>(100&#8211;100)</td><td>100</td><td>(100&#8211;100)</td></tr><tr><td>C3</td><td>100</td><td>(90.9&#8211;100)</td><td>C3</td><td>100</td><td>(70&#8211;100)</td><td>100</td><td>(76.4&#8211;100)</td></tr><tr><td>C4</td><td>100</td><td>(86.7&#8211;100)</td><td>C4</td><td>80</td><td>(50&#8211;100)</td><td>100</td><td>(77.5&#8211;100)</td></tr><tr><td>C5</td><td>100</td><td>(95&#8211;100)</td><td>C5</td><td>80</td><td>(50&#8211;100)</td><td>100</td><td>(70&#8211;100)</td></tr><tr><td>C6</td><td>100</td><td>(88.9&#8211;100)</td><td>C6</td><td>80</td><td>(25&#8211;100)</td><td>94.1</td><td>(70&#8211;100)</td></tr><tr><td></td><td></td><td></td><td>C7</td><td>50</td><td>(0&#8211;100)</td><td>88.9</td><td>(56.3&#8211;100)</td></tr><tr><td></td><td></td><td></td><td>C8</td><td>50</td><td>(0&#8211;90)</td><td>75</td><td>(50&#8211;100)</td></tr><tr><td>Overall DSI</td><td>100</td><td>(91&#8211;100)</td><td></td><td>100</td><td>(50&#8211;100)</td><td>100</td><td>(75&#8211;100)</td></tr></table>
c651a3aab586906f4a6fec046062f4fe15e4eee59c9014bf3a62d2cc09c2222e.png
complex
<table><tr><td>Trait</td><td>Rationale</td><td>Categories</td><td>Codes</td></tr><tr><td rowspan="7">Potential size (mm)</td><td rowspan="7">The predator may prefer a particular size range because prey size is a trade&#8208;off among costs and benefits of foraging</td><td>&#8804;2.5</td><td>&lt;2.5</td></tr><tr><td>2.5&#8211;5</td><td>2.5&#8211;5</td></tr><tr><td>5&#8211;10</td><td>5&#8211;10</td></tr><tr><td>10&#8211;20</td><td>10&#8211;20</td></tr><tr><td>20&#8211;40</td><td>20&#8211;40</td></tr><tr><td>40&#8211;80</td><td>40&#8211;80</td></tr><tr><td>&gt;80</td><td>&gt;80</td></tr><tr><td rowspan="4">Body shape (including cases/tubes)</td><td rowspan="4">Body shape can affect handling efficiency</td><td>Cylindrical</td><td>cyl</td></tr><tr><td>Spherical</td><td>sph</td></tr><tr><td>Conical</td><td>con</td></tr><tr><td>Flattened</td><td>flat</td></tr><tr><td rowspan="3">Body flexibility (including cases/tubes)</td><td rowspan="3">Higher body flexibility may be preferred because it compromises lower handling time</td><td>None</td><td>f.no</td></tr><tr><td>Weak</td><td>f.weak</td></tr><tr><td>High</td><td>f.high</td></tr><tr><td rowspan="5">Concealment</td><td rowspan="5">Prey concealment (colored patterns, accessories) may reduce vulnerability to predation</td><td>Fixed accessory (nets, retreats)</td><td>net</td></tr><tr><td>Movable accessory (cases, tubes)</td><td>case</td></tr><tr><td>Solidly colored</td><td>c.sol</td></tr><tr><td>Variable</td><td>c.var</td></tr><tr><td>Patterned</td><td>c.patt</td></tr><tr><td rowspan="2">Morphological defenses</td><td rowspan="2">Morphological defenses may reduce vulnerability to predation</td><td>Cerci, silk, spine</td><td>def.sp</td></tr><tr><td>None</td><td>def.no</td></tr><tr><td rowspan="6">Locomotion and substrate relation</td><td rowspan="6">Crawlers, burrowers and attached organisms may be more vulnerable to predation because the fish foraging preferences (benthic)</td><td>Surface swimmer</td><td>surf.s</td></tr><tr><td>Full water swimmer</td><td>wat.s</td></tr><tr><td>Crawler</td><td>craw</td></tr><tr><td>Burrower</td><td>burw</td></tr><tr><td>Interstitial</td><td>int</td></tr><tr><td>Attached</td><td>att</td></tr><tr><td rowspan="4">Tendency to drift in the water column</td><td rowspan="4">Drift tendency may increase vulnerability to predation</td><td>None</td><td>d.no</td></tr><tr><td>Weak</td><td>d.weak</td></tr><tr><td>Medium</td><td>d.med</td></tr><tr><td>High</td><td>d.high</td></tr><tr><td rowspan="5">Diel drift behavior</td><td rowspan="5">Nocturnal drift may reduce vulnerability to predation because foraging efficiency can decrease with a decrease in luminosity</td><td>None</td><td>none</td></tr><tr><td>Nocturnal</td><td>noct</td></tr><tr><td>Dawn</td><td>dawn</td></tr><tr><td>Daylight</td><td>d.light</td></tr><tr><td>Twilight</td><td>t.light</td></tr><tr><td rowspan="3">Agility</td><td rowspan="3">High agility may increase encounter rate with the predator, increasing prey vulnerability to predation</td><td>None (sluggish)</td><td>a.no</td></tr><tr><td>Weak</td><td>a.weak</td></tr><tr><td>High</td><td>a.high</td></tr><tr><td rowspan="2">Movement frequency</td><td rowspan="2">Continuous movement may increase vulnerability to predation because it may reduce hunting time</td><td>Continuous</td><td>cont</td></tr><tr><td>Discontinuous</td><td>disc</td></tr><tr><td rowspan="4">Trajectory on the bottom substratum or in the drift</td><td rowspan="4">Random trajectory may reduce vulnerability to predation because it may increase hunting time</td><td>None</td><td>t.no</td></tr><tr><td>Linear</td><td>t.lin</td></tr><tr><td>By random</td><td>t.rand</td></tr><tr><td>Oscillatory</td><td>t.oscil</td></tr><tr><td rowspan="2">Aggregation tendency</td><td rowspan="2">Aggregation may increase vulnerability trough increasing conspicuous to predators, but may be also an antipredator strategy</td><td>Weak</td><td>ag.weak</td></tr><tr><td>High</td><td>ag.high</td></tr><tr><td rowspan="8">Feeding habits</td><td rowspan="8">Habitat use by the predatory fish may affect differently to the potential prey depending on prey feeding habits</td><td>Absorber</td><td>abs</td></tr><tr><td>Deposit feeder</td><td>dpfd</td></tr><tr><td>Shredder</td><td>shrd</td></tr><tr><td>Scraper</td><td>scrp</td></tr><tr><td>Filter&#8208;feeder</td><td>filt</td></tr><tr><td>Piercer</td><td>pier</td></tr><tr><td>Predator</td><td>pred</td></tr><tr><td>Parasite</td><td>par</td></tr></table>
2c341b83d76e2e408679113d71962597fd8187c2e0ffd9aec2b59e22b8c5e71e.png
simple
<table><tr><td>Author</td><td>Study design</td><td>Aim of the study</td><td>Sample size</td><td>Conclusion</td></tr><tr><td>Dunn M, et al<sup>32</sup>Michigan,USA 2007</td><td>. Case control</td><td>Assessment of OPG in regulatingmechanically induced bone modeling in a rat model of orthodontic toothmovement.</td><td>39 male Sprague-Dawley rats &#187; 9rats without appliances: (3 rats without injections, 3 rats with vehicleand 3 rats with high-dose OPG) &#187; 30 rats with orthodontic forces: (10rats with 0.5 mg/Kg OPG-Fc, 10 rats with 5.0 mg/Kg OPG-Fc and 10 ratswith vehicle)</td><td>Local delivery of OPG-Fc inhibitsosteoclastogenesis and tooth movement at targeted dental sites.</td></tr><tr><td>Keles A, et al<sup>31</sup>BostonUSA 2007</td><td>Case control</td><td>Evaluation of the efficacy ofpamidronate<i>versus</i> osteoprotegerin (OPG) in theinhibition of bone resorption and tooth movement.</td><td>18 C57Bl/6 male mice into 3 groupsof 6 mice: &#187; Control group (vehicle) &#187; 5 mg/kg-1 pamidronate &#187; 10 mg/kg-1OPG</td><td>OPG results in a more powerfulinhibitor of osteoclast recruitment and activity than pamidronate, with areduction of osteoclasts number of 95% and tooth movement of 77%.</td></tr></table>
721f9e0f982277474b8c1b92cb5016b915f41dfe838a260d0934f610a035906b.png
simple
<table><tr><td></td><td>UBS time A</td><td>BBS time A</td><td>UBS time B</td><td>BBS time B</td><td>UBS time C</td><td>BBS time C</td><td>UBS time D</td><td>BBS time D</td></tr><tr><td>UBS time A</td><td></td><td>0.43</td><td>0.54</td><td>-</td><td>0.56</td><td>-</td><td>0.55</td><td>-</td></tr><tr><td>BBS time A</td><td>0.43</td><td></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>0.48</td></tr><tr><td>UBS time B</td><td>0.54</td><td>-</td><td></td><td>0.54</td><td>0.64</td><td>-</td><td>0.56</td><td>-</td></tr><tr><td>BBS time B</td><td>-</td><td>-</td><td>0.54</td><td></td><td>0.42</td><td>0.63</td><td>0.41</td><td>0.50</td></tr><tr><td>UBS time C</td><td>0.56</td><td>-</td><td>0.64</td><td>0.42</td><td></td><td>0.53</td><td>0.69</td><td>-</td></tr><tr><td>BBS time C</td><td>-</td><td>-</td><td>-</td><td>0.63</td><td>0.53</td><td></td><td>0.46</td><td>0.57</td></tr><tr><td>UBS time D</td><td>0.55</td><td>-</td><td>0.56</td><td>0.41</td><td>0.69</td><td>0.46</td><td></td><td>0.54</td></tr><tr><td>BBS time D</td><td>-</td><td>0.48</td><td>-</td><td>0.50</td><td>-</td><td>0.57</td><td>0.54</td><td></td></tr></table>
f564c31d8ff5d5ffa45accb3e47f7e940ec0aee7a511713458b7d5c7379fd6d3.png
simple
<table><tr><td>Pattern</td><td>PT (s)</td><td>APTT (s)</td><td>FIB (g/L)</td><td>D-D (ug/ml)</td></tr><tr><td>Dampness-heat accumulation</td><td>12.25 &#177; 1.08</td><td>39.38 &#177; 6.33</td><td>3.65 &#177; 1.08</td><td>2.30 &#177; 0.46<sup><i>&#8727;&#8727;</i></sup></td></tr><tr><td>Liver-kidney yin deficiency</td><td>14.34 &#177; 0.56</td><td>40.81 &#177; 4.75</td><td>2.98 &#177; 0.35</td><td>0.65 &#177; 0.13<sup><i>&#8727;</i></sup></td></tr><tr><td>Qi and yin deficiency</td><td>12.58 &#177; 0.64</td><td>42.13 &#177; 5.05</td><td>3.41 &#177; 0.85</td><td>0.53 &#177; 0.27<sup><i>&#8727;</i></sup></td></tr><tr><td>Blood-heat bleeding</td><td>13.17 &#177; 0.78</td><td>39.13 &#177; 1.96</td><td>3.56 &#177; 0.48</td><td>2.28 &#177; 0.76<sup><i>&#8727;&#8727;</i></sup></td></tr></table>
b5d134b8166feed9f8df2d4c02d2927709a260d28f5619bcf25b937d53c504fa.png
complex
<table><tr><td></td><td colspan="3">Where did you go for the first consultation during the past 30 days</td></tr><tr><td></td><td>Categories</td><td>Frequency</td><td>Percent (%)</td></tr><tr><td>Did not access healthcare (1&#8211;5)</td><td>1 = Drugs at Home</td><td>32</td><td>2.4</td></tr><tr><td rowspan="4"></td><td>2 = Neighbor/Friend</td><td>5</td><td>0.4</td></tr><tr><td>3 = Community health worker</td><td>12</td><td>0.9</td></tr><tr><td>4 = Homapak drug distributor</td><td>1</td><td>0.1</td></tr><tr><td>5 = Ordinary shop</td><td>13</td><td>1.0</td></tr><tr><td rowspan="6">Accessed healthcare (6&#8211;11)</td><td>6 = Drug shop/Pharmacy</td><td>134</td><td>10.1</td></tr><tr><td>7 = Private clinic</td><td>408</td><td>30.9</td></tr><tr><td>8 = Health unit government</td><td>414</td><td>31.3</td></tr><tr><td>9 = Health unit NGO</td><td>48</td><td>3.6</td></tr><tr><td>10 = Hospital government</td><td>160</td><td>12.1</td></tr><tr><td>11 = Hospital NGO</td><td>54</td><td>4.1</td></tr><tr><td rowspan="2">Did not access healthcare (12, 96)</td><td>12 = Traditional healer</td><td>25</td><td>1.9</td></tr><tr><td>96 = Other (specify)</td><td>15</td><td>1.1</td></tr><tr><td></td><td>Total</td><td>1,321</td><td>100</td></tr></table>
2c2557265d74370ed3ed068fceca7abe7443d03919f7d89c96a86a9c64d01993.png
complex
<table><tr><td>Sample</td><td>Sample</td><td>Library prep/</td><td>Seq</td><td colspan="6"><i>Anabaena</i> sp. genome</td></tr><tr><td></td><td>date</td><td>Seq platform</td><td>output</td><td colspan="6"></td></tr><tr><td></td><td></td><td></td><td>(Gbp)</td><td colspan="6"></td></tr><tr><td></td><td></td><td></td><td></td><td>N50</td><td>Mean</td><td>No.</td><td>Max</td><td>Total</td><td>Unique</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>cov.</td><td>contigs</td><td>contig</td><td>length</td><td>core</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>(nt)</td><td>(nt)</td><td>genes</td></tr><tr><td><i>Anabaena</i></td><td>Dec</td><td>Blue</td><td colspan="7"></td></tr><tr><td>sp. WA102</td><td>2014</td><td>Pippin/</td><td>1.13</td><td>5,715,573</td><td>50x</td><td>3*</td><td>5,705,437</td><td>5,807,452</td><td>104</td></tr><tr><td>culture</td><td></td><td>PacBio</td><td colspan="7"></td></tr><tr><td>est. from</td><td>Dec</td><td>TruSeq/</td><td colspan="7"></td></tr><tr><td>Anderson</td><td>2013</td><td>HiSeq2000</td><td>3.83</td><td>15,892</td><td>129x</td><td>819</td><td>66,878</td><td>5,698,213</td><td>105</td></tr><tr><td>Lake</td><td></td><td>100bp PE</td><td colspan="7"></td></tr><tr><td>May 2013</td><td colspan="9"></td></tr><tr><td>WA25</td><td>July</td><td>TruSeq/</td><td></td><td>Shotgun</td><td></td><td></td><td colspan="3"></td></tr><tr><td></td><td>2012/</td><td>HiSeq2000</td><td>30.1</td><td>metagenome</td><td colspan="5"></td></tr><tr><td></td><td>Anderson</td><td>100bp PE</td><td></td><td>of surface</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Lake</td><td></td><td></td><td>lake water</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><i>Anabaena</i></td><td colspan="9"></td></tr><tr><td>sp. AL93</td><td colspan="9"></td></tr><tr><td>culture</td><td>Jan</td><td>Nextera/</td><td colspan="7"></td></tr><tr><td>est. from</td><td>2013</td><td>MiSeq</td><td>1.36</td><td>46,264</td><td>149x</td><td>314</td><td>133,848</td><td>5,757,055</td><td>105</td></tr><tr><td>American</td><td></td><td>250bp PE</td><td colspan="7"></td></tr><tr><td>Lake</td><td colspan="9"></td></tr><tr><td>1993</td><td></td><td></td><td></td><td colspan="6"></td></tr></table>
c2e419a14b5bac158d301681bb4cc721feb036643bec43212e43b6f45c42ef0e.png
simple
<table><tr><td>Variables</td><td>Adjusted R<sup>2</sup></td><td>Beta</td></tr><tr><td><underline>Block 1: Demographic Variables</underline></td><td>0.07</td><td></td></tr><tr><td>Age</td><td></td><td>0.19***</td></tr><tr><td>Gender (1 = female, 2 = male)</td><td></td><td>-0.08</td></tr><tr><td>Employment status (1 = employed, 2 = unemployed)</td><td></td><td>0.19***</td></tr><tr><td>Source (1 = internet, 2 = paper)</td><td></td><td>0.01</td></tr><tr><td><underline>Block 2: Theory of Planned Behaviour Variables</underline></td><td>0.51</td><td></td></tr><tr><td>Attitude</td><td></td><td>-0.47****</td></tr><tr><td>Subjective norm</td><td></td><td>-0.22****</td></tr><tr><td>Perceived control</td><td></td><td>-0.19***</td></tr><tr><td>Self-efficacy</td><td></td><td>-0.06</td></tr><tr><td><underline>Block 3: Extended Theory of Planned Behaviour Variables</underline></td><td>0.56</td><td></td></tr><tr><td>Anticipated regret</td><td></td><td>-0.19***</td></tr><tr><td>Last year, did you have a vaccination for ordinary seasonal flu?, (1 = yes)</td><td></td><td>-0.04</td></tr><tr><td>Do you intend to have a vaccination for ordinary seasonal flu this year? (1 = yes)</td><td></td><td>-0.14*</td></tr><tr><td>Knowledge</td><td></td><td>0.02</td></tr><tr><td><underline>Block 4: Health Belief Model Variables</underline></td><td>0.60</td><td></td></tr><tr><td>Perceived susceptibility</td><td></td><td>0.01</td></tr><tr><td>Perceived severity</td><td></td><td>-0.06</td></tr><tr><td><i>Perceived benefits:</i></td><td></td><td></td></tr><tr><td>Vaccination is a good idea because I feel less worried about catching swine flu</td><td></td><td>0.07</td></tr><tr><td>Vaccination decreases my chance of getting swine flu or its complications</td><td></td><td>-0.24***</td></tr><tr><td>If I get vaccinated for swine fu, I will decrease the frequency of having to consult my doctor</td><td></td><td>-0.12**</td></tr><tr><td><i>Perceived barriers:</i></td><td></td><td></td></tr><tr><td>The side-effects of swine flu vaccination interfere with my usual activities</td><td></td><td>-0.04</td></tr><tr><td>I am scared of needles</td><td></td><td>0.05</td></tr><tr><td>I cannot be bothered to get a swine flu vaccination</td><td></td><td>0.13***</td></tr></table>
7cedc65effdc3d7d06bad09371fd6f11bfb03aa7265bcac38353aba09de25a14.png
complex
<table><tr><td rowspan="2">Radiographs &amp; event forms</td><td colspan="3">Pre-surgery</td><td>Surgery</td><td colspan="9">Post-surgery</td></tr><tr><td>Screening</td><td>Enrolment</td><td>Baseline</td><td>(Day 0)</td><td>&#8804; 48 hrs Post surgery</td><td>D/C</td><td>1 wk (24 hrs-10 ds)</td><td>10 wk (8-12 wks)</td><td>6 mo (5-7 mos)</td><td>9 mo (8-10 mos)</td><td>12 mo (11-13 mos)</td><td>18 mo (17-19 mos)</td><td>24 mo (&#8805;24 mos)</td></tr><tr><td>Radiographs</td><td> </td><td> </td><td>&#9679;</td><td> </td><td>&#9679;</td><td> </td><td> </td><td>&#9679;</td><td> </td><td> </td><td>&#9679;</td><td> </td><td>&#9679;</td></tr><tr><td>Screening</td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Informed consent</td><td> </td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Randomization</td><td> </td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Baseline</td><td> </td><td> </td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Patient contact</td><td> </td><td>&#9679;</td><td> </td><td> </td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td></tr><tr><td>Pre-Op care</td><td> </td><td> </td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Fracture characteristics</td><td> </td><td> </td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Surgical report</td><td> </td><td> </td><td> </td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Post-Op care</td><td> </td><td> </td><td> </td><td> </td><td>&#9679;</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Clinic or telephone follow-up</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td><td>&#9679;</td></tr><tr><td>RS</td><td> </td><td> </td><td> </td><td> </td><td>*</td><td> </td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td></tr><tr><td>AE</td><td> </td><td> </td><td> </td><td>*</td><td>*</td><td> </td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td></tr><tr><td>Hospital D/C</td><td> </td><td> </td><td> </td><td> </td><td> </td><td>&#9679;</td><td>*</td><td>*</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Missed</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Follow-up</td><td> </td><td> </td><td> </td><td> </td><td> </td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td> </td></tr><tr><td>Early W/D</td><td> </td><td> </td><td> </td><td> </td><td> </td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td><td>*</td></tr></table>
9baaa740657a6c2dcc0dedf4de91cbb0310631a76da1e31a4f53c7bafb4cfba9.png
simple
<table><tr><td>Gene</td><td>Forward Primer</td><td>Reverse Primer</td><td>Product Size (bp)</td></tr><tr><td>AFP</td><td>CACTGCTGCAACTCTTCGTA</td><td>CTTTGGACCCTCTTCTGTGA</td><td>300</td></tr><tr><td>Alb</td><td>GACAAGGAAAGCTGCCTGAC</td><td>TTCTGCAAAGTCAGCATTGG</td><td>174</td></tr><tr><td>Trf</td><td>ACCATGTTGTGGTCTCACGA</td><td>ACAGAAGGTCCTTGGTGGTG</td><td>135</td></tr><tr><td>CPS</td><td>AGGATGTCAAGGTGTTTGGC</td><td>GCTTAACTAGCAGGCGGATG</td><td> 93</td></tr><tr><td>&#946;-actin</td><td>GACCTCTATGCCAACACAGT</td><td>AGTACTTGCGCTCAGGAGGA</td><td>139</td></tr></table>
68d79680d34265a478554dd5d10192e58b9e2d0e224325269752b2da480153d1.png
complex
<table><tr><td>Predictor</td><td><i>B</i></td><td><i>OR [95% CI]</i></td><td><i>p</i></td></tr><tr><td>Detect (DL and DnL)</td><td colspan="3"></td></tr><tr><td colspan="4"> Response time</td></tr><tr><td>Accuracy</td><td>0.13</td><td>1.14 [1.10, 1.18]</td><td>&lt;0.001</td></tr><tr><td><i>d'</i></td><td>&#8722;0.01</td><td>0.99 [0.98, 1.01]</td><td>0.40</td></tr><tr><td><i>c</i></td><td>0.004</td><td>1.00 [0.99, 1.01]</td><td>0.42</td></tr><tr><td colspan="4"> General belief about percentage of images manipulated = High (71&#8211;100%)</td></tr><tr><td>Accuracy</td><td>0.16</td><td>1.18 [1.02, 1.36]</td><td>0.03</td></tr><tr><td><i>d'</i></td><td>0.09</td><td>1.09 [0.97, 1.23]</td><td>0.14</td></tr><tr><td><i>c</i></td><td>&#8722;0.04</td><td>0.96 [0.90, 1.03]</td><td>0.25</td></tr><tr><td colspan="4"> Gender = Female</td></tr><tr><td>Accuracy</td><td>&#8722;0.01</td><td>0.99 [0.86, 1.15]</td><td>0.92</td></tr><tr><td><i>d'</i></td><td>&#8722;0.03</td><td>0.97 [0.86, 1.09]</td><td>0.60</td></tr><tr><td><i>c</i></td><td>&#8722;0.01</td><td>0.99 [0.93, 1.06]</td><td>0.82</td></tr><tr><td colspan="4"> Interest in photography = Interested</td></tr><tr><td>Accuracy</td><td>0.17</td><td>1.19 [1.02, 1.39]</td><td>0.03</td></tr><tr><td><i>d'</i></td><td>0.04</td><td>1.04 [0.92, 1.18]</td><td>0.56</td></tr><tr><td><i>c</i></td><td>&#8722;0.05</td><td>0.95 [0.89, 1.02]</td><td>0.18</td></tr><tr><td colspan="4"> Frequency of taking photos = Daily/weekly</td></tr><tr><td>Accuracy</td><td>&#8722;0.01</td><td>0.99 [0.84, 1.17]</td><td>0.91</td></tr><tr><td><i>d'</i></td><td>&#8722;0.07</td><td>0.93 [0.82, 1.07]</td><td>0.31</td></tr><tr><td><i>c</i></td><td>&#8722;0.05</td><td>0.95 [0.88, 1.02]</td><td>0.18</td></tr><tr><td>Locate (DL and nDL)</td><td colspan="3"></td></tr><tr><td> Response time</td><td>0.10</td><td>1.11 [1.08, 1.14]</td><td>&lt;0.001</td></tr><tr><td> General belief about percentage of images manipulated = High (71&#8211;100%)</td><td>&#8722;0.01</td><td>0.99 [0.87, 1.12]</td><td>0.84</td></tr><tr><td> Gender = Female</td><td>&#8722;0.10</td><td>0.91 [0.80, 1.03]</td><td>0.14</td></tr><tr><td> Interest in photography = Interested</td><td>0.16</td><td>1.17 [1.02, 1.34]</td><td>0.02</td></tr><tr><td> Frequency of taking photos = Daily/weekly</td><td>&#8722;0.08</td><td>0.92 [0.80, 1.06]</td><td>0.27</td></tr><tr><td>Detect and locate (DL)</td><td colspan="3"></td></tr><tr><td> Response time: detect</td><td>0.17</td><td>1.19 [1.15, 1.23]</td><td>&lt;0.001</td></tr><tr><td> Response time: locate</td><td>0.13</td><td>1.14 [1.11, 1.18]</td><td>&lt;0.001</td></tr><tr><td> General belief about percentage of images manipulated = High (71&#8211;100%)</td><td>0.05</td><td>1.05 [0.91, 1.20]</td><td>0.51</td></tr><tr><td> Gender = Female</td><td>&#8722;0.13</td><td>0.88 [0.77, 1.01]</td><td>0.07</td></tr><tr><td> Interest in photography = Interested</td><td>0.20</td><td>1.22 [1.06, 1.41]</td><td>0.01</td></tr><tr><td> Frequency of taking photos = Daily/weekly</td><td>&#8722;0.09</td><td>0.92 [0.78, 1.07]</td><td>0.28</td></tr></table>
b41af71b2e3acd219a5298c06ecb20bc635ed83972c3765e5d402efc4f179b84.png
complex
<table><tr><td> </td><td>Male</td><td>Female</td><td>P-value</td></tr><tr><td>Number of patients</td><td>110</td><td>51</td><td> </td></tr><tr><td>Age (mean, SD)</td><td>36 (10.3)</td><td>40 (10.0)</td><td>0.013</td></tr><tr><td>Age of onset (median, range)</td><td>20 (12&#8211;39)</td><td>25 (13&#8211;48)</td><td>0.057</td></tr><tr><td>Psychiatric hospital admissions (median, range)</td><td>6 (1&#8211;24)</td><td>4 (0&#8211;20)</td><td>0.091</td></tr><tr><td>Suicide attempts (median, range)</td><td>0 (0&#8211;6)</td><td>0 (0&#8211;5)</td><td>0.674</td></tr><tr><td>Years of evolution of disease (median, range)</td><td>13 (0&#8211;45)</td><td>11 (0&#8211;49)</td><td>0.578</td></tr><tr><td>Marital status (N, percentage)</td><td> </td><td> </td><td> </td></tr><tr><td> Single</td><td>95 (87%)</td><td>32 (62%)</td><td rowspan="4">0.002</td></tr><tr><td> Married or paired</td><td>7 (6%)</td><td>12 (23%)</td></tr><tr><td> Separated or divorced</td><td>8 (7%)</td><td>5 (11%)</td></tr><tr><td> Widowed</td><td>0 (0%)</td><td>2 (4%)</td></tr><tr><td>Drug abuse (N, percentage)</td><td>81 (74%)</td><td>33 (65%)</td><td>0.246</td></tr></table>
a2f237e7281196ae401e6533e55b8ca535101d6994c80123ac042f1ce890c88f.png
complex
<table><tr><td> </td><td colspan="7">Red clade</td><td colspan="7">Green clade</td><td colspan="7">Black clade</td><td> </td></tr><tr><td> </td><td>CabpIAP</td><td>IAP31</td><td>IAP44</td><td>IAP51</td><td>IAP77</td><td>IAP90</td><td>IAP110</td><td>IAP176</td><td>IAP182</td><td>IAP186</td><td>IAP195</td><td>IAP236</td><td>*IAP281Y</td><td>IAP268</td><td>IAP506</td><td>IAP655</td><td>IAP1112</td><td>IAP1248</td><td>IAP1252</td><td>IAP1259</td><td>IAP1334</td><td>Average</td></tr><tr><td>Mouse 1</td><td>74</td><td>52</td><td>70</td><td>77</td><td>60</td><td>80</td><td>71</td><td>69</td><td>70</td><td>61</td><td>70</td><td>62</td><td> </td><td>77</td><td>77</td><td>76</td><td>66</td><td>LOD</td><td>83</td><td>82</td><td>88</td><td>72</td></tr><tr><td>Mouse 2</td><td>77</td><td>60</td><td>77</td><td>75</td><td>60</td><td>71</td><td>72</td><td>60</td><td>71</td><td>68</td><td>76</td><td>68</td><td> </td><td>84</td><td>86</td><td>70</td><td>69</td><td>83</td><td>77</td><td>78</td><td>86</td><td>73</td></tr><tr><td>Mouse 3</td><td>81</td><td>57</td><td>77</td><td>78</td><td>66</td><td>76</td><td>72</td><td>66</td><td>74</td><td>55</td><td>73</td><td>67</td><td> </td><td>76</td><td>71</td><td>76</td><td>68</td><td>84</td><td>78</td><td>84</td><td>LOD</td><td>72</td></tr><tr><td>Mouse 4</td><td>72</td><td>61</td><td>80</td><td>77</td><td>65</td><td>68</td><td>69</td><td>56</td><td>77</td><td>56</td><td>54</td><td>65</td><td> </td><td>73</td><td>82</td><td>70</td><td>60</td><td>89</td><td>80</td><td>81</td><td>86</td><td>71</td></tr><tr><td>Mouse 5</td><td>74</td><td>59</td><td>71</td><td>78</td><td>61</td><td>80</td><td>75</td><td>65</td><td>70</td><td>69</td><td>69</td><td>63</td><td> </td><td>80</td><td>81</td><td>70</td><td>LOD</td><td>76</td><td>78</td><td>82</td><td>90</td><td>73</td></tr><tr><td>Mouse 6</td><td>76</td><td>57</td><td>78</td><td>74</td><td>65</td><td>73</td><td>71</td><td>63</td><td>64</td><td>67</td><td>76</td><td>58</td><td>64</td><td>77</td><td>94</td><td>76</td><td>63</td><td>78</td><td>LOD</td><td>85</td><td>86</td><td>72</td></tr><tr><td>Mouse 7</td><td>66</td><td>62</td><td>80</td><td>75</td><td>61</td><td>73</td><td>78</td><td>54</td><td>67</td><td>65</td><td>64</td><td>66</td><td> </td><td>75</td><td>75</td><td>74</td><td>60</td><td>85</td><td>78</td><td>82</td><td>86</td><td>71</td></tr><tr><td>Mouse 8</td><td>76</td><td>60</td><td>75</td><td>78</td><td>62</td><td>72</td><td>64</td><td>63</td><td>71</td><td>65</td><td>73</td><td>60</td><td> </td><td>78</td><td>93</td><td>70</td><td>62</td><td>81</td><td>79</td><td>84</td><td>LOD</td><td>72</td></tr><tr><td>Mouse 9</td><td>67</td><td>62</td><td>83</td><td>73</td><td>64</td><td>70</td><td>67</td><td>69</td><td>75</td><td>69</td><td>74</td><td>63</td><td>67</td><td>76</td><td>76</td><td>74</td><td>68</td><td>87</td><td>83</td><td>86</td><td>86</td><td>73</td></tr><tr><td>Mouse 10</td><td>82</td><td>62</td><td>80</td><td>47</td><td>68</td><td>69</td><td>57</td><td>57</td><td>78</td><td>73</td><td>65</td><td>58</td><td> </td><td>82</td><td>92</td><td>79</td><td>60</td><td>84</td><td>82</td><td>81</td><td>91</td><td>72</td></tr><tr><td>Mouse 11</td><td>70</td><td>60</td><td>87</td><td>69</td><td>65</td><td>71</td><td>73</td><td>65</td><td>70</td><td>68</td><td>72</td><td>54</td><td>64</td><td>80</td><td>76</td><td>73</td><td>63</td><td>87</td><td>87</td><td>84</td><td>90</td><td>73</td></tr><tr><td>Mouse 12</td><td>48</td><td>61</td><td>77</td><td>70</td><td>66</td><td>71</td><td>57</td><td>63</td><td>74</td><td>71</td><td>76</td><td>64</td><td>61</td><td>84</td><td>94</td><td>75</td><td>64</td><td>81</td><td>82</td><td>81</td><td>89</td><td>72</td></tr><tr><td>Mouse 13</td><td>79</td><td>64</td><td>81</td><td>73</td><td>64</td><td>69</td><td>66</td><td>67</td><td>69</td><td>68</td><td>75</td><td>62</td><td>64</td><td>80</td><td>81</td><td>72</td><td>66</td><td>LOD</td><td>77</td><td>84</td><td>86</td><td>72</td></tr><tr><td>Mouse 14</td><td>79</td><td>58</td><td>79</td><td>72</td><td>68</td><td>76</td><td>57</td><td>63</td><td>69</td><td>68</td><td>78</td><td>71</td><td> </td><td>79</td><td>82</td><td>77</td><td>69</td><td>84</td><td>84</td><td>84</td><td>90</td><td>74</td></tr><tr><td>Mouse 15</td><td>74</td><td>55</td><td>80</td><td>75</td><td>68</td><td>74</td><td>71</td><td>60</td><td>72</td><td>66</td><td>71</td><td>60</td><td> </td><td>81</td><td>80</td><td>71</td><td>64</td><td>83</td><td>84</td><td>85</td><td>89</td><td>73</td></tr><tr><td>Mouse 16</td><td>73</td><td>56</td><td>81</td><td>71</td><td>70</td><td>69</td><td>48</td><td>60</td><td>83</td><td>71</td><td>75</td><td>67</td><td>57</td><td>83</td><td>74</td><td>73</td><td>66</td><td>82</td><td>79</td><td>85</td><td>88</td><td>72</td></tr><tr><td>Mouse 17</td><td>76</td><td>59</td><td>71</td><td>78</td><td>62</td><td>78</td><td>72</td><td>66</td><td>66</td><td>67</td><td>68</td><td>65</td><td>65</td><td>78</td><td>LOD</td><td>77</td><td>65</td><td>82</td><td>79</td><td>83</td><td>91</td><td>72</td></tr><tr><td>mean</td><td>73</td><td>59</td><td>78</td><td>73</td><td>64</td><td>73</td><td>67</td><td>63</td><td>72</td><td>66</td><td>71</td><td>63</td><td>63</td><td>79</td><td>82</td><td>74</td><td>65</td><td>83</td><td>81</td><td>83</td><td>88</td><td>72</td></tr><tr><td>median</td><td>74</td><td>60</td><td>79</td><td>75</td><td>65</td><td>72</td><td>71</td><td>63</td><td>71</td><td>68</td><td>73</td><td>63</td><td>64</td><td>79</td><td>81</td><td>74</td><td>65</td><td>83</td><td>80</td><td>84</td><td>88</td><td>72</td></tr><tr><td>stdev</td><td>8</td><td>3</td><td>4</td><td>7</td><td>3</td><td>4</td><td>8</td><td>4</td><td>5</td><td>5</td><td>6</td><td>4</td><td>3</td><td>3</td><td>8</td><td>3</td><td>3</td><td>3</td><td>3</td><td>2</td><td>2</td><td>1</td></tr><tr><td>min</td><td>48</td><td>52</td><td>70</td><td>47</td><td>60</td><td>68</td><td>48</td><td>54</td><td>64</td><td>55</td><td>54</td><td>54</td><td>57</td><td>73</td><td>71</td><td>70</td><td>60</td><td>76</td><td>77</td><td>78</td><td>86</td><td>71</td></tr><tr><td>max</td><td>82</td><td>64</td><td>87</td><td>78</td><td>70</td><td>80</td><td>78</td><td>69</td><td>83</td><td>73</td><td>78</td><td>71</td><td>67</td><td>84</td><td>94</td><td>79</td><td>69</td><td>89</td><td>87</td><td>86</td><td>91</td><td>74</td></tr><tr><td>range</td><td>34</td><td>12</td><td>17</td><td>31</td><td>10</td><td>12</td><td>30</td><td>15</td><td>19</td><td>18</td><td>25</td><td>18</td><td>11</td><td>11</td><td>24</td><td>9</td><td>10</td><td>13</td><td>10</td><td>8</td><td>5</td><td>3</td></tr></table>
0cad36fe1c1bba851eaafc777e95686b15bbcf6ba00ac641ae2726478c3e1d14.png
simple
<table><tr><td>Algorithm</td><td>Average Error (&#176;)</td><td>Average Time (s)</td></tr><tr><td>Radon transform</td><td>0.17</td><td>8.61</td></tr><tr><td>MBR correction</td><td>0.16</td><td>1.13</td></tr></table>
66ebdb56b4f8e896dce2b1eaef16163fca67ac65d598d4918d9e1760cf8f84a6.png
simple
<table><tr><td></td><td>Normal range</td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td></tr><tr><td>Haemoglobin (g/L)</td><td>110&#8211;165</td><td>206</td><td>201</td><td></td></tr><tr><td>Total white cells (&#215;10<sup>9</sup> cells/L)</td><td>3 &#183; 5&#8211;10 &#183; 0</td><td>8 &#183; 9</td><td>58</td><td></td></tr><tr><td>Neutrophils (&#215;10<sup>9</sup> cells/L)</td><td>1 &#183; 2&#8211;6 &#183; 8</td><td>5 &#183; 79</td><td>41 &#183; 8</td><td></td></tr><tr><td>Lymphocytes (&#215;10<sup>9</sup> cells/L)</td><td>1 &#183; 2&#8211;3 &#183; 2</td><td>2 &#183; 76</td><td>10 &#183; 9</td><td></td></tr><tr><td>Platelets (&#215;10<sup>9</sup> cells/L)</td><td>150&#8211;390</td><td>18</td><td>162</td><td></td></tr><tr><td>Prothrombin time (s)</td><td>12&#8211;14</td><td>24 &#183; 8</td><td>15 &#183; 9</td><td></td></tr><tr><td>Activated partial thromboplastin time (s)</td><td>25&#8211;37</td><td>53 &#183; 1</td><td>67 &#183; 3</td><td></td></tr><tr><td>INR</td><td>0 &#183; 8&#8211;1 &#183; 5</td><td>2 &#183; 52</td><td>1 &#183; 43</td><td></td></tr><tr><td>D-dimer (mg/L)</td><td>&lt;0 &#183; 3</td><td>0 &#183; 2</td><td>0 &#183; 2</td><td></td></tr><tr><td>Urea (mmol/L)</td><td>2 &#183; 5&#8211;7 &#183; 5</td><td>7 &#183; 9</td><td>14 &#183; 8</td><td></td></tr><tr><td>Creatinine (&#956;mol/L)</td><td>44&#8211;135</td><td>161</td><td>253</td><td></td></tr><tr><td>Bilirubin (&#956;mol/L)</td><td>3 &#183; 42&#8211;20.5</td><td>17 &#183; 4</td><td>61 &#183; 8</td><td></td></tr><tr><td>Total protein (g/L)</td><td>60&#8211;80</td><td>30</td><td>60</td><td></td></tr><tr><td>Albumin (g/L)</td><td>35&#8211;50</td><td>23</td><td>35</td><td></td></tr><tr><td>Globulin (g/L)</td><td>25&#8211;35</td><td>7</td><td>25</td><td></td></tr><tr><td>Alanine aminotransferase (U/L)</td><td>0&#8211;40</td><td>35 &#183; 4</td><td>68</td><td></td></tr><tr><td>Aspartate aminotransferase (U/L)</td><td>0&#8211;37</td><td>67</td><td>479 &#183; 8</td><td></td></tr><tr><td>Lactate dehydrogenase (U/L)</td><td>109&#8211;245</td><td>127</td><td>585</td><td></td></tr><tr><td>Creatinine kinase (U/L)</td><td>24&#8211;195</td><td>146</td><td>9868</td><td></td></tr><tr><td>C-reactive protein (mg/L)</td><td>0&#8211;10</td><td>73</td><td>150</td><td></td></tr><tr><td>Glucose (mmol/L)</td><td>3 &#183; 9&#8211;6 &#183; 1</td><td>19</td><td>5 &#183; 1</td><td></td></tr><tr><td>Ka (mmol/L)</td><td>3 &#183; 5&#8211;5 &#183; 1</td><td>2 &#183; 6</td><td>3 &#183; 03</td><td></td></tr><tr><td>Na (mmol/L)</td><td>135&#8211;147</td><td>60</td><td>114</td><td></td></tr><tr><td>Cl (mmol/L)</td><td>95&#8211;106</td><td>40</td><td>80</td><td></td></tr><tr><td>Ca (mmol/L)</td><td>2 &#183; 25&#8211;2 &#183; 75</td><td>1 &#183; 62</td><td>2 &#183; 09</td><td></td></tr><tr><td>Urinalysis</td><td></td><td></td><td></td><td></td></tr><tr><td> PH value</td><td>5 &#183; 0&#8211;7 &#183; 0</td><td>5 &#183; 5</td><td>5 &#183; 0</td><td></td></tr><tr><td> Protein (mg/dl)</td><td></td><td>100</td><td>100</td><td></td></tr><tr><td> Ketone (mg/dl)</td><td></td><td>15</td><td>Neg</td><td></td></tr><tr><td> Bilirubin (mg/dl)</td><td></td><td>0 &#183; 5</td><td>0 &#183; 5</td><td></td></tr><tr><td> Urobilinogen (mg/dl)</td><td></td><td>8</td><td>4</td><td></td></tr><tr><td> Blood (mg/dl)</td><td></td><td>Neg</td><td>1</td><td></td></tr><tr><td> Leu (leu/ul)</td><td></td><td>75</td><td>Neg</td><td></td></tr><tr><td>Bacterial Diagnostic test</td><td></td><td></td><td></td><td></td></tr><tr><td> Microscopy</td><td>-</td><td>+</td><td>+</td><td>+</td></tr><tr><td> RT-PCR</td><td>-</td><td>+</td><td>+</td><td>+</td></tr><tr><td> IHA</td><td>-</td><td>1:40 (serum)</td><td>1:2560 (serum) 1:160 (tissue fluid)</td><td>1:800 (serum)</td></tr><tr><td> rIHA</td><td>-</td><td>1:6400 (nasopharyngeal swab) 1:12800 (sputum)</td><td>1:1024 (serum)</td><td>1:5120 (serum)</td></tr></table>
86c4f3d64716b749c9f1740386504895476c307949448d624aaba8db71b59662.png
simple
<table><tr><td></td><td>2009</td><td>2010</td><td>2011</td><td>2012</td><td>2013</td></tr><tr><td>Percent (+) of all tests run</td><td>12.22%</td><td>15.45%</td><td>12.30%</td><td>13.70%</td><td>13.70%</td></tr><tr><td>NEW (+) as % of all tests run</td><td>5.90%</td><td>7.86%</td><td>5.60%</td><td>7.01%</td><td>6.10%</td></tr><tr><td>Profile of a NEW (+) out of ALL new (+)&#8217;s</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Incomplete-vaccination</td><td>86.59% (71/82)</td><td>89.52% (94/105)</td><td>85.92% (61/71)</td><td>86.08% (68/79)</td><td>95.45% (63/66)</td></tr><tr><td>Full-vaccination</td><td>13.41% (11/82)</td><td>10.48% (11/105)</td><td>14.08% (10/71)</td><td>13.92% (11/79)</td><td>4.55% (3/66)</td></tr><tr><td>Infection rate (IR) based on vaccine status*:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>ALL incomplete-vaccination</td><td>16.86% (71/421)</td><td>32.08% (94/293)</td><td>18.32% (61/333)</td><td>23.13% (68/294)</td><td>20.32% (63/310)</td></tr><tr><td>Complete-vaccination</td><td>1.13% (11/970)</td><td>1.04% (11/1053)</td><td>1.07% (10/933)</td><td>1.32% (11/833)</td><td>0.39% (3/762)</td></tr><tr><td>Negative infection rate based on vaccine status</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>ALL incomplete-vaccination</td><td>83.14% (350/421)</td><td>67.92% (199/293)</td><td>81.68% (272/333)</td><td>76.87% (226/294)</td><td>79.68% (247/310)</td></tr><tr><td>Complete-vaccination</td><td>98.87% (959/970)</td><td>98.96% (1042/1053)</td><td>98.93% (923/933)</td><td>98.68% (822/833)</td><td>99.61% (759/762)</td></tr><tr><td>Chi-square test statistic</td><td>130.95</td><td>307.01</td><td>137.89</td><td>158.56</td><td>151.47</td></tr><tr><td>P-value</td><td>&lt;0.0001</td><td>&lt;0.0001</td><td>&lt;0.0001</td><td>&lt;0.0001</td><td>&lt;0.0001</td></tr><tr><td>Preventative fraction (PF) against infection**</td><td>93.29%</td><td>96.76%</td><td>94.16%</td><td>94.29%</td><td>98.08%</td></tr><tr><td>Risk ratio (RR)***</td><td>14.92</td><td>30.85</td><td>17.12</td><td>17.52</td><td>52.10</td></tr></table>
1f31943bfc014919c02c50f0842b9f197b3f989f9a897b3582b101b8ae1ddec5.png
simple
<table><tr><td>Compound number</td><td>Alkyl substitute</td><td>MIC <i>M. tuberculosis</i> (ng/ml)</td><td>log<i>P</i>*</td></tr><tr><td>10926013</td><td>Methyl</td><td>250</td><td>1.31</td></tr><tr><td>10926021</td><td>Ethyl</td><td>62</td><td>1.64</td></tr><tr><td>10926027</td><td>Propyl</td><td>3.7</td><td>2.11</td></tr><tr><td>10926172</td><td>Butyl</td><td>1.9</td><td>2.51</td></tr><tr><td>11026100</td><td>Isobutyl</td><td>1.9</td><td>2.51</td></tr><tr><td>11026142</td><td>1-Ethylpropyl</td><td>0.37</td><td>2.99</td></tr><tr><td>11026128</td><td>1-<i>sec</i>-Butyl</td><td>0.37</td><td>2.52</td></tr><tr><td>11026129, PBTZ129</td><td>2-Cyclohexylethyl</td><td>0.19</td><td>3.52</td></tr><tr><td>11026131</td><td>1-Methylbutyl</td><td>0.19</td><td>3.11</td></tr><tr><td>11026134, PBTZ134</td><td>Heptyl</td><td>0.19</td><td>3.30</td></tr><tr><td>11026137, PBTZ137</td><td>4-Phenoxybutyl</td><td>1.5</td><td>3.35</td></tr><tr><td>11026139, PBTZ139</td><td>4-Phenylbutyl</td><td>0.37</td><td>4.05</td></tr><tr><td>10926168</td><td>Cyclohexyl</td><td>0.75</td><td>3.09</td></tr><tr><td>10926169, PBTZ169</td><td>Cyclohexylmethyl</td><td>&#8804;0.19</td><td>3.20</td></tr></table>
76ff143d8c9a1d1d7a0e92932657c17d58bf815f95ede0ada7a4ab0de8e7fac9.png
simple
<table><tr><td>Score</td><td>Reactions</td></tr><tr><td>&#8722;</td><td>Negative reaction</td></tr><tr><td>+?</td><td>Doubtful reaction; faint erythema only</td></tr><tr><td>+</td><td>Weak (non-vesicular) positive reaction; erythema, infiltration and possibly papules</td></tr><tr><td>++</td><td>Strong (vesicular) positive reaction; erythema, infiltration, papules, vesicles</td></tr><tr><td>+++</td><td>Extreme positive reaction; bullous reaction</td></tr><tr><td>IR</td><td>Irritant reaction</td></tr></table>
ea14cfca3869669b28da700fb991f1f897b4aab75ef86092c95ba20f53a91f73.png
simple
<table><tr><td>Eligible</td><td>Ineligible</td></tr><tr><td>Sexually active</td><td>Unable or unwilling to provide a reliable method of contact for the field team</td></tr><tr><td>16 years old or above</td><td>Likely to move permanently out of the study area within the next year</td></tr><tr><td>HIV negative at screening</td><td>Likely to have sex more than 14 times a week on a regular basis during the course of following up</td></tr><tr><td>Willing to undergo regular HIV testing and receive the result before randomization</td><td>Using spermicides regularly</td></tr><tr><td>Willing to undergo regular speculum examinations and genital infection screens</td><td>Pregnant or within six weeks postpartum at enrolment</td></tr><tr><td>Willing to have regular urine pregnancy tests</td><td>Had a severe clinical or laboratory abnormality</td></tr><tr><td>Willing to use study gel as instructed</td><td>Requiring referral for assessment of a clinically suspicious cervical lesion</td></tr><tr><td>Willing to receive health education about condoms</td><td>Had treatment to the cervix, or to the womb through the cervix, within 30 days of enrolment</td></tr><tr><td>Willing and able to give informed consent</td><td>Had known latex allergy</td></tr><tr><td> </td><td>Participating, or having participated within 30 days of enrolment, in a clinical trial of an unlicensed product, microbicide, barrier method or any other intervention likely to impact on the outcome of this trial</td></tr><tr><td> </td><td>Considered unlikely to be able to comply with the protocol</td></tr></table>
c7d177ce5f7c61ce2d86fc8d46e56ef8ae931a6ad1b161f6e6247b3fac935dd8.png
simple
<table><tr><td>Malaria is caused by:</td><td>Total (N = 34)</td></tr><tr><td>Self<sup>1</sup></td><td></td></tr><tr><td>Mentioned mosquitoes as cause</td><td>33 (97.1%)</td></tr><tr><td>Mentioned environmental cause<sup>2</sup></td><td>9 (26.5%)</td></tr><tr><td>Mentioned bad food/water consumption as cause</td><td>8 (23.5%)</td></tr><tr><td>Mentioned cold temperatures/rain as cause</td><td>13 (38.2%)</td></tr><tr><td>Mentioned mosquitoes solely as cause</td><td>15 (44.1%)</td></tr><tr><td>Mentioned mosquitoes plus additional cause</td><td>18 (52.9%)</td></tr><tr><td>Mentioned both an accurate and an inaccurate cause</td><td>16 (47.1%)</td></tr><tr><td>Others</td><td></td></tr><tr><td>Mentioned mosquitoes as cause</td><td>20 (58.8%)</td></tr><tr><td>Mentioned environmental cause</td><td>5 (14.7%)</td></tr><tr><td>Mentioned bad food/water consumption as cause</td><td>6 (17.6%)</td></tr><tr><td>Mentioned cold temperatures/rain as cause</td><td>6 (17.6%)</td></tr><tr><td>Mentioned mosquitoes solely as cause</td><td>14 (41.2%)</td></tr><tr><td>Mentioned mosquitoes plus additional cause</td><td>6 (17.6%)</td></tr><tr><td>Did not mention moquitoes; mentioned other cause</td><td>9 (26.5%)</td></tr><tr><td>Did not know cause</td><td>5 (14.7%)</td></tr></table>
a7515f6bd3ddb05697c8aca691736b61a080693dcdcec2dbc5ae1b52611c01b1.png
simple
<table><tr><td>Antibody</td><td>Type</td><td>Dilution</td><td>Source</td></tr><tr><td>Cytokeratin 7</td><td>Rabbit-Monoclonal</td><td>1:100</td><td>Biocare Medical, Concord, CA</td></tr><tr><td>Cytokeratin 20</td><td>Mouse Monoclonal</td><td>1:200</td><td>Biocare Medical, Concord, CA</td></tr><tr><td>CDX-2</td><td>Mouse Monoclonal</td><td>1:100</td><td>Biocare Medical, Concord, CA</td></tr><tr><td>Villin</td><td>Mouse Monoclonal</td><td>1:100</td><td>Biocare Medical, Concord, CA</td></tr><tr><td>&#946;-catenin</td><td>Mouse Monoclonal</td><td>1:200</td><td>DAKO, Carpinteria, CA</td></tr><tr><td>E-cadherin</td><td>Mouse Monoclonal</td><td>1:2000</td><td>BD Transduction Labs, San Jose, CA</td></tr></table>
fb7e9bcdda5102d5b58b8378416598d62cdb00a948080d9e4a27e79909b08a18.png
simple
<table><tr><td>Name</td><td>5<sup>&#8242;</sup> -3<sup>&#8242;</sup></td><td>Length</td></tr><tr><td>PrimerF1</td><td>AGTATCGTTGAGAAGAATCG</td><td>20</td></tr><tr><td>PrimerF2</td><td>TATGCTTTCCTGGCGGCGGTAC</td><td>22</td></tr><tr><td>PrimerF3</td><td>GAAGGGGAGACAAGCAGATCAA</td><td>22</td></tr><tr><td>PrimerF4</td><td>CTGCAAGAGAGGAAAAAGACCA</td><td>22</td></tr><tr><td>PrimerF5</td><td>GGAGGGGCAGAGTAGGCAGAAA</td><td>22</td></tr><tr><td>PrimerF6</td><td>CCGTTGGCTCGTGGAGAAAGGA</td><td>22</td></tr><tr><td>PrimerF7</td><td>TCAGCGGAGATGACTGTGTCGT</td><td>22</td></tr><tr><td>PrimerR1</td><td>CCTTCATTTCCTCCTCTTTTGT</td><td>22</td></tr><tr><td>PrimerR2</td><td>TGAACGGCTTTTCCTATGGAGT</td><td>22</td></tr><tr><td>PrimerR3</td><td>CAAACATCAATCCAACTGCCGA</td><td>22</td></tr><tr><td>PrimerR4</td><td>AGTCCATTGGGCATGTGTATGT</td><td>22</td></tr><tr><td>PrimerR5</td><td>TCTGCATGAGCATCGGTTCTTC</td><td>22</td></tr><tr><td>PrimerR6</td><td>AAATGGTTAGAGCAGAAGGGAA</td><td>22</td></tr><tr><td>PrimerR7</td><td>TCTTCCTCACCACCAGCTACAT</td><td>22</td></tr></table>
168a527c7630e5a3e0dcf29d6e83c9c1e624569ef5d40c3f66201ae1b7a24c6e.png
complex
<table><tr><td> </td><td colspan="2">Controls</td><td colspan="2">Cases</td><td> </td><td> </td><td colspan="2"> </td></tr><tr><td>Medications</td><td>%</td><td>(n)</td><td>%</td><td>(n)</td><td>Crude OR (95% CI)</td><td>ORs (95% CI) adjusted for age and sex</td><td>ORs (95% CI) adjusted for age, sex and other risk factors*</td><td>ORs (95%CI) adjusted for age, sex, other risk factors* and the use of FRIDs</td></tr><tr><td>All medications</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> <i>0 medication</i></td><td>40.7</td><td>(8318)</td><td>28.3</td><td>(130)</td><td>1.00</td><td>(REF)</td><td>1.00 (Ref)</td><td>1.00 (Ref)</td></tr><tr><td> <i>1 medication</i></td><td>12.0</td><td>(2443)</td><td>7.4</td><td>(34)</td><td>0.91 (0.60-1.38)</td><td>0.95 (0.63-1.45)</td><td>1.26 (0.75-2.11)</td><td>1.40 (0.82-2.40)</td></tr><tr><td> <i>2 medications</i></td><td>11.2</td><td>(2283)</td><td>11.7</td><td>(54)</td><td>1.63 (1.14-2.32)</td><td>1.44 (1.01-2.05)</td><td>1.74 (1.10-2.77)</td><td>2.06 (1.16-3.64)</td></tr><tr><td> <i>3 medications</i></td><td>9.8</td><td>(1998)</td><td>9.6</td><td>(44)</td><td>1.58 (1.09-2.31)</td><td>1.34 (0.91-1.95)</td><td>1.50 (0.94-2.41)</td><td>1.83 (0.94-3.57)</td></tr><tr><td> <i>4 medications</i></td><td>8.0</td><td>(1636)</td><td>9.8</td><td>(45)</td><td>1.82 (1.24-2.68)</td><td>1.45 (0.98-2.16)</td><td>1.74 (1.07-2.81)</td><td>2.14 (1.13-4.05)</td></tr><tr><td> <i>&#8805;5 medications</i></td><td>18.4</td><td>(3768)</td><td>33.3</td><td>(153)</td><td>2.58 (1.98-3.36)</td><td>1.79 (1.36-2.35)</td><td>1.53 (1.06-2.21)</td><td>1.92 (1.08-3.41)</td></tr></table>
ccfd7146a7a2acb884f11ecd49a6611ccda06767c1fce056e59ffd41597e53ec.png
simple
<table><tr><td>Variable</td><td>Mean (SD)</td><td>N</td><td>%</td></tr><tr><td>Age</td><td>37.2 (6.1)</td><td></td><td></td></tr><tr><td>Marital status</td><td></td><td></td><td></td></tr><tr><td> Married</td><td></td><td>231</td><td>96.3</td></tr><tr><td> Widowed/Divorced</td><td></td><td>9</td><td>3.8</td></tr><tr><td>Education</td><td></td><td></td><td></td></tr><tr><td> Primary</td><td></td><td>70</td><td>29.2</td></tr><tr><td> Secondary</td><td></td><td>52</td><td>21.6</td></tr><tr><td> High school</td><td></td><td>78</td><td>32.5</td></tr><tr><td> University</td><td></td><td>40</td><td>16.7</td></tr><tr><td>History of breast problems</td><td></td><td></td><td></td></tr><tr><td> Yes</td><td></td><td>29</td><td>12.1</td></tr><tr><td> No</td><td></td><td>211</td><td>87.9</td></tr><tr><td>Performing BSE</td><td></td><td></td><td></td></tr><tr><td> Yes (regular* &amp; irregular**)</td><td></td><td>76</td><td>31.7</td></tr><tr><td> No (never done)</td><td></td><td>164</td><td>68.3</td></tr></table>
61188b5d79a751602e6ff7d41f76be4ded667310a3861c8ae0180ae8d59e219e.png
complex
<table><tr><td rowspan="2">Characteristics</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td></td><td>HR (95% CI)</td><td><i>P</i>-value*</td><td>HR (95% CI)</td><td><i>P</i>-value*</td></tr><tr><td colspan="5">HBP1 IHC</td></tr><tr><td> Absent/decreased</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td> Preserved</td><td>0.48 (0.24&#8211;0.96)</td><td>0.039</td><td>0.38 (0.15&#8211;0.96)</td><td>0.042</td></tr><tr><td colspan="5">&#946;-catenin nuclear accumulation</td></tr><tr><td> Yes</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td> No</td><td>0.49 (0.24&#8211;0.99)</td><td>0.047</td><td>0.38 (0.15&#8211;0.96)</td><td>0.041</td></tr><tr><td colspan="5">Smoking habit</td></tr><tr><td> Non-smoker</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td> Smoker</td><td>0.66 (0.28&#8211;1.57)</td><td>0.348</td><td>0.58 (0.20&#8211;1.72)</td><td>0.326</td></tr><tr><td colspan="5">Tumour type</td></tr><tr><td> ADC</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td> SCC</td><td>1.01 (0.73&#8211;2.17)</td><td>0.973</td><td>1.17 (0.38&#8211;3.67)</td><td>0.784</td></tr><tr><td colspan="5">Tumour stage</td></tr><tr><td> Early (I/II)</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td> Late (III/IV)</td><td>1.58 (0.77&#8211;3.26)</td><td>0.213</td><td>0.68 (0.21&#8211;2.26)</td><td>0.532</td></tr><tr><td colspan="5">Lymph node status</td></tr><tr><td> N0</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td> &#8805;N1</td><td>2.01 (0.99&#8211;4.10)</td><td>0.055</td><td>3.34 (1.02&#8211;10.92)</td><td>0.046</td></tr></table>
29ed74125247f31e7b52b1d0c46784513a9dfb9ec69941577769d200f44d7388.png
simple
<table><tr><td></td><td>AF Group</td><td>Control group</td><td>P value</td></tr><tr><td>Age (year)</td><td>3/0&#177;69</td><td>8/0&#177;72</td><td>0.27</td></tr><tr><td>Male</td><td>13</td><td>13</td><td></td></tr><tr><td>Female</td><td>12</td><td>12</td><td></td></tr><tr><td>Low Education (%)</td><td>5/0&#177;25</td><td>3/0&#177;33</td><td>0.08</td></tr><tr><td>Smoke (%)</td><td>1/0&#177;14</td><td>2/0&#177;17</td><td>0.12</td></tr><tr><td>BMI</td><td>4/0&#177;26</td><td>2/0&#177;27</td><td>0.17</td></tr></table>
bede2c2e88880238445411818b1236bf32ca2638b2898c08bde2eae427aaeaa3.png
complex
<table><tr><td rowspan="3">Mutated gene</td><td rowspan="3">Expressing neurons+</td><td colspan="4">Number of turns/min for the 5th minute</td><td rowspan="3"><i>p</i> value</td></tr><tr><td colspan="2">Wild-type control</td><td colspan="2">Mutant</td></tr><tr><td>150 mOsm</td><td>400 mOsm</td><td>150 mOsm</td><td>400 mOsm</td></tr><tr><td><i>gpa-8</i></td><td>AQR, PQR, URX</td><td>9.58 &#177; 1.02 (24)</td><td>24.61 &#177; 1.51 (23)</td><td>7.33 &#177; 0.85 (21)</td><td>20.67 &#177; 1.89 (21)</td><td>0.538</td></tr><tr><td><i>gpa-13</i></td><td>PQR</td><td>7.19 &#177; 1.13 (16)</td><td>16.13 &#177; 2.91 (15)</td><td>9.63 &#177; 2.23 (16)</td><td>21.69 &#177; 1.98 (16)</td><td>0.467</td></tr><tr><td><i>gcy-1</i></td><td>URX</td><td>8.19 &#177; 1.50 (16)</td><td>29.00 &#177; 1.91 (16)</td><td>5.88 &#177; 1.01 (16)</td><td>25.31 &#177; 2.22 (16)</td><td>0.691</td></tr><tr><td><i>gcy-25</i></td><td>AQR, PQR, URX</td><td>11.07 &#177; 1.52 (15)</td><td>26.73 &#177; 2.10 (15)</td><td>8.50 &#177; 1.10 (16)</td><td>23.13 &#177; 1.26 (16)</td><td>0.734</td></tr><tr><td><i>gcy-28</i></td><td>Widely expressed</td><td>9.31 &#177; 1.76 (16)</td><td>24.63 &#177; 2.40 (16)</td><td>9.00 &#177; 1.14 (16)</td><td>32.06 &#177; 2.18 (16)</td><td>0.049#</td></tr><tr><td><i>gcy-32</i></td><td>AQR, PQR, URX</td><td>11.06 &#177; 1.80 (16)</td><td>27.60 &#177; 1.77 (15)</td><td>7.71 &#177; 0.71 (14)</td><td>25.81 &#177; 1.61 (16)</td><td>0.622</td></tr><tr><td><i>gcy-33</i></td><td>AQR, PQR, URX</td><td>10.94 &#177; 2.24 (16)</td><td>22.88 &#177; 2.67 (16)</td><td>8.88 &#177; 1.13 (16)</td><td>18.87 &#177; 2.34 (15)</td><td>0.655</td></tr><tr><td><i>gcy-34</i></td><td>AQR, PQR, URX</td><td>7.33 &#177; 0.84 (15)</td><td>22.94 &#177; 2.14 (16)</td><td>7.73 &#177; 1.01 (15)</td><td>20.19 &#177; 2.37 (16)</td><td>0.377</td></tr><tr><td><i>gcy-35</i></td><td>AQR, PQR, URX</td><td>9.83 &#177; 1.39 (23)</td><td>30.08 &#177; 1.25 (24)</td><td>9.68 &#177; 1.26 (22)</td><td>28.46 &#177; 1.40 (24)</td><td>0.578</td></tr><tr><td><i>gcy-36</i></td><td>AQR, PQR, URX</td><td>9.83 &#177; 1.39 (23)</td><td>30.08 &#177; 1.25 (24)</td><td>8.42 &#177; 1.18 (24)</td><td>27.39 &#177; 1.99 (23)</td><td>0.665</td></tr><tr><td><i>gcy-37</i></td><td>AQR, PQR, URX</td><td>9.94 &#177; 1.25 (16)</td><td>26.69 &#177; 2.15 (16)</td><td>6.93 &#177; 0.73 (15)</td><td>21.87 &#177; 2.14 (15)</td><td>0.592</td></tr></table>
744bed717437b61b8c29b60f02862becf987137ea7968ffe2231c8f680f5f9eb.png
simple
<table><tr><td>Line</td><td>Independent lines</td><td>Individual plants per line</td><td>Repetitions per line</td><td>Total <i>n</i> of cells</td><td>Total <i>n</i> of Golgi bodies</td></tr><tr><td>STtmd-mRFP/GFP-HDEL</td><td>1</td><td>5</td><td>3</td><td>41</td><td>332</td></tr><tr><td>mRFP-AtCASP/GFP-HDEL</td><td>2</td><td>7 and 4</td><td>3 and 2</td><td>4632</td><td>388240</td></tr><tr><td>mRFP-AtCASP-&#8710;CC/GFP-HDEL</td><td>2</td><td>6 and 4</td><td>3 and 2</td><td>4323</td><td>456174</td></tr></table>
24627ae348963735b5aaa376fb6f525263256898e0460b3781063b662423b287.png
complex
<table><tr><td rowspan="2">Pediatric-onset CD patients</td><td>Low BMD</td><td>Normal BMD</td><td rowspan="2">p-value</td></tr><tr><td>Z-score&lt;&#8722;1</td><td>Z-score &#8805;&#8722;1</td></tr><tr><td>n=77</td><td>n=46</td><td>n=31</td><td> </td></tr><tr><td>%</td><td>60%</td><td>40%</td><td> </td></tr><tr><td><i>NOD2 </i>variant n (%)</td><td>24 (52%)</td><td>10 (32%)</td><td>p=0.10</td></tr><tr><td>One variant allele</td><td>17</td><td>5</td><td>p=0.061</td></tr><tr><td>Two variant alleles</td><td>7</td><td>5</td><td>p=0.75</td></tr><tr><td>Homozygous variant alleles</td><td>7</td><td>0</td><td>p=0.037*</td></tr><tr><td>Gender: female/male in %</td><td>45/55</td><td>48/52</td><td>p=0.89</td></tr><tr><td>Age: y</td><td> </td><td> </td><td> </td></tr><tr><td>mean/SD</td><td>25/12.8</td><td>24/13.9</td><td>p=0.62</td></tr><tr><td>median/interquartile range</td><td>21/17-30</td><td>19/15-29</td><td>p=0.29</td></tr><tr><td>average disease duration/SD</td><td>12.2/11.6</td><td>11.6/10.8</td><td>p=0.84</td></tr><tr><td>Age at diagnosis: y</td><td> </td><td> </td><td> </td></tr><tr><td>mean/SD</td><td>13/3.6</td><td>12/5.1</td><td>p=0.33</td></tr><tr><td>median/interquartile range</td><td>14/11-16</td><td>13/10-17</td><td>p=0.69</td></tr><tr><td>Localization: n (%)</td><td> </td><td> </td><td> </td></tr><tr><td>L1 ileal</td><td>8 (17%)</td><td>9 (29%)</td><td>p=0.27</td></tr><tr><td>L2 colonic</td><td>8 (17%)</td><td>6 (19%)</td><td>p=1.0</td></tr><tr><td>L3 ileocolonic</td><td>30 (65%)</td><td>16 (52%)</td><td>p=0.25</td></tr><tr><td>L4 isolated upper disease</td><td>0 (0%)</td><td>0 (0%)</td><td>p=1.0</td></tr><tr><td>Upper GI involvement</td><td>15 (33%)</td><td>13 (42%)</td><td>p=0.47</td></tr><tr><td>Behaviour: n (%)</td><td> </td><td> </td><td> </td></tr><tr><td>B1 non-stricturing/penetrating</td><td>27 (59%)</td><td>20 (65%)</td><td>p=0.64</td></tr><tr><td>B2 stricturing</td><td>11 (23%)</td><td>6 (19%)</td><td>p=0.78</td></tr><tr><td>B3 penetrating intern</td><td>6 (13%)</td><td>3 (10%)</td><td>p=0.73</td></tr><tr><td>B3p penetrating perianal</td><td>9 (19%)</td><td>3 (10%)</td><td>p=0.34</td></tr><tr><td>Underweight at diagnosis</td><td>14/27 (52%)</td><td>5/22 (32%)</td><td>p=0.0453*</td></tr><tr><td>Underweight in 1y follow-up</td><td>14 (30%)</td><td>2 (6%)</td><td>p=0.0113*</td></tr><tr><td>Short stature</td><td>5 (11%)</td><td>1 (3%)</td><td>p=0.39</td></tr><tr><td>Treatment: n (%)</td><td> </td><td> </td><td> </td></tr><tr><td>Steroid dependent/refractory</td><td>23 (50%)</td><td>9 (29%)</td><td>p=0.10</td></tr><tr><td>Azathioprine / MTX</td><td>35 (76%)</td><td>15 (48%)</td><td>p=0.016*</td></tr><tr><td>Anti-TNF&#945;-antibody</td><td>20 (44%)</td><td>7 (26%)</td><td>p=0.09</td></tr></table>
a6360c041cb0c5cfa36d73e0c3f368d5819388d2fd4bb3027b50ba4d9705a7eb.png
simple
<table><tr><td>Lipids (abnormal range)</td><td>Females</td><td>Males</td><td>P value *</td></tr><tr><td>Cholesterol (&gt; 5.0 mmol/L)</td><td>211/313 (67.4%)</td><td>66/ 123 (53.7%)</td><td>&#8804; 0.01</td></tr><tr><td>Triglycerides (&gt; 1.92 mmol/L)</td><td>108/313 (34.5%)</td><td>50/ 123 (40.7%)</td><td>ns</td></tr><tr><td>HDL cholesterol (&lt; 1.00 mmol/L)</td><td>9/199 (4.5%)</td><td>13/72 (18.1%)</td><td>&#8804; 0.001</td></tr><tr><td>LDL cholesterol (&gt; 3.00 mmol/L)</td><td>121/194 (62.4%)</td><td>37/66 (56.1%)</td><td>ns</td></tr></table>
d17abdaab62b9bafbd6a64ec568fd5326ee1ebd5db8839bf71ddc88daf2fa84d.png
simple
<table><tr><td>Sensor Error</td><td>Parameter Value</td></tr><tr><td>Constant bias of gyroscope</td><td>0.002 (&#176;/h)</td></tr><tr><td>Constant bias of accelerometer</td><td>1.96 &#215; 10<sup>-4</sup> (m/s<sup>2</sup>)</td></tr><tr><td>Scale factor error of gyroscope</td><td>5 &#215; 10<sup>-6</sup> (&#176;/h)<sup>-1</sup></td></tr><tr><td>Installation error of gyroscope</td><td>2 &#215; 10<sup>-10</sup> (&#176;/h)</td></tr></table>
127459f66a0903da193a397f214e689ba9a6363606ed624dc58ea7cefa623475.png
complex
<table><tr><td></td><td>No.</td><td>Mean &#177; SD</td><td>Median (range)</td><td><i>p</i>-Value</td></tr><tr><td colspan="5">Sex</td></tr><tr><td> Male</td><td>49</td><td>9.21 &#177; 7.09</td><td>7.77 (27.88)</td><td></td></tr><tr><td> Female</td><td>34</td><td>7.72 &#177; 5.21</td><td>6.40 (19.19)</td><td>0.2966</td></tr><tr><td colspan="5">Residence</td></tr><tr><td> Rural</td><td>30</td><td>8.52 &#177; 6.31</td><td>7.31 (20.11)</td><td>0.9281</td></tr><tr><td> Urban</td><td>53</td><td>8.65 &#177; 6.51</td><td>6.86 (27.42)</td><td></td></tr><tr><td colspan="5">Smoking</td></tr><tr><td> Yes</td><td>32</td><td>8.75 &#177; 6.86</td><td>7.08 (27.42)</td><td></td></tr><tr><td> No</td><td>51</td><td>8.5 &#177; 6.16</td><td>6.86 (26.96)</td><td>0.8634</td></tr><tr><td colspan="5">Occupation</td></tr><tr><td> Farmer</td><td>10</td><td>13.34 &#177; 8.29</td><td>11.88 (1.83&#8211;28.79)</td><td>0.0827</td></tr><tr><td> Housewife</td><td>29</td><td>7.56 &#177; 6.05</td><td>5.94 (0.91&#8211;27.88)</td><td></td></tr><tr><td> Industrial</td><td>19</td><td>8.68 &#177; 5.46</td><td>7.77 (0.91&#8211;16.45)</td><td></td></tr><tr><td> Professional</td><td>25</td><td>7.84 &#177; 6.14</td><td>5.03 (1.37&#8211;25.14)</td><td></td></tr></table>
e93712c10a1c0d48ca14f2147f82f7b2d0198e7318cd91dde1ab68201d6b2028.png
complex
<table><tr><td rowspan="3"></td><td colspan="4">Fulfilment of ASAS axSpA criteria</td></tr><tr><td colspan="2">SPACE</td><td colspan="2">DESIR</td></tr><tr><td>OR (95% CI)</td><td><i>P</i>- value</td><td>OR (95% CI)</td><td><i>P</i>- value</td></tr><tr><td>Any PFH</td><td>2.1 (1.4-3.1)</td><td>&lt;0.001</td><td>1.3 (1.0-1.9)</td><td>0.091</td></tr><tr><td>AS</td><td>3.3 (2.0-5.3)</td><td>&lt;0.001</td><td>2.1 (1.3-3.3)</td><td>&lt;0.001</td></tr><tr><td>AAU</td><td>7.4 (2.5-21.7)</td><td>&lt;0.001</td><td>5.0 (1.5-16.7)</td><td>0.009</td></tr><tr><td>ReA</td><td>0.6 (0.2-1.9)</td><td>0.421</td><td>0.3 (0.05-1.5)</td><td>0.132</td></tr><tr><td>IBD</td><td>1.1 (0.5-2.2)</td><td>0.798</td><td>0.8 (0.4-1.6)</td><td>0.521</td></tr><tr><td>Psoriasis</td><td>1.2 (0.8-2.0)</td><td>0.388</td><td>1.2 (0.8-1.8)</td><td>0.464</td></tr></table>
31a6edfc74b2f71a8931c2b76a1f49a17783f1473461206a19075f6b335a9688.png
complex
<table><tr><td></td><td>Group PC(n = 27)</td><td>Group VC(n = 27)</td><td><i>p</i> value</td></tr><tr><td>Age (year)</td><td>44.4 &#177; 12.3</td><td>41.1 &#177; 100</td><td>NS</td></tr><tr><td>Weight (kg)</td><td>78.9 &#177; 8.8</td><td>79.5 &#177; 10.3</td><td>NS</td></tr><tr><td>Gender (M/F)</td><td>20/7</td><td>22/5</td><td>NS</td></tr><tr><td colspan="4">HR (beats/min)</td></tr><tr><td> Pre</td><td>79.7 &#177; 10.4</td><td>76.5 &#177; 12.7</td><td>NS</td></tr><tr><td> Prone</td><td>78.7 &#177; 11.0</td><td>73.1 &#177; 9.4</td><td>NS</td></tr><tr><td> Post</td><td>76.1 &#177; 94</td><td>74.8 &#177; 8.2</td><td>NS</td></tr><tr><td colspan="4">SAP (mmHg)</td></tr><tr><td> Pre</td><td>133 &#177; 12.9</td><td>132 &#177; 14.5</td><td>NS</td></tr><tr><td> Prone</td><td>116 &#177; 13.1</td><td>117 &#177; 14.0</td><td>NS</td></tr><tr><td> Post</td><td>125 &#177; 11.9</td><td>123 &#177; 12.7</td><td>NS</td></tr><tr><td colspan="4">MAP (mmHg)</td></tr><tr><td> Pre</td><td>103 &#177; 13.4</td><td>103 &#177; 15.4</td><td>NS</td></tr><tr><td> Prone</td><td>93.9 &#177; 13.6</td><td>94.1 &#177; 8.5</td><td>NS</td></tr><tr><td> Post</td><td>92.8 &#177; 14.1</td><td>96.2 &#177; 13.6</td><td>NS</td></tr></table>
e59e6e666fda29dc8da043b44ba40e7fd9cac1788f9e09b38f750ad5d81defe0.png
simple
<table><tr><td></td><td>Mean Value (m)</td></tr><tr><td>Set 1</td><td>0.2189 &#177; 0.0003</td></tr><tr><td>Set 2</td><td>0.2117 &#177; 0.0003</td></tr><tr><td>Set 3</td><td>0.2189 &#177; 0.0003</td></tr><tr><td>Set 4</td><td>0.2087 &#177; 0.0003</td></tr></table>
698978dd46068d7707435b0cad4ade5c9f79cc1a98712d8a801870e442bca2f7.png
complex
<table><tr><td rowspan="3">Discovery method</td><td colspan="4">Predicted validation success (%)</td></tr><tr><td colspan="2">Infinium</td><td colspan="2">Axiom</td></tr><tr><td>Predictive</td><td>Filtering</td><td>Predictive</td><td>Filtering</td></tr><tr><td>BOWTIE2</td><td>75.7</td><td>45.6</td><td>83.3</td><td>61.7</td></tr><tr><td>BWA</td><td>72.1</td><td>39.7</td><td>78.5</td><td>54.6</td></tr><tr><td>NEWBLER</td><td>46.8</td><td>27.3</td><td>48.9</td><td>35.5</td></tr><tr><td>SWAP454</td><td>57.0</td><td>34.6</td><td>61.8</td><td>45.9</td></tr></table>
b509c5ef347d1f663cd02a99f68591f14d849941fe565162e6b0c0e6fd65cfdc.png
complex
<table><tr><td>Gender</td><td colspan="2">Reporting</td></tr><tr><td></td><td>Plausible Reporters</td><td>Non-Plausible Reporters</td></tr><tr><td>Female</td><td>57.3% (<i>n</i> = 311)</td><td>46.7% (<i>n</i> = 685)</td></tr><tr><td>Male</td><td>42.7% (<i>n</i> = 232)</td><td>53.3% (<i>n</i> = 781)</td></tr></table>
e3717bc62a5cbb9501dced700e5d16028ef5dabfcb345c4b3cc458e618ef3036.png
simple
<table><tr><td>Gene name</td><td>Accession number</td><td>Primer sequences (forward/reverse)</td><td>Tm(&#176;C)</td><td>Amplication length</td><td>Amplification efficacy (%)</td></tr><tr><td>h2afz</td><td>NM_016750</td><td>GTGGACTGTATCTCTGTGAA/GGTTGGTTGGAAGGCTAA</td><td>60</td><td>89</td><td>92.1</td></tr><tr><td>sdha</td><td>NM_023281</td><td>ATTCATTGTCTACTTCTCACT/AGGGTTTATTTGGCTTACA</td><td>58</td><td>108</td><td>90.6</td></tr><tr><td>tgfb1</td><td>NM_011577</td><td>TATACTGAGACACCTTGG/GTGATAGTCCTGAATAATTTG</td><td>55</td><td>83</td><td>97.2</td></tr><tr><td>gapdh</td><td>NM_008084</td><td>AGTGGCAAAGTGGAGATT/GTGGAGTCATACTGGAACA</td><td>60</td><td>83</td><td>91.5</td></tr><tr><td>actb</td><td>NM_007393</td><td>ATCTTCCGCCTTAATACT/GCCTTCATACATCAAGTT</td><td>56</td><td>98</td><td>90.7</td></tr><tr><td>sptbn</td><td>NM_175836</td><td>TCTAATGGTTACTTGCTTGT/CAATAGTTACAGTGACAGAGA</td><td>55</td><td>101</td><td>91.2</td></tr><tr><td>ablim</td><td>NM_178688</td><td>GTATTCAGTGTTCACAGT/AATAGCATTAACCAGTAAGA</td><td>55</td><td>106</td><td>90.1</td></tr><tr><td>ywhaz</td><td>NM_001253807</td><td>CAGTAGATGGAGAAAGATTTGC/GGGACAATTAGGGAAGTAAGT</td><td>60</td><td>92</td><td>93.5</td></tr><tr><td>wrnip</td><td>NM_030215</td><td>ATGAGTAGGATGCTTGTA/TAACCACCTCCATCTATG</td><td>56</td><td>130</td><td>91.6</td></tr><tr><td>18 s</td><td>X00686</td><td>CGCCGCTAGAGGTGAAATTCT/CGAACCTCCGACTTTCGTTCT</td><td>60</td><td>102</td><td>93.6</td></tr></table>
fa391c08930f8ab468220568001e77ed88e0f4a312d1a23f04342c9b0e0e67b5.png
simple
<table><tr><td>Basins</td><td><i>Q</i> and SSC time span</td><td>Area (km<sup>2</sup>)</td><td>Characters</td></tr><tr><td>Da River Basin</td><td>1988&#8211;2004monthly</td><td>55000</td><td>No big dam in the upstream before 2004 Main vegetation cover: forest</td></tr><tr><td>Chiang Sean Basin</td><td>1986&#8211;1991monthly</td><td>185,000</td><td>No big dam before 1992 Main vegetation cover: grass and forest</td></tr><tr><td>Nam Muc Basin</td><td>1997&#8211;2006monthly</td><td>2,200</td><td>No big dam existedMain vegetation cover: forest</td></tr></table>
b7ecd8ec06c6043b3831ca71e2e5de4558a94ff33db4d7d9fb17ae39cd472d45.png
complex
<table><tr><td rowspan="3">Characteristic</td><td colspan="2">Public</td><td colspan="2">Private</td><td rowspan="3">p<sup>b</sup></td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Maternal age (years)</td><td colspan="5"> </td></tr><tr><td>12&#8211;19</td><td>1,487</td><td>19.7</td><td>128</td><td>5.7</td><td>&lt; 0.001</td></tr><tr><td>20&#8211;34</td><td>5,396</td><td>71.3</td><td>1,716</td><td>76.0</td><td> </td></tr><tr><td>35 or more</td><td>683</td><td>9.0</td><td>415</td><td>18.3</td><td> </td></tr><tr><td>Total</td><td>7,566<sup>a</sup></td><td>100</td><td>2,259</td><td>100</td><td> </td></tr><tr><td>Skin colour</td><td colspan="5"> </td></tr><tr><td>Indigenous</td><td>25</td><td>0.3</td><td>5</td><td>0.2</td><td>&lt; 0.001</td></tr><tr><td>Black</td><td>835</td><td>11.0</td><td>95</td><td>4.2</td><td> </td></tr><tr><td>Brown</td><td>4,139</td><td>54.8</td><td>835</td><td>36.9</td><td> </td></tr><tr><td>Oriental</td><td>83</td><td>1,1</td><td>30</td><td>1,3</td><td> </td></tr><tr><td>White</td><td>2,482</td><td>32,8</td><td>1,294</td><td>57.3</td><td> </td></tr><tr><td>Total</td><td>7,564<sup>a</sup></td><td>100</td><td>2,259</td><td>100</td><td> </td></tr><tr><td>Education</td><td colspan="5"> </td></tr><tr><td>Elementary school</td><td>4,172</td><td>55.3</td><td>330</td><td>14.7</td><td>&lt; 0.001</td></tr><tr><td>High school</td><td>3,153</td><td>41.8</td><td>1,265</td><td>56.4</td><td> </td></tr><tr><td>College or more</td><td>220</td><td>2.9</td><td>649</td><td>28.9</td><td> </td></tr><tr><td>otal</td><td>7,545<sup>a</sup></td><td>100</td><td>2,244<sup>a</sup></td><td>100</td><td> </td></tr><tr><td>Marital status</td><td colspan="5"> </td></tr><tr><td>With partner</td><td>5,734</td><td>75.8</td><td>1,990</td><td>88.2</td><td>&lt; 0.001</td></tr><tr><td>No partner</td><td>1,832</td><td>24.2</td><td>267</td><td>11.8</td><td> </td></tr><tr><td>Total</td><td>7,566<sup>a</sup></td><td>100</td><td>2,257<sup>a</sup></td><td>100</td><td> </td></tr><tr><td>Paid work</td><td colspan="5"> </td></tr><tr><td>No</td><td>4,790</td><td>63.3</td><td>674</td><td>29.8</td><td>&lt; 0.001</td></tr><tr><td>Yes</td><td>2,777</td><td>36.7</td><td>1,585</td><td>70.2</td><td> </td></tr><tr><td>Total</td><td>7,567<sup>a</sup></td><td>100</td><td>2,259</td><td>100</td><td> </td></tr><tr><td>Economic class</td><td colspan="5"> </td></tr><tr><td>A or B</td><td>1,376</td><td>18.3</td><td>1,416</td><td>63.5</td><td>&lt; 0.001</td></tr><tr><td>C</td><td>4,780</td><td>63.5</td><td>770</td><td>34.5</td><td> </td></tr><tr><td>D or E</td><td>1,372</td><td>18.2</td><td>45</td><td>2.0</td><td> </td></tr><tr><td>Total</td><td>7,528<sup>a</sup></td><td>100</td><td>2,231<sup>a</sup></td><td>100</td><td> </td></tr><tr><td>Hospital location</td><td colspan="5"> </td></tr><tr><td>Capital</td><td>2,507</td><td>33.1</td><td>766</td><td>33.9</td><td>0.486</td></tr><tr><td>Regional</td><td>5,062</td><td>66.9</td><td>1,493</td><td>66.1</td><td> </td></tr><tr><td>Total</td><td>7,569</td><td>100</td><td>2,259</td><td>100</td><td> </td></tr><tr><td>Previous cesarian section</td><td colspan="5"> </td></tr><tr><td>No</td><td>2,603</td><td>34.4</td><td>350</td><td>15.5</td><td>&lt; 0.001</td></tr><tr><td>Yes</td><td>1,608</td><td>21.2</td><td>653</td><td>28.9</td><td> </td></tr><tr><td>Primiparae</td><td>3,358</td><td>44.4</td><td>1,256</td><td>55.6</td><td> </td></tr><tr><td>Total</td><td>7,569</td><td>100</td><td>2,259</td><td>100</td><td> </td></tr><tr><td>Antenatal complications</td><td colspan="5"> </td></tr><tr><td>No</td><td>4,161</td><td>55.0</td><td>1,378</td><td>61.0</td><td>&lt; 0.001</td></tr><tr><td>Yes</td><td>3,408</td><td>45.0</td><td>881</td><td>39.0</td><td> </td></tr><tr><td>Total</td><td>7,569</td><td>100</td><td>2,259</td><td>100</td><td> </td></tr><tr><td>Labour complications</td><td colspan="5"> </td></tr><tr><td>No</td><td>2,312</td><td>30.5</td><td>675</td><td>29.9</td><td>0.016</td></tr><tr><td>Yes</td><td>1,419</td><td>18.7</td><td>372</td><td>16.5</td><td> </td></tr><tr><td>No labour</td><td>3,838</td><td>50.8</td><td>1,212</td><td>53.6</td><td> </td></tr><tr><td>otal</td><td>7,569</td><td>100</td><td>2,259</td><td>100</td><td> </td></tr></table>
f524114ccd3d72275ddfcc7f1ee85046e7a428d1a36020a9d6a22008876bb75d.png
complex
<table><tr><td rowspan="3">Variable</td><td colspan="2">2 year</td><td colspan="2">3 year</td><td colspan="2">5 year</td><td colspan="2">10 year</td></tr><tr><td>Univariate</td><td>Multivariate</td><td>Univariate</td><td>Multivariate</td><td>Univariate</td><td>Multivariate</td><td>Univariate</td><td>Multivariate</td></tr><tr><td>HR (95% C.I)</td><td>HR (95% C.I)</td><td>HR (95% C.I)</td><td>HR (95% C.I)</td><td>HR (95% C.I)</td><td>HR (95% C.I)</td><td>HR (95% C.I)</td><td>HR (95% C.I)</td></tr><tr><td>Hb trajectory</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Normal Hb</td><td>Ref.</td><td>Ref.</td><td>Ref.</td><td>Ref.</td><td>Ref.</td><td>Ref.</td><td>Ref.</td><td>Ref.</td></tr><tr><td>Persisted anemia</td><td>7.8(2.9-21.1)**</td><td>3.4(1.2-10.2)*</td><td>5.6(2.8-11.3)**</td><td>2.9(1.3-6.2)*</td><td>4.9(2.9-8.3)**</td><td>2.4(1.3-4.3)*</td><td>4.2(2.6-6.7)**</td><td>2.2(1.3-3.8)*</td></tr><tr><td>Improved anemia</td><td>4.0(1.2-13.2)*</td><td>2.1(0.5-8.8)</td><td>2.5(1.0-6.1)</td><td>1.6(0.5-4.5)</td><td>2.7(1.4-5.3)*</td><td>2.0(0.9-4.2)</td><td>2.2(1.2-4.0)*</td><td>1.8(0.9-3.5)</td></tr><tr><td>Mild anemia</td><td>2.5(0.9-6.6)</td><td>1.5(0.6-4.1)</td><td>1.9(1.0-3.8)*</td><td>1.2(0.60-2.5)</td><td>1.7(0.9-2.7)</td><td>1.0(0.6-1.8)</td><td>1.6(1.0-2.5)*</td><td>1.1(0.7-1.7)</td></tr><tr><td>Low normal Hb</td><td>1.9(0.8-4.8)</td><td>1.3(0.5-3.4)</td><td>1.5(0.8-2.8)</td><td>1.1(0.6-2.1)</td><td>1.5(0.9-2.3)</td><td>1.0(0.6-1.6)</td><td>1.3(0.9-2.0)</td><td>1.1(0.7-1.6)</td></tr></table>
5d8693dc9a2d2f740231697d5955c6cd9962ca1fe8397232befa726caaa5a57c.png
complex
<table><tr><td> </td><td> </td><td>Control group (<i>n</i> = 26)</td><td>UTI group (<i>n</i> = 24)</td><td><i>P</i></td></tr><tr><td rowspan="2">FDP (<i>&#956;</i>g/ml)</td><td>BOD</td><td>1.76 &#177; 1.11</td><td>1.84 &#177; 1.70</td><td>0.854</td></tr><tr><td>POD1</td><td>6.87 &#177; 5.19</td><td>5.04 &#177; 2.63</td><td>0.142</td></tr><tr><td rowspan="2">Fbg (mg/dl)</td><td>BOD</td><td>307.30 &#177; 118.49</td><td>278.15 &#177; 78.01</td><td>0.314</td></tr><tr><td>POD1</td><td>329.64 &#177; 125.57</td><td>294.70 &#177; 80.56</td><td>0.252</td></tr><tr><td rowspan="2">D-dimer (mg/L)</td><td>BOD</td><td>0.36 &#177; 0.42</td><td>0.37 &#177; 0.64</td><td>0.963</td></tr><tr><td>POD1</td><td>2.30 &#177; 1.96</td><td>1.57 &#177; 1.08</td><td>0.128</td></tr><tr><td rowspan="2">INR</td><td>BOD</td><td>1.02 &#177; 0.08</td><td>1.01 &#177; 0.67</td><td>0.778</td></tr><tr><td>POD1</td><td>1.08 &#177; 0.11</td><td>1.11 &#177; 0.08</td><td>0.290</td></tr></table>
11caee0c0c3e977c9dfca9e6992c5153275d519b51cce4038a0426435ca8b565.png
simple
<table><tr><td>Libraries</td><td>LS1 mean</td><td>Nb. of concordant identifications</td><td>LS1 mean of concordant identifications</td><td>Nb. of non-concordant identifications</td><td>LS1 mean of non -concordant identifications</td><td>Mean of the difference between LS1 and LS2</td><td>Max frequency parameter (%)</td><td>Nb. of peaks parameter</td></tr><tr><td>B1</td><td>1.34</td><td>449</td><td>1.58</td><td>361</td><td>1.04</td><td>0.38</td><td>25</td><td>70</td></tr><tr><td>B1b</td><td>1.34</td><td>449</td><td>1.58</td><td>361</td><td>1.04</td><td>0.38</td><td>25</td><td>100</td></tr><tr><td>B1c</td><td>1.34</td><td>449</td><td>1.58</td><td>361</td><td>1.04</td><td>0.38</td><td>50</td><td>70</td></tr><tr><td>B1d</td><td>1.36</td><td>473</td><td>1.60</td><td>337</td><td>1.03</td><td>0.40</td><td>50</td><td>100</td></tr><tr><td>B1e</td><td>1.34</td><td>449</td><td>1.58</td><td>361</td><td>1.04</td><td>0.38</td><td>75</td><td>70</td></tr><tr><td>B1f</td><td>1.32</td><td>445</td><td>1.56</td><td>365</td><td>1.03</td><td>0.36</td><td>75</td><td>100</td></tr><tr><td>B1g</td><td>1.39</td><td>473</td><td>1.63</td><td>337</td><td>1.05</td><td>0.43</td><td>100</td><td>70</td></tr><tr><td>B1h</td><td>1.39</td><td>473</td><td>1.63</td><td>337</td><td>1.05</td><td>0.43</td><td>100</td><td>100</td></tr><tr><td>B7</td><td>1.80</td><td>611</td><td>1.96</td><td>199</td><td>1.30</td><td>0.53</td><td>25</td><td>70</td></tr><tr><td>B7g</td><td>1.80</td><td>595</td><td>1.96</td><td>215</td><td>1.35</td><td>0.50</td><td>100</td><td>70</td></tr></table>
83d6ee0ae465659d379981cec6236c199e216c3680d27193664d40eaeecee9b3.png
complex
<table><tr><td>Months</td><td>sAPP&#946;</td><td>APP 110 kDa</td><td>Serotonin</td></tr><tr><td colspan="4">7</td></tr><tr><td> WT</td><td>3780 &#177; 330 (5)-</td><td>99 &#177; 8 (5)-</td><td>59 &#177; 11 (5)-</td></tr><tr><td> WT Chol</td><td>3600 &#177; 330 (5) ns</td><td>80 &#177; 8 (5) ns</td><td>62 &#177; 11 (4) ns</td></tr><tr><td colspan="4">14</td></tr><tr><td> WT</td><td>3809 &#177; 332 (5)</td><td>146 &#177; 16 (5)-</td><td>70 &#177; 8 (5)-</td></tr><tr><td> WT Chol</td><td>2097 &#177; 909 (4) ns</td><td>180 &#177; 29 (5) ns</td><td>58 &#177; 15 (5) ns</td></tr><tr><td colspan="4">20</td></tr><tr><td> WT</td><td>2077 &#177; 464 (4)</td><td>76 &#177; 18 (6)</td><td>640 &#177; 127 (5)-</td></tr><tr><td> WT Chol</td><td>868 &#177; 396 (4) p = 0.09</td><td>105 &#177; 33 (5) ns</td><td>529 &#177; 163 (5) ns</td></tr></table>
b03f693254710b2d5396ceed8641867bfcce89b4e13d0b359d0caa4b77fd6a0c.png
simple
<table><tr><td>Symptom</td><td>Median (IQR)</td><td>Rank</td><td>Low (score 1&#8211;3) N (%)</td><td>Medium (score 4&#8211;7) N (%)</td><td>High (score 8&#8211;10) N (%)</td></tr><tr><td>Weight gain</td><td>9 (6&#8211;10)</td><td>1</td><td>74 (12.3)</td><td>145 (24)</td><td>385 (63.7)</td></tr><tr><td>Insomnia</td><td>8 (5&#8211;10)</td><td>2</td><td>75 (12.4)</td><td>210 (34.8)</td><td>319 (52.8)</td></tr><tr><td>Moon face</td><td>8 (5&#8211;10)</td><td>2</td><td>125 (20.7)</td><td>149 (24.7)</td><td>330 (54.6)</td></tr><tr><td>High blood pressure</td><td>8 (4&#8211;10)</td><td>4</td><td>150 (24.8)</td><td>138 (22.8)</td><td>316 (52.3)</td></tr><tr><td>Reduced bone strength</td><td>8 (4&#8211;10)</td><td>4</td><td>133 (22)</td><td>134 (22.2)</td><td>337 (55.8)</td></tr><tr><td>Eye disease</td><td>8 (3&#8211;10)</td><td>6</td><td>164 (27.2)</td><td>93 (15.4)</td><td>347 (57.5)</td></tr><tr><td>Cardiovascular disease</td><td>8 (1&#8211;10)</td><td>7</td><td>216 (35.8)</td><td>56 (9.3)</td><td>332 (55)</td></tr><tr><td>Diabetes</td><td>8 (1&#8211;10)</td><td>7</td><td>206 (34.1)</td><td>86 (14.2)</td><td>312 (51.7)</td></tr><tr><td>Infections</td><td>8 (1&#8211;10)</td><td>7</td><td>182 (30.1)</td><td>116 (19.2)</td><td>306 (50.7)</td></tr><tr><td>Changes in mood</td><td>7 (5&#8211;9)</td><td>10</td><td>110 (18.2)</td><td>239 (39.6)</td><td>255 (42.2)</td></tr><tr><td>Skin changes</td><td>7 (5&#8211;9)</td><td>10</td><td>109 (18)</td><td>214 (35.4)</td><td>281 (46.5)</td></tr><tr><td>Palpitations</td><td>7 (4&#8211;9)</td><td>12</td><td>125 (20.7)</td><td>212 (35.1)</td><td>267 (44.2)</td></tr><tr><td>Indigestion</td><td>6 (3&#8211;8)</td><td>13</td><td>152 (25.2)</td><td>276 (45.7)</td><td>176 (29.1)</td></tr><tr><td>Acne</td><td>1 (1&#8211;6)</td><td>14</td><td>359 (59.4)</td><td>138 (22.8)</td><td>107 (17.7)</td></tr></table>
daafc7f86c1e350f2a87df00efeee2002e7131ededbf7904688daa15aa415f22.png
complex
<table><tr><td>Couple no.</td><td colspan="5">Females</td><td colspan="4">Males</td><td></td></tr><tr><td></td><td>Visits to ANC<sup>1</sup></td><td>Visits to CHC<sup>2</sup></td><td>Participation in childbirth and parenthood classes</td><td>Visit to dental hygienist during pregnancy</td><td>Ever visited open pre-school</td><td>Visits to ANC</td><td>Visits to CHC</td><td>Participation in childbirth and parenthood classes</td><td>Visit to dental hygienist during pregnancy</td><td>Ever visited open pre-school</td></tr><tr><td>1</td><td>Most visits</td><td>Most visits</td><td>ANC and CHC</td><td>No</td><td>Yes</td><td>Most visits</td><td>Sometimes</td><td>Only ANC</td><td>No</td><td>Yes</td></tr><tr><td>2</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>No</td><td>Yes</td><td>Most visits</td><td>Sometimes</td><td>Only ANC</td><td>No</td><td>Yes</td></tr><tr><td>3</td><td>Most visits</td><td>Most visits</td><td>Only CHC</td><td>No</td><td>Yes</td><td>Most visits</td><td>Most visits</td><td>No</td><td>No</td><td>Yes</td></tr><tr><td>4</td><td>Most visits</td><td>Most visits</td><td>ANC and CHC</td><td>Yes</td><td>Yes</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>Yes</td><td>No</td></tr><tr><td>5</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>Yes</td><td>Yes</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>Yes</td><td>Yes</td></tr><tr><td>6</td><td>Most visits</td><td>Most visits</td><td>Only CHC</td><td>No</td><td>Yes</td><td>Most visits</td><td>Most visits</td><td>Only CHC</td><td>No</td><td>Yes</td></tr><tr><td>7</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>No</td><td>Yes</td><td>Sometimes</td><td>Seldom</td><td>Only ANC</td><td>No</td><td>No</td></tr><tr><td>8</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>No</td><td>Yes</td><td>Sometimes</td><td>Sometimes</td><td>Only ANC</td><td>No</td><td>Yes</td></tr><tr><td>9</td><td>Most visits</td><td>Most visits</td><td>ANC and CHC</td><td>No</td><td>Yes</td><td>Most visits</td><td>Most visits</td><td>ANC and CHC</td><td>No</td><td>Yes</td></tr><tr><td>10</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>No</td><td>No</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>No</td><td>No</td></tr><tr><td>11</td><td>Most visits</td><td>Most visits</td><td>ANC and CHC</td><td>No</td><td>Yes</td><td>Sometimes</td><td>Sometimes</td><td>ANC and CHC</td><td>No</td><td>Yes</td></tr><tr><td>12</td><td>Most visits</td><td>Most visits</td><td>Only ANC</td><td>Yes</td><td>Yes</td><td>Seldom</td><td>Seldom</td><td>ANC (once)</td><td>No</td><td>Yes</td></tr></table>
55044837b1f137dfa7163d2f92f7d411a5aab31cb86005f6ebf63256080fb031.png
simple
<table><tr><td></td><td>Total</td><td><i>sea</i></td><td><i>seb</i></td><td><i>sec</i></td><td><i>sed</i></td><td><i>see</i></td><td><i>seg</i></td><td><i>seh</i></td><td><i>sei</i></td><td><i>selj</i></td><td><i>sek</i></td><td><i>sell</i></td><td><i>sem</i></td><td><i>sen</i></td><td><i>seo</i></td><td><i>sep</i></td><td><i>seq</i></td><td><i>ser</i></td><td><i>tsst&#8208;1</i></td></tr><tr><td>Shopping baskets (<i>n</i> = 740)</td><td>46</td><td>2</td><td>5</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>14</td><td>1</td><td>8</td><td>&#8211;</td><td>1</td><td>3</td><td>6</td><td>12</td><td>10</td><td>6</td><td>&#8211;</td><td>&#8211;</td><td>8</td></tr><tr><td>Percentage</td><td></td><td>4.3</td><td>10.9</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>30.4</td><td>2.2</td><td>17.4</td><td>&#8211;</td><td>2.2</td><td>6.5</td><td>13.0</td><td>26.1</td><td>21.7</td><td>13.0</td><td>&#8211;</td><td>&#8211;</td><td>17.4</td></tr></table>
088669846884a6ea6a3449bad1be0e55e7a1ff9bd66ff06c0bb59ddf36baac03.png
complex
<table><tr><td></td><td></td><td colspan="3">Admission appropriateness</td><td colspan="3">Length of stay appropriateness</td></tr><tr><td></td><td></td><td>Yes</td><td>No</td><td>P Value</td><td>Yes</td><td>No</td><td>P Value</td></tr><tr><td></td><td></td><td>% (n)</td><td>% (n)</td><td></td><td>% (n)</td><td>% (n)</td><td></td></tr><tr><td>Gender</td><td>Female</td><td>70.7 (41)</td><td>29.3 (17)</td><td>0.678</td><td>37.5 (15)</td><td>62.5 (25)</td><td>0.932</td></tr><tr><td></td><td>Male</td><td>74.1 (43)</td><td>25.9 (15)</td><td></td><td>36.6 (15)</td><td>63.4 (26)</td><td></td></tr><tr><td>Admitted via the emergency department?</td><td>Yes</td><td>68.1 (47)</td><td>31.9 (22)</td><td>0.210</td><td>40.0 (18)</td><td>60.0 (27)</td><td>0.537</td></tr><tr><td></td><td>No</td><td>78.7 (37)</td><td>21.3 (10)</td><td></td><td>33.3 (12)</td><td>66.7 (24)</td><td></td></tr><tr><td>Presented with a neurologically related problem?</td><td>Yes</td><td>64.3 (27)</td><td>35.7 (15)</td><td>0.315</td><td>34.6 (9)</td><td>65.4 (17)</td><td>0.343</td></tr><tr><td></td><td>No</td><td>73.7 (42)</td><td>26.3 (15)</td><td></td><td>46.3 (19)</td><td>53.7 (22)</td><td></td></tr><tr><td>Place of residence</td><td>Nursing/residential home</td><td>88.0 (22)</td><td>12.0 (3)</td><td>0.049*</td><td>33.7 (7)</td><td>66.7 (14)</td><td>0.683</td></tr><tr><td></td><td>Own home</td><td>68.1 (62)</td><td>31.9 (29)</td><td></td><td>38.3 (23)</td><td>61.7 (37)</td><td></td></tr><tr><td>Household members</td><td>Lives with others</td><td>69.4 (43)</td><td>30.6 (19)</td><td>0.795</td><td>54.8 (23)</td><td>45.2 (19)</td><td>&lt; 0.001*</td></tr><tr><td></td><td>Lives alone</td><td>66.7 (20)</td><td>33.3 (10)</td><td></td><td>5.3 (1)</td><td>94.7 (18)</td><td></td></tr><tr><td>Receives home help</td><td>Yes</td><td>74.3 (26)</td><td>25.7 (9)</td><td>0.262</td><td>25.0 (6)</td><td>75.0 (18)</td><td>0.058</td></tr><tr><td></td><td>No</td><td>62.7 (32)</td><td>37.3 (19)</td><td></td><td>50.0 (16)</td><td>50.0 (16)</td><td></td></tr><tr><td>Referred to in-patient physiotherapy</td><td>Yes</td><td>n/a</td><td>n/a</td><td>n/a</td><td>25.0 (10)</td><td>75.0 (30)</td><td>0.027*</td></tr><tr><td></td><td>No</td><td></td><td></td><td></td><td>48.8 (20)</td><td>51.2 (21)</td><td></td></tr><tr><td>Referred to social services</td><td>Yes</td><td>n/a</td><td>n/a</td><td>n/a</td><td>9.1 (1)</td><td>90.9 (10)</td><td>0.039*</td></tr><tr><td></td><td>No</td><td></td><td></td><td></td><td>41.4 (29)</td><td>58.6 (41)</td><td></td></tr><tr><td>Transferred on discharge</td><td>Yes</td><td>74.2 (66)</td><td>235.8 (23)</td><td>0.155</td><td>18.2 (2)</td><td>81.8 (9)</td><td>0.164</td></tr><tr><td></td><td>No</td><td>57.0 (11)</td><td>42.1 (8)</td><td></td><td>40.0 (28)</td><td>60.0 (42)</td><td></td></tr><tr><td></td><td></td><td>Median (IQR)</td><td>Median (IQR)</td><td>P Value</td><td>Median (IQR)</td><td>Median (IQR)</td><td>P Value</td></tr><tr><td colspan="2">Age (119)</td><td>71.5(53.3&#8211;78.5)</td><td>74.0(59.3&#8211;83.0)</td><td>0.177</td><td>72.5(I62.5-81.0)</td><td>76.0(58.0&#8211;83.0)</td><td>0.984</td></tr><tr><td colspan="2">Number of LTNCs (119)</td><td>1 (1.0&#8211;2.0)</td><td>1 (1.0&#8211;2.0)</td><td>0.876</td><td>1 (1.0&#8211;2.0)</td><td>1 (1.0&#8211;1.0)</td><td>0.016*</td></tr><tr><td colspan="2">Number of presenting complaints (119)</td><td>1 (1.0&#8211;2.0)</td><td>1 (1.0&#8211;2.0)</td><td>0.829</td><td>1 (1.0&#8211;1.0)</td><td>2 (1.0&#8211;2.0)</td><td>0.040*</td></tr><tr><td colspan="2">FIM score (73) (Score range 1&#8211;126, 126 indicates no impairment)</td><td>111.0(103.0&#8211;120.0)</td><td>113.0(103.0&#8211;120.0)</td><td>0.873</td><td>103.0(96.0&#8211;122.0)</td><td>107.0(45.0&#8211;115.0)</td><td>0.228</td></tr><tr><td colspan="2">GDNS (walking) (74) (score range 1&#8211;5, 5 indicates no impairment)</td><td>2.0 (1.5&#8211;4.0)</td><td>2.0 (0.0&#8211;4.0)</td><td>0.616</td><td>2.5 (0.0&#8211;4.0)</td><td>3.5 (2.0&#8211;4.0)</td><td>0.194</td></tr><tr><td colspan="2">GDNS (speech) (74) (score range 1&#8211;5, 5 indicates no impairment)</td><td>0.5 (0.0&#8211;0.0)</td><td>0.0 (0.0&#8211;2.0)</td><td>0.122</td><td>0.0 (0.0-0.0)</td><td>0.0 (0.0&#8211;3.0)</td><td>0.078</td></tr><tr><td colspan="2">MMSE (49) (score range 1&#8211;30, 30 indicates no impairment)</td><td>24.0(23.0&#8211;28.5)</td><td>26.0(24.0&#8211;28.0)</td><td>0.445</td><td>24.0(18.5&#8211;26.5)</td><td>26.5(23.0&#8211;29.0)</td><td>0.119</td></tr><tr><td colspan="2">Length of stay (119)</td><td>8.0 (4.0&#8211;13.0)</td><td>4.0 (2.0&#8211;13.0)</td><td>0.063</td><td>4.0 (2.0&#8211;8.0)</td><td>10.0 (5.0&#8211;14.0)</td><td>&lt; 0.001*</td></tr></table>
9a88ffc33f79e11f9467d4f3193c214bff8e355fb557c29b3b84296fd3beaf26.png
complex
<table><tr><td>Junior</td><td>Intermediate</td><td>Senior</td></tr><tr><td>Supports skills acquisition by using Modelling</td><td>Support growing independent practice by using Coaching</td><td>Fix gaps in competence development by using exploration</td></tr><tr><td>&#8220;...<i>because at this point rather than learning the theory stuff what I want is to acquire clinical abilities and skills when approaching the patients</i>&#8221; (Junior Resident #26).</td><td>&#8220;<i>I think this is the most important one</i>, <i>because it allows me to perform the clinical activities independently whilst receiving supervision and feedback in order to improve the abilities step by step</i>.&#8221; (Intermediate Resident #3)</td><td>&#8220;<i>In this moment my training is almost complete and I think about what am I lacking to face a competitive working market</i>&#8221; (Senior Resident # 75).</td></tr><tr><td>Overcoming deficiencies by using Coaching</td><td>Help expand knowledge base and engage in dialogue with supervisor by using Articulation</td><td>Help expand knowledge base and engage in dialogue with supervisor by using articulation</td></tr><tr><td>&#8220;<i>I think that in this stage of training it would help me to have more feedback with regard to the quality</i>, <i>pertinence and rationally of my actions</i>&#8221; (Resident (Junior) #34)</td><td>&#8220;<i>Laying the foundations of my actions and exploring my strengths and weaknesses allow me to develop and improve my clinical criterion and my decision</i>-<i>making skills</i>&#8221; (Resident (Intermediate) #22)</td><td>&#8220;<i>In this year I think that one already has enough knowledge and training to show what do you know and what you don</i>&#8217;<i>t</i>.&#8221; (Senior Resident #24)</td></tr><tr><td>&#8220;<i>At this level of academic training</i>, <i>initial phase</i>, <i>I will be better helped by permanent feedback in order to fix the fails and to strengthen the right choices</i>...&#8221; ( Junior Resident #71)</td><td rowspan="3">&#8220;<i>Because I consider that it motivates you to make your own decisions and it makes you feel important in the patient care</i>&#8221; (Intermediate Resident #65)</td><td>&#8220;<i>It allow us not only to answer questions but also to formulate them</i>&#8221; (Senior Resident #54)</td></tr><tr><td>Encourage participation by creating a Safe Learning Environment</td><td>Gain confidence in own performance by not be coerced using a Safe learning environment</td></tr><tr><td>&#8220; <i>I think that the supervisor</i>-<i>trainee relationship is very important. If the supervisor creates an environment of trust and respect</i>, <i>it is possible to loose a little bit that formality and rigidity a teacher has and one can ask questions</i>, <i>formulate doubts and even have more security as a student</i>..&#8221; (Junior Resident #80)</td><td>&#8220;...<i>this is the moment to give confidence and respect</i> (<i>to the resident</i>) <i>in terms of what has been taught and modeled</i>, <i>this can only be reflected in a safe learning environment that not coerce our free performance</i>.&#8221; (Senior Resident #18)</td></tr></table>
1e2f34f24111c1dee757f414b235f97892970d783f0f9aec228fcffa9a752975.png
complex
<table><tr><td> </td><td>Item</td><td>Geniposide</td><td>Baicalin</td><td>Palmatine</td><td>Berberine</td><td>Baicalein</td><td>Wogonin</td></tr><tr><td rowspan="2">HRT</td><td>Retention time (<i>t</i><sub><i>R</i></sub>, min)</td><td>17.39</td><td>36.02</td><td>39.54</td><td>39.75</td><td>48.29</td><td>58.33</td></tr><tr><td>Amount (<i>&#956;</i>g<sup>a</sup>)</td><td>15.71 &#177; 0.08</td><td>8.72 &#177; 0.41</td><td>1.10 &#177; 0.03</td><td>19.08 &#177; 0.51</td><td>3.98 &#177; 0.02</td><td>3.50 &#177; 0.01</td></tr></table>
d8b57c3aaf12760c55f6f79a53b5a091deba84d253427cf905118d76f1e2c9b6.png
simple
<table><tr><td>Template</td><td>Primer/probe (label)</td><td>Sequence (5'-3')</td></tr><tr><td><i>IS</i>481</td><td>Forward primer</td><td>GCCGGATGAACACCCATAAG</td></tr><tr><td></td><td>Reverse primer</td><td>GCGATCAATTGCTGGACCAT</td></tr><tr><td></td><td>Probe (FAM)</td><td>CGATTGACCTTCCTACGTC-MGB</td></tr><tr><td><i>IS</i>1001</td><td>Forward primer</td><td>AATTGCTGCAAGCCAACCA</td></tr><tr><td></td><td>Reverse primer</td><td>CCAGAGCCGTTTGAGTTCGT</td></tr><tr><td></td><td>Probe (VIC)</td><td>ACATAGACCGTCAGCAG-MGB</td></tr><tr><td><i>IS</i>1002</td><td>Forward primer</td><td>CTAGGTCGAGCCCTTCTTGTTAAC</td></tr><tr><td></td><td>Reverse primer</td><td>GCGGGCAAGCCACTTGTA</td></tr><tr><td></td><td>Probe (CY5)</td><td>CATCGTCCAGTTCTGTTGCATCACCC-BBQ</td></tr><tr><td>PhHV</td><td>Forward primer</td><td>GGGCGAATCACAGATTGAATC</td></tr><tr><td></td><td>Reverse primer</td><td>GCGGTTCCAAACGTACCAA</td></tr><tr><td></td><td>Probe (NED)</td><td>TTTTTATGTGTCCGCCACCA-MGB</td></tr></table>
5f53a2084338e0dfed7aa1674dee0df074dc9e1ff4f5f3dece436e9bdf945d56.png
simple
<table><tr><td>Groups</td><td>Bilateral hippocampus transfection</td><td>Drug administration via caudal vein</td></tr><tr><td>Control</td><td>No surgery</td><td>Saline (10 mL/kg)</td></tr><tr><td>Sham</td><td>Lentiviral</td><td>Saline (10 mL/kg)</td></tr><tr><td>Model</td><td>Lentiviral+miR-30e</td><td>Saline (10 mL/kg)</td></tr><tr><td>TSA low</td><td>Lentiviral+miR-30e</td><td>TSA (10 mL/kg, 1 mg/mL)</td></tr><tr><td>TSA high</td><td>Lentiviral+miR-30e</td><td>TSA (10 mL/kg, 2 mg/mL)</td></tr></table>
a78e9169424e6b77723684ced6c7b344b99c34ba305e1afaab56e0d75d540c01.png
complex
<table><tr><td>Session</td><td>TAKE 5</td><td>Waist Winners Too</td></tr><tr><td>1</td><td>Benefits of losing weight and motivation towards a healthy lifestyle</td><td>Introduction to health and weight</td></tr><tr><td>2</td><td>Introduction to individualised energy deficit diet and the importance of physical activity</td><td>Planning meals</td></tr><tr><td rowspan="2">3</td><td>Principles of healthy eating and improving physical activity levels</td><td rowspan="2">Food labelling and fats</td></tr><tr><td>Introduction to physical activity diaries and pedometer</td></tr><tr><td rowspan="2">4</td><td>Healthy ways to cook, meal planning and shopping lists</td><td rowspan="2">Food labelling salt and sugar</td></tr><tr><td>Emotions and overeating</td></tr><tr><td rowspan="2">5</td><td>Disadvantages of eating out and take-aways</td><td rowspan="2">Shopping, budgeting, snacks, eating out and take-aways</td></tr><tr><td>Using behaviour change to alter &#8216;bad habits&#8217;</td></tr><tr><td>6</td><td>Coping with cravings and evaluating knowledge of physical activity</td><td>Alcohol and other drinks</td></tr><tr><td>7</td><td>Diet myths and introduction to new ways to motivate participation in physical activity</td><td>Benefits of exercise</td></tr><tr><td>8</td><td>Relapse prevention</td><td>Review</td></tr><tr><td>9</td><td>Evaluate success up to now</td><td>What have we learned</td></tr></table>
1df29a4f561b6778c85fb57cecedc6e06fa5d4fdb7bb0c18f675a56342473b8a.png
simple
<table><tr><td>Groups</td><td>Body weight (g)</td><td>Splenomegaly (g)</td><td>Tumor volume (mL)</td><td>Packed cell volume (mL)</td><td>Viable tumor cell count (&#215;10<sup>6 </sup>cells/mL)</td></tr><tr><td>Control L5178Y</td><td>30.83 &#177; 2.41</td><td>0.23 &#177; 0.05</td><td>2.67 &#177; 1.08</td><td>1.30 &#177; 0.49</td><td>412.62 &#177; 35.14</td></tr><tr><td>L5178Y + Globulin UF</td><td>29.32 &#177; 2.89</td><td>0.23 &#177; 0.11</td><td>3.00 &#177; 1.22</td><td>1.12 &#177; 0.87</td><td>286.96 &#177; 92.84</td></tr><tr><td>L5178Y + Glutelin UF</td><td>27.5 &#177; 1.73</td><td>0.19 &#177; 0.02</td><td>4.20 &#177; 0.64 *</td><td>1.97 &#177; 0.60</td><td>415.80 &#177; 92.88</td></tr><tr><td>L5178Y + Albumin SFD</td><td>28.08 &#177; 2.38</td><td>0.20 &#177; 0.07</td><td>0.60 &#177; 0.75 *</td><td>0.50 &#177; 0.30 *</td><td>750.00 &#177; 47.03 *</td></tr><tr><td>L5178Y + Glutelin SFD</td><td>31.06 &#177; 3.20</td><td>0.21 &#177; 0.01</td><td>3.50 &#177; 3.46</td><td>1.02 &#177; 0.95</td><td>365.10 &#177; 223.82</td></tr></table>
5bdb4980199c59f017058a3a7bbe519ae1fa9190b57e41c4b642ee23aebae763.png
complex
<table><tr><td>Weather season</td><td>Monitoring period</td><td>Variable</td><td>Soil temperature</td><td>Soil moisture</td></tr><tr><td rowspan="3">Wet season</td><td>September 2012 </td><td></td><td><i>r</i> = 0.2253 <i>P</i> = 0.1464</td><td><i>r</i> = 0.1955 <i>P</i> = 0.2091</td></tr><tr><td>November 2012 </td><td></td><td><i>r</i> = &#8722;0.5169 <i>P</i> = 0.0001</td><td><i>r</i> = 0.1127 <i>P</i> = 0.4264</td></tr><tr><td>January 2013</td><td rowspan="2">Soil CO<sub>2</sub> emission</td><td><i>r</i> = &#8722;0.4829 <i>P</i> = 0.0004</td><td><i>r</i> = 0.2290 <i>P</i> = 0.1135</td></tr><tr><td rowspan="2">Dry season</td><td>April 2013</td><td><i>r</i> = &#8722;0.7431 <i>P</i> = 0.0001</td><td><i>r</i> = &#8722;0.0776 <i>P</i> = 0.5558</td></tr><tr><td>July 2013</td><td></td><td><i>r</i> = &#8722;0.5992 <i>P</i> = 0.0001</td><td><i>r</i> = &#8722;0.2299 <i>P</i> = 0.0854</td></tr><tr><td colspan="2">Pooling data throughout the wet and dry seasons</td><td></td><td><i>r</i> = &#8722;0.1119 <i>P</i> = 0.0710</td><td><i>r</i> = 0.1027 <i>P</i> = 0.0980</td></tr></table>
07295d0fc0d87fd545c23389a42c749b693dfb4bae897170b2bc65387328a036.png
complex
<table><tr><td>Variable</td><td>Experimental schools(mean standard error)</td><td>Control schools(mean standard error)</td><td><i>t </i>(8)</td><td>Cohen's <i>d</i></td></tr><tr><td colspan="5">Screen time</td></tr><tr><td>Child report (hours/week)</td><td>32.5(0.6)</td><td>31.2(1.0)</td><td>.26</td><td>.69</td></tr><tr><td>Parent report (hours/week)</td><td>22.8(0.7)</td><td>24.6(0.3)</td><td>-2.15<sup>a</sup></td><td>1.26</td></tr><tr><td colspan="5">Fruit and vegetable consumption</td></tr><tr><td>Child report (servings/day)</td><td>4.4(0.2)</td><td>4.2(0.1)</td><td>1.78<sup>b</sup></td><td>.52</td></tr><tr><td>Parent report (servings/week)</td><td>24.9(0.7)</td><td>22.6(0.4)</td><td>2.69<sup>a</sup></td><td>1.36</td></tr><tr><td colspan="5">Physical activity</td></tr><tr><td>Pedometer (steps/day)</td><td>12,250(260)</td><td>11,870(232)</td><td>.91</td><td>1.83</td></tr><tr><td colspan="5">Body mass index</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)</td><td>19.0(0.02)</td><td>19.0(0.03)</td><td>.05</td><td>.38</td></tr></table>
451b4ed88ab25e317ee0c176c2db6bdbfcbfc662282292e2dbed399169f3166e.png
simple
<table><tr><td> </td><td>PCOS group</td><td>Control group</td><td><i>P</i></td></tr><tr><td>Total macular thickness (<i>&#956;</i>m)</td><td> </td><td> </td><td> </td></tr><tr><td> Central subfield (CSF)</td><td>242.9 &#177; 19.7</td><td>241.2 &#177; 19.8</td><td><i>0.701</i><sup>1</sup></td></tr><tr><td> Superior inner macula (SIM)</td><td>320.0 &#177; 15.0</td><td>323.8 &#177; 14.1</td><td><i>0.239</i><sup>1</sup></td></tr><tr><td> Temporal inner macula (TIM)</td><td>305.5 &#177; 12.3</td><td>308.6 &#177; 14.2</td><td><i>0.297</i><sup>1</sup></td></tr><tr><td> Inferior inner macula (IIM)</td><td>316.3 &#177; 14.5</td><td>317.0 &#177; 21.4</td><td><i>0.865</i><sup>1</sup></td></tr><tr><td> Nasal inner macula (NIM)</td><td>322.5 &#177; 15.4</td><td>322.8 &#177; 15.5</td><td><i>0.941</i><sup>1</sup></td></tr><tr><td> Superior outer macula (SOM)</td><td>282.6 &#177; 15.0</td><td>285.6 &#177; 14.6</td><td><i>0.358</i><sup>1</sup></td></tr><tr><td> Temporal outer macula (TOM)</td><td>260.7 &#177; 12.6</td><td>263.5 &#177; 13.6</td><td><i>0.349</i><sup>1</sup></td></tr><tr><td> Inferior outer macula (IOM)</td><td>268.9 &#177; 14.8</td><td>268.8 &#177; 15.0</td><td><i>0.980</i><sup>1</sup></td></tr><tr><td> Nasal outer macula (NOM)</td><td>300.7 &#177; 14.1</td><td>299.4 &#177; 19.6</td><td><i>0.737</i><sup>1</sup></td></tr><tr><td>Retinal nerve fiber layer (macula, <i>&#956;</i>m)</td><td> </td><td> </td><td> </td></tr><tr><td> Average macular RNFL </td><td>38.6 &#177; 4.8</td><td>41.0 &#177; 9.5</td><td><i>0.168</i><sup>1</sup></td></tr><tr><td> Superior macular</td><td>33.9 &#177; 5.2</td><td>35.2 &#177; 7.3</td><td><i>0.334</i><sup>1</sup></td></tr><tr><td> Temporal macular</td><td>52.5 &#177; 15.0</td><td>54.2 &#177; 16.1</td><td><i>0.636</i><sup>1</sup></td></tr><tr><td> Inferior macular</td><td>33.8 &#177; 7.2</td><td>35.6 &#177; 7.0</td><td><i>0.258</i><sup>1</sup></td></tr><tr><td> Nasal macular</td><td>35.0 &#177; 11.3</td><td>35.2 &#177; 8.0</td><td><i>0.945</i><sup>1</sup></td></tr></table>
f12e9f6735216b1c5c0c844555116cc3af839fad5bcad825f15b961d1a4deacf.png
complex
<table><tr><td>Knowledge</td><td>Frequency</td><td>Percentage</td></tr><tr><td colspan="3">Do you think Condoms can prevent STDs? (<i>N</i> = 581)</td></tr><tr><td> Yes</td><td>443</td><td>76.2</td></tr><tr><td> No</td><td>134</td><td>23.1</td></tr><tr><td> Probably</td><td>4</td><td>0.7</td></tr><tr><td colspan="3">Can HIV transmit through kissing and sharing equipment(<i>N</i> = 583)</td></tr><tr><td> Yes</td><td>243</td><td>41.7</td></tr><tr><td> No</td><td>307</td><td>52.6</td></tr><tr><td> I don&#8217;t know</td><td>33</td><td>5.7</td></tr><tr><td colspan="3">Is HIV STDs? (<i>N</i> = 491)</td></tr><tr><td> Yes</td><td>440</td><td>89.6</td></tr><tr><td> No</td><td>51</td><td>10.4</td></tr><tr><td colspan="3">Can HIV transmit through breast feeding (<i>N</i> = 563)</td></tr><tr><td> Yes</td><td>311</td><td>55.2</td></tr><tr><td> No</td><td>252</td><td>44.8</td></tr><tr><td colspan="3">Know about STDs (<i>N</i> = 576)</td></tr><tr><td> Yes</td><td>510</td><td>88.45</td></tr><tr><td> No</td><td>66</td><td>11.5</td></tr></table>
e623f84c3bcbbb6f4ff2b236a9867f4dab5c681fd67901a46707327cb9ae9b59.png
complex
<table><tr><td rowspan="2">Items</td><td colspan="3">2010</td><td colspan="3">2011</td></tr><tr><td>Gaoyou</td><td>Pukou</td><td>Rudong</td><td>Gaoyou</td><td>Pukou</td><td>Rudong</td></tr><tr><td>Outpatient reimbursement rate(%)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Village clinics</td><td>25</td><td>40</td><td>25</td><td>35</td><td>40</td><td>30</td></tr><tr><td>THCs</td><td>25</td><td>30</td><td>20</td><td>30</td><td>30</td><td>25</td></tr><tr><td>County-level hospital</td><td>20</td><td>20</td><td>15</td><td>20</td><td>20</td><td>20</td></tr><tr><td>Yearly maximum payment amount</td><td>500</td><td>600</td><td>460</td><td>600</td><td>600</td><td>500</td></tr><tr><td>Rural per capita net income (yuan RMB)</td><td>8825</td><td>11188</td><td>9120</td><td>10170</td><td>13204</td><td>10500</td></tr></table>
fa0409861456990a579b4c91a3a26b3160f91b4e000d18056d9c3ef712533ace.png
simple
<table><tr><td></td><td>IVT Macular Thickness</td><td>SBT Macular Thickness</td><td>p &lt; 0.05</td></tr><tr><td>Baseline</td><td>386.3 &#177; 12.4</td><td>384.1 &#177; 18.9</td><td>0.721</td></tr><tr><td>1 month</td><td>222.7 &#177; 13.4</td><td>220.1 &#177; 15.1</td><td>0.625</td></tr><tr><td>3 months</td><td>228.1 &#177; 10.6</td><td>231.3 &#177; 10.9</td><td>0.580</td></tr><tr><td>6 months</td><td>385.2 &#177; 11.3</td><td>235.4 &#177; 8.7</td><td>0.001</td></tr></table>
c7bfc95005547b6ca3c338aacd109180e97065a728669f419cb5c242f8221e0b.png
simple
<table><tr><td> </td><td>Number of patients</td><td>Interval between uterine surgery and diagnosis of BML</td><td>Size or type of uterine myoma</td><td>Adjuvant treatment</td><td>Outcome (follow-up period)</td></tr><tr><td>Rivera <i>et al.</i>[3]</td><td>2</td><td>11 years</td><td>6 cm</td><td>GnRH agonist, tamoxifen, aromatase inhibitor</td><td>5 years</td></tr><tr><td> </td><td> </td><td>3 years</td><td>22 &#215; 16 &#215; 10 cm, intramural</td><td>GnRH agonist tamoxifen, aromatase inhibitor</td><td>2 years</td></tr><tr><td>Egberts <i>et al.</i>[4].</td><td>1</td><td>10 years</td><td>-</td><td>GnRH agonist</td><td>3 years</td></tr><tr><td>Mogi <i>et al</i>. [31].</td><td>1</td><td>7 years</td><td>14 m</td><td>GnRH agonist</td><td>-</td></tr><tr><td>Bodner-Alder <i>et al.</i>[32].</td><td>1</td><td>1 year</td><td>6 &#215; 7 cm, subserosal</td><td>GnRH agonist</td><td>3 months</td></tr><tr><td>Nasu <i>et al.</i>[10].</td><td>1</td><td>10 years</td><td>-</td><td>Aromatase inhibitor</td><td>15 months</td></tr><tr><td>Beck <i>et al</i>. [33].</td><td>1</td><td>5 years</td><td>10 &#215; 10 cm, 8 &#215; 8 cm subserosal</td><td>Progesterone</td><td>1 year</td></tr><tr><td>Wentling <i>et al</i>. [34].</td><td>1</td><td>6 years</td><td>5 cm</td><td>Progesterone</td><td>3 years</td></tr><tr><td>Goyle <i>et al</i>. [11].</td><td>1</td><td>5 years</td><td>-</td><td>progesterone</td><td>3 months</td></tr><tr><td>Moon <i>et al</i>. [9].</td><td>1</td><td>-</td><td>6 &#215; 5 cm</td><td>observation</td><td>6 months</td></tr><tr><td>Awonuga <i>et al.</i>[35].</td><td>2</td><td>3 years</td><td>21 cm</td><td>Observation</td><td>-</td></tr><tr><td> </td><td> </td><td>6 years</td><td>Six, ~30 cm (multiple)</td><td>Tamoxifen</td><td>2 years</td></tr><tr><td>Ki <i>et al.</i> (this case report)</td><td>4</td><td>None</td><td>Small</td><td>Observation</td><td>16 years</td></tr><tr><td> </td><td> </td><td>None</td><td>10 &#215; 10 cm</td><td>Observation</td><td>3 months</td></tr><tr><td> </td><td> </td><td>7 years</td><td>8 &#215; 8 cm, 5 &#215; 7 cm</td><td>Observation</td><td>2 months</td></tr><tr><td> </td><td> </td><td>11 years</td><td>10.5 &#215; 8 cm, subserosal</td><td>Observation</td><td>2 years</td></tr></table>
092ee2c3a090dd8619e3609836e30f95d13f4f9072eb0a1947825d0d6de586dc.png
simple
<table><tr><td>Predictors<sup>a</sup></td><td>Level</td><td><i>&#946;</i></td><td><i>p</i></td><td>95% Confidence Interval</td></tr><tr><td>Sex</td><td>Male/female</td><td>-0.505</td><td>0.135</td><td>-1.169, 0.158</td></tr><tr><td>Living with partner</td><td>Yes/no</td><td>0.756</td><td>0.039<sup>&#8224;</sup></td><td>0.040, 1.472</td></tr><tr><td>Age</td><td>Continuous</td><td>0.016</td><td>0.263</td><td>-0.012, 0.043</td></tr><tr><td>Number of hospitalization days</td><td>Continuous</td><td>0.007</td><td>0.386</td><td>-0.009, 0.024</td></tr><tr><td>Discharged to nursing home</td><td>Yes/no</td><td>1.074</td><td>0.191</td><td>-0.539, 2.688</td></tr><tr><td>Discharged to home</td><td>Yes/no</td><td>1.087</td><td>0.169</td><td>-0.466, 2.640</td></tr><tr><td>Stroke type</td><td>Ischemic/haemorrhagic</td><td>0.210</td><td>0.658</td><td>-0.722, 1.142</td></tr><tr><td>Stroke location</td><td>Left/right</td><td>0.297</td><td>0.365</td><td>-0.348, 0.942</td></tr><tr><td>Diabetes</td><td>Yes/no</td><td>-0.214</td><td>0.589</td><td>-0.994, 0.566</td></tr><tr><td>Alive within 10-year ref/per</td><td>Yes/no</td><td>0.136</td><td>0.705</td><td>-0.569, 0.640</td></tr><tr><td><i>Explained variance</i></td><td><i>0.047 (R</i><sup><i>2</i></sup><i>)</i></td><td></td><td></td><td></td></tr></table>
e068c8a05f622eb5ddfb9a325682c702208bee7866d802819c6f21d66ce572db.png
complex
<table><tr><td rowspan="2">Isolate no.</td><td rowspan="2">Isolate or accession no.<sup><i>a</i></sup></td><td rowspan="2">Organism</td><td colspan="2">Amino acid residue at position corresponding to nonsynonymous mutation:</td></tr><tr><td>K137R</td><td>P533L</td></tr><tr><td></td><td>PF3D7_1343700</td><td>P. falciparum</td><td>K168</td><td>P553</td></tr><tr><td></td><td>PVX_083080</td><td>P. vivax</td><td>K152</td><td>P539</td></tr><tr><td></td><td>PKH_121080</td><td>P. knowlesi</td><td>K152</td><td>P539</td></tr><tr><td>1</td><td>PM1A</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>2</td><td>PM2</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>3</td><td>PMS</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>4</td><td>PM1381</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>5</td><td>PM17</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>6</td><td>PM18</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>7</td><td>PM048</td><td>P. malariae</td><td></td><td>L</td></tr><tr><td>8</td><td>PM1S</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>9</td><td>PM4</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>10</td><td>PM2848</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>11</td><td>PM454</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>12</td><td>PM5</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>13</td><td>PM1454</td><td>P. malariae</td><td></td><td>P</td></tr><tr><td>14</td><td>PoW1</td><td>P. ovalewallikeri</td><td>K</td><td></td></tr><tr><td>15</td><td>PoW21</td><td>P. ovalewallikeri</td><td>K</td><td></td></tr><tr><td>16</td><td>PoW23</td><td>P. ovalewallikeri</td><td>K</td><td></td></tr><tr><td>17</td><td>PoC13</td><td>P. ovalecurtisi</td><td>K</td><td></td></tr><tr><td>18</td><td>PoW20</td><td>P. ovalewallikeri</td><td>R</td><td></td></tr></table>
c5324837c9d91486e904ef5e8ace626ed2b85c638937668eea64dbd3112987b2.png
complex
<table><tr><td>Haplotype</td><td>Control Freq.</td><td>Case Freq.</td><td>Coef.</td><td>Odds Ratio</td><td>95% CI</td><td>Z-Score</td><td>P-value</td></tr><tr><td></td><td colspan="7">Discovery Cohort (363 patients)</td></tr><tr><td>TG</td><td>0.33</td><td>0.21</td><td></td><td>1.00</td><td>(reference)</td><td></td><td></td></tr><tr><td>CA</td><td>0.39</td><td>0.42</td><td>0.42</td><td>1.52</td><td>(1.05, 2.21)</td><td>2.21</td><td>0.027</td></tr><tr><td>CG</td><td>0.21</td><td>0.23</td><td>0.56</td><td>1.75</td><td>(1.12, 2.72)</td><td>2.46</td><td>0.014</td></tr><tr><td>TA</td><td>0.07</td><td>0.15</td><td>1.21</td><td>3.36</td><td>(1.77, 6.37)</td><td>3.71</td><td>0.000</td></tr><tr><td></td><td colspan="7">Validation Cohort (209 patients)</td></tr><tr><td>TG</td><td>0.34</td><td>0.20</td><td></td><td>1.00</td><td>(reference)</td><td></td><td></td></tr><tr><td>CA</td><td>0.40</td><td>0.49</td><td>0.68</td><td>1.98</td><td>(1.19, 3.27)</td><td>2.65</td><td>0.008</td></tr><tr><td>CG</td><td>0.18</td><td>0.23</td><td>0.75</td><td>2.11</td><td>(0.99, 4.50)</td><td>1.94</td><td>0.053</td></tr><tr><td>TA</td><td>0.09</td><td>0.09</td><td>0.63</td><td>1.87</td><td>(0.67, 5.23)</td><td>1.20</td><td>0.230</td></tr></table>
2016a6a22c4bb64509ae4e91e3e50fcc31be13c4b78eba0271bcbfcc4d82b856.png
simple
<table><tr><td>Material</td><td>No. of samples</td><td>No. of positives</td></tr><tr><td>Manure</td><td>114</td><td>1</td></tr><tr><td>Soil</td><td>84</td><td>0</td></tr><tr><td>Silage</td><td>4</td><td>0</td></tr><tr><td>Before pasteurisation</td><td>11</td><td>3</td></tr><tr><td>After pasteurisation</td><td>11</td><td>0</td></tr><tr><td>After digestion</td><td>11</td><td>0</td></tr></table>
fcf2a52adfb80ada49777dfeaee616335a789a9d935c774f59a57ec23fd0b0eb.png
simple
<table><tr><td>Peak</td><td>Start</td><td>RT</td><td>End</td><td>Height</td><td>Area</td><td>Area %</td><td>AreaSumPercent</td><td>BasePeakMz</td></tr><tr><td>1</td><td>0.423</td><td>0.474</td><td>0.574</td><td>1605457</td><td>7925924</td><td>20.49</td><td>5.51</td><td>150.1117</td></tr><tr><td>2</td><td>0.641</td><td>0.691</td><td>0.741</td><td>1260173</td><td>3247945</td><td>8.4</td><td>2.26</td><td>139.0495</td></tr><tr><td>3</td><td>5.433</td><td>5.517</td><td>5.617</td><td>929895</td><td>3587468</td><td>9.27</td><td>2.5</td><td>453.3415</td></tr><tr><td>4</td><td>9.274</td><td>9.357</td><td>9.441</td><td>2115277</td><td>5968077</td><td>15.43</td><td>4.15</td><td>568.2943</td></tr><tr><td>5</td><td>9.508</td><td>9.574</td><td>9.675</td><td>1806352</td><td>5584557</td><td>14.44</td><td>3.89</td><td>383.1507</td></tr><tr><td>6</td><td>15.853</td><td>16.054</td><td>16.438</td><td>2043093</td><td>25462871</td><td>65.83</td><td>17.72</td><td>326.377</td></tr><tr><td>7</td><td>18.024</td><td>18.108</td><td>18.225</td><td>3059381</td><td>14141487</td><td>36.56</td><td>9.84</td><td>311.1631</td></tr><tr><td>8</td><td>19.56</td><td>19.711</td><td>19.945</td><td>1145362</td><td>9522103</td><td>24.62</td><td>6.63</td><td>338.34</td></tr><tr><td>9</td><td>21.397</td><td>21.497</td><td>21.614</td><td>2927045</td><td>14662592</td><td>37.91</td><td>10.2</td><td>413.2648</td></tr><tr><td>10</td><td>24.036</td><td>24.654</td><td>25.271</td><td>1030920</td><td>38679784</td><td>100</td><td>26.91</td><td>663.451</td></tr></table>
539a492dcb46be56ce292100659ba734c182690ff0175cc73be6455d7225a8a1.png
complex
<table><tr><td>Characteristic</td><td>Entire Cohort (<i>n =</i> 88)</td><td>PD-L1 &#8805;36.5 &#8710;Ct</td><td>PD-L1 &lt; 36.5 &#8710;Ct</td><td><i>p</i>-Value</td><td>PD-L1 IHC &#8805; 1% (IC)</td><td>PD-L1 IHC &lt; 1% (IC)</td><td><i>p</i>-Value</td></tr><tr><td>pT-Stage</td><td></td><td></td><td></td><td rowspan="4">0.096</td><td></td><td></td><td rowspan="4">0.27</td></tr><tr><td>pT2</td><td>24 (27%)</td><td>13 (28%)</td><td>11 (26%)</td><td>8 (28%)</td><td>16 (27%)</td></tr><tr><td>pT3</td><td>47 (53%)</td><td>28 (61%)</td><td>19 (45%)</td><td>18 (62%)</td><td>29 (49%)</td></tr><tr><td>pT4</td><td>17 (20%)</td><td>5 (11%)</td><td>12 (29%)</td><td>3 (10%)</td><td>14 (24%)</td></tr><tr><td>pN-Stage</td><td></td><td></td><td></td><td rowspan="4">0.014</td><td></td><td></td><td rowspan="4">0.019</td></tr><tr><td>pN0</td><td>60 (68%)</td><td>36 (78%)</td><td>24 (57%)</td><td>23 (79%)</td><td>37 (63%)</td></tr><tr><td>pN1</td><td>9 (10%)</td><td>1 (2%)</td><td>8 (19%)</td><td>0 (0%)</td><td>9 (15%)</td></tr><tr><td>pN2</td><td>19 (22%)</td><td>9 (20%)</td><td>10 (24%)</td><td>6 (21%)</td><td>13 (22%)</td></tr><tr><td>Grading</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>WHO 1973</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>G2</td><td>4 (5%)</td><td>3 (7%)</td><td>1 (2%)</td><td>0.34</td><td>2 (7%)</td><td>2 (3%)</td><td>0.47</td></tr><tr><td>G3</td><td>84 (95%)</td><td>43 (93%)</td><td>41 (98%)</td><td></td><td>27 (93%)</td><td>57 (97%)</td><td></td></tr><tr><td></td><td>0 (0%)</td><td>0 (0%)</td><td>0 (0%)</td><td>1.0</td><td>0 (0%)</td><td>0 (0%)</td><td>1.00</td></tr><tr><td>WHO 2016</td><td>88 (100%)</td><td>46 (100%)</td><td>42 (100%)</td><td></td><td>29 (100%)</td><td>59 (100%)</td><td></td></tr><tr><td>Low grade</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>High grade</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>L1</td><td>50 (57%)</td><td>22 (48%)</td><td>28 (66%)</td><td>0.074</td><td>13 (45%)</td><td>37 (62%)</td><td>0.11</td></tr><tr><td>V1</td><td>26 (30%)</td><td>11 (24%)</td><td>15 (36%)</td><td>0.23</td><td>7 (24%)</td><td>19 (32%)</td><td>0.43</td></tr><tr><td>Pn1</td><td>27 (30%)</td><td>17 (37%)</td><td>10 (24%)</td><td>0.18</td><td>12 (41%)</td><td>15 (25%)</td><td>0.13</td></tr><tr><td>Carcinoma <i>in situ</i></td><td>62 (70%)</td><td>32 (70%)</td><td>30 (71%)</td><td>0.85</td><td>17 (58%)</td><td>45 (76%)</td><td>0.092</td></tr><tr><td>Median age (Min./Max.)</td><td>70.2 (41.3&#8211;90.8)</td><td>70.1 (50.7&#8211;85.4)</td><td>70.7 (41.3&#8211;90.8)</td><td>0.45</td><td>70.05 (53.6&#8211;84.4)</td><td>70.28 (41.3&#8211;90.8)</td><td>0.64</td></tr><tr><td>Adjuvant platinum-containing chemotherapy</td><td>29 (33%)</td><td>14 (30%)</td><td>15 (36%)</td><td>0.60</td><td>8 (28%)</td><td>21 (36%)</td><td>0.45</td></tr><tr><td>Median survival time (Min./Max.)</td><td>26.6 (0.03&#8211;135.7)</td><td>39.7 (0.83&#8211;135.7)</td><td>14.53 (0.03&#8211;114.83)</td><td>0.0065</td><td>40.9 (0.08&#8211;135.7)</td><td>20.83 (0.03&#8211;129.4)</td><td>0.088</td></tr><tr><td>Censors:</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Alive</td><td>28 (32%)</td><td>18 (39%)</td><td>10 (24%)</td><td>0.12</td><td>12 (41%)</td><td>16 (27%)</td><td>0.18</td></tr><tr><td>Deceased</td><td>60 (68%)</td><td>28 (61%)</td><td>32 (76%)</td><td>0.12</td><td>17 (59%)</td><td>43 (73%)</td><td>0.18</td></tr><tr><td>Tumor specific death</td><td>37 (42%)</td><td>15 (33%)</td><td>22 (52%)</td><td>0.15</td><td>10 (34%)</td><td>27 (46%)</td><td>0.31</td></tr></table>
f80583840ef39205075f8aa14a22f15fa6179de63fe6bdb1d5ebca8fbd3f788a.png
complex
<table><tr><td>Assembly</td><td><i>k</i>-mer</td><td>No. transcripts</td><td>Total Mbp</td><td>Mean transcript length (bp)</td><td>N50 (bp)</td><td>RMBT (%)</td><td>No. transcripts &gt;1 kb</td><td>CEGMA complete/partial (%)</td></tr><tr><td colspan="9">(A) ALL READS: 138 MILLION PAIRS</td></tr><tr><td>Oases SK</td><td>39</td><td>153,729</td><td>255</td><td>1662</td><td>3659</td><td>92</td><td>64,243</td><td>n/d</td></tr><tr><td>Oases MK</td><td></td><td>1,208,328</td><td>2601</td><td>2153</td><td>3487</td><td>96</td><td>763,694</td><td>n/d</td></tr><tr><td>CLC SK</td><td>25</td><td>220,829</td><td>145</td><td>657</td><td>877</td><td>86</td><td>32,545</td><td>n/d</td></tr><tr><td>CLC MK</td><td></td><td>201,432</td><td>210</td><td>1042</td><td>1707</td><td>95</td><td>62,038</td><td>n/d</td></tr><tr><td colspan="9">(B) SUB-SAMPLE OF READS: 30 MILLION PAIRS</td></tr><tr><td>Oases SK</td><td>23</td><td>78,640</td><td>125</td><td>1588</td><td>3144</td><td>90</td><td>34,850</td><td>87.5/98.8</td></tr><tr><td>Oases MK</td><td></td><td>507,954</td><td>1014</td><td>1996</td><td>3068</td><td>94</td><td>319,913</td><td>92.7/99.6</td></tr><tr><td>CLC SK</td><td>25</td><td>97,375</td><td>76</td><td>781</td><td>1346</td><td>87</td><td>16,121</td><td>79.8/94.0</td></tr><tr><td>CLC MK</td><td></td><td>144,789</td><td>190</td><td>1315</td><td>2635</td><td>95</td><td>51,516</td><td>94.8/99.2</td></tr><tr><td>ABySS SK</td><td>35</td><td>53,368</td><td>47</td><td>878</td><td>1439</td><td>59</td><td>12,936</td><td>33.1/65.3</td></tr><tr><td>ABySS MK</td><td></td><td>89,457</td><td>108</td><td>1204</td><td>2158</td><td>87</td><td>32,797</td><td>83.5/96.8</td></tr></table>
228c75463efaa506ba8baf972e4882fb2e6c4856a8c4c59115fc83a0fee76b6c.png
complex
<table><tr><td rowspan="2">Amino Acid</td><td colspan="2">Relative Content (g/100 g) <sup>a,b</sup></td></tr><tr><td>ACP</td><td>CCP</td></tr><tr><td>Asp</td><td>5.68</td><td>5.17</td></tr><tr><td>Glu</td><td>10.51</td><td>11.53</td></tr><tr><td>Ser</td><td>3.38</td><td>3.17</td></tr><tr><td>Gly</td><td>19.84</td><td>21.28</td></tr><tr><td>His</td><td>3.27</td><td>2.97</td></tr><tr><td>Thr</td><td>7.90</td><td>8.51</td></tr><tr><td>Ala</td><td>4.09</td><td>4.68</td></tr><tr><td>Pro</td><td>12.47</td><td>12.18</td></tr><tr><td>Arg</td><td>8.61</td><td>8.47</td></tr><tr><td>Tyr</td><td>2.28</td><td>1.79</td></tr><tr><td>Val</td><td>3.06</td><td>2.90</td></tr><tr><td>Met</td><td>1.79</td><td>1.27</td></tr><tr><td>Cys</td><td>2.39</td><td>2.08</td></tr><tr><td>Ile</td><td>4.11</td><td>3.93</td></tr><tr><td>Leu</td><td>0.70</td><td>0.08</td></tr><tr><td>Phe</td><td>9.31</td><td>9.36</td></tr><tr><td>Lys</td><td>0.61</td><td>0.62</td></tr><tr><td>Total</td><td>100.00</td><td>100.00</td></tr></table>
cb016346f8e4307d3271a43d7b603938f8091d872c016e47e18ae6d5ed01edab.png
complex
<table><tr><td rowspan="2"></td><td>Boys</td><td>Girls</td></tr><tr><td>N = 139</td><td>N = 144</td></tr><tr><td></td><td>Mean [percentage]</td><td>Mean [percentage]</td></tr><tr><td>Migrant families</td><td>[79.7%]</td><td>[83.0%]</td></tr><tr><td>Native-born families</td><td>[20.3%]</td><td>[17.0%]</td></tr><tr><td>Age</td><td>4.25 (SD 0.88)</td><td>4.25 (SD 0.82)</td></tr><tr><td><i>Area of education</i></td><td></td><td></td></tr><tr><td>St Gallus</td><td>[25.2%]</td><td>[30.6%]</td></tr><tr><td>St Pius</td><td>[19.4%]</td><td>[14.6%]</td></tr><tr><td>St Fidelis</td><td>[17.3%]</td><td>[16.0%]</td></tr><tr><td>St. Martin</td><td>[15.1%]</td><td>[17.4%]</td></tr><tr><td>St. Michael</td><td>[23.0%]</td><td>[21.4%]</td></tr><tr><td><i>Origin of migrant families:</i></td><td></td><td></td></tr><tr><td>Asia</td><td>[40.2%]</td><td>[45.5%]</td></tr><tr><td>Africa</td><td>[40.2%]</td><td>[30.3%]</td></tr><tr><td>Eastern Europe</td><td>[15.2%]</td><td>[5.1%]</td></tr><tr><td>Western Europe</td><td>[3.3%]</td><td>[15.2%]</td></tr><tr><td>North and South America</td><td>[1.1%]</td><td>[4%]</td></tr></table>
2469abbb6cf8939247c98ae58f6ffa7b3cf04e2eab5ea0bad4b5d9ae522c92ce.png
complex
<table><tr><td> </td><td> </td><td>ILOC</td><td>p-value</td><td>PLOC</td><td>p-value</td><td>CLOC</td><td>p-value</td></tr><tr><td>Behaviour</td><td> </td><td>OR (95% CI)</td><td> </td><td>OR (95% CI)</td><td> </td><td>OR (95% CI)</td><td> </td></tr><tr><td rowspan="3">Cigarette smoking (N=3229 )</td><td>Non-Smoker</td><td>1</td><td> </td><td>1</td><td> </td><td>1</td><td> </td></tr><tr><td>Ex-Smoker</td><td>1.01 (0.95-1.07)</td><td>0.826</td><td>0.95 (0.89-1.01)</td><td>0.084</td><td>0.96 (0.91-1.02)</td><td>0.230</td></tr><tr><td>Smoker</td><td>1.01 (0.96-1.06)</td><td>0.778</td><td>0.97 (0.92-1.02)</td><td>0.165</td><td>1.09 (1.04-1-15)</td><td>0.001</td></tr><tr><td rowspan="5">Alcohol consumption (N=3271)</td><td>Never</td><td>1</td><td> </td><td>1</td><td> </td><td>1</td><td> </td></tr><tr><td>Less than once a week</td><td>1.03 (0.96-1.11)</td><td>0.449</td><td>1.03 (0.95-1.11)</td><td>0.494</td><td>0.97 (0.90-1.04)</td><td>0.397</td></tr><tr><td>Once a week</td><td>1.04 (0.97-1-12)</td><td>0.318</td><td>0.99 (0.92-1.07)</td><td>0.847</td><td>0.96 (0.89-1.04)</td><td>0.318</td></tr><tr><td>Several times every week</td><td>1.04 (0.97-1-12)</td><td>0.297</td><td>0.94 (0.87-1.01)</td><td>0.111</td><td>1.02 (0.95-1.10)</td><td>0.563</td></tr><tr><td>Every day or more</td><td>1.07 (0.93-1.23)</td><td>0.363</td><td>0.95 (0.82-1.09)</td><td>0.442</td><td>1.19 (0.97-1.07)</td><td>0.013</td></tr><tr><td rowspan="2">Drug intake (N=3189)</td><td>No</td><td>1</td><td rowspan="2">0.801</td><td>1</td><td rowspan="2">0.012</td><td>1</td><td rowspan="2">0.319</td></tr><tr><td>Yes</td><td>0.99 (0.93-1.06)</td><td>0.92 (0.85-0.98)</td><td>1.04 (0.97-1.11)</td></tr><tr><td rowspan="3">Weight (N=3154)</td><td>Underweight</td><td>0.93 (0.84-1.02)</td><td>0.116</td><td>1.10 (0.99-1.22)</td><td>0.069</td><td>0.91 (0.82-1.01)</td><td>0.068</td></tr><tr><td>Normal weight</td><td>1</td><td> </td><td>1</td><td> </td><td>1</td><td> </td></tr><tr><td>Overweight</td><td>0.98 (0.93-1.04)</td><td>0.562</td><td>1.04 (0.99-1.10)</td><td>0.133</td><td>1.04 (0.98-1.09)</td><td>0.019</td></tr><tr><td rowspan="3">Physical activity (N=3263)</td><td>At least 3 times a week</td><td>1</td><td> </td><td>1</td><td> </td><td>1</td><td> </td></tr><tr><td>1 to 2 times a week</td><td>0.87 (0.83-0.91)</td><td>&lt;0.001</td><td>1.08 (1.03-1.13)</td><td>0.002</td><td>1.06 (1.01-1.11)</td><td>0.019</td></tr><tr><td>Less than once a week</td><td>0.86 (0.81-0.91)</td><td>&lt;0.001</td><td>1.07 (1.01-1.13)</td><td>0.026</td><td>1.12 (1.06-1.18)</td><td>&lt;0.001</td></tr><tr><td rowspan="4">Importance of healthy nutrition (N=3281)</td><td>Very important</td><td>1</td><td> </td><td>1</td><td> </td><td>1</td><td> </td></tr><tr><td>Somewhat important</td><td>0.89 (0.84-0.94)</td><td>&lt;0.001</td><td>1.02 (0.97-1.08)</td><td>0.458</td><td>1.04 (0.99-1.10)</td><td>0.140</td></tr><tr><td>Important</td><td>0.79 (0.74-0.84)</td><td>&lt;0.001</td><td>0.96 (0.90-1.02)</td><td>0.135</td><td>1.10 (1.04-1.17)</td><td>0.001</td></tr><tr><td>Somewhat unimportant</td><td>0.79 (0.72-0.87)</td><td>&lt;0.001</td><td>0.90 (0.82-0.99)</td><td>0.025</td><td>1.25 (1.14-1.37)</td><td>&lt;0.001</td></tr><tr><td> </td><td>Very unimportant</td><td>0.64 (0.55-0.74)</td><td>&lt;0.001</td><td>0.83 (0.71-0.97)</td><td>0.016</td><td>1.29 (1.11-1.49)</td><td>0.001</td></tr></table>
b7d67f440601d2a69af6d03005f6f8845bfdfaf8b7ca9d52b838fb96b185ea1c.png
simple
<table><tr><td>Cluster</td><td>Tree distance</td><td><i>q</i></td><td><i>q<sup>+</sup></i></td></tr><tr><td>dro1</td><td>0.039669</td><td>0.961108</td><td>1</td></tr><tr><td>dro2</td><td>0.21</td><td>0.810584</td><td>0.849477</td></tr><tr><td>dro_anoGam</td><td>0.191225384</td><td>0.825946</td><td>0.864839</td></tr><tr><td>dro_apiMel</td><td>0.231922</td><td>0.793008</td><td>0.8319</td></tr><tr><td>dro_triCas</td><td>0.324132615</td><td>0.723154</td><td>0.762047</td></tr><tr><td>all</td><td>0.3252756</td><td>0.722328</td><td>0.761221</td></tr></table>
d70e6e178a1815898dd30ca5632ab5315e146a8437906cc174bd7e5f69507700.png
complex
<table><tr><td rowspan="2">PHB/ENR-50 composition</td><td rowspan="2">Clay content (wt%)</td><td colspan="4">DSC *</td><td colspan="5">TG-DTG **</td></tr><tr><td><i>T</i><sub>g1</sub> (&#176;C)</td><td><i>T</i><sub>g2</sub> (&#176;C)</td><td><i>T<sub>m</sub></i> (&#176;C)</td><td>&#8710;<i>H</i><sub>m</sub> (J/g)</td><td><i>T</i><sub>10</sub> (&#176;C)</td><td><i>T</i><sub>20</sub> (&#176;C)</td><td><i>T</i><sub>30</sub> (&#176;C)</td><td><i>T</i><sub>max1</sub> (&#176;C)</td><td><i>T</i><sub>max2</sub> (&#176;C)</td></tr><tr><td rowspan="4">30/70</td><td>0</td><td>&#8722;18.1</td><td>&#8211;</td><td>169.6</td><td>25.8</td><td>255.6</td><td>281.5</td><td>370.4</td><td>280.9</td><td>433.1</td></tr><tr><td>1</td><td>&#8722;18.8</td><td>53.5</td><td>172.4</td><td>4.1</td><td>270.4</td><td>318.5</td><td>366.7</td><td>332.8</td><td>438.2</td></tr><tr><td>3</td><td>&#8211;</td><td>49.3</td><td>&#8211;</td><td>&#8211;</td><td>296.3</td><td>366.7</td><td>403.7</td><td>310.9</td><td>432.7</td></tr><tr><td>5</td><td>&#8211;</td><td>60.0</td><td>&#8211;</td><td>&#8211;</td><td>314.8</td><td>377.8</td><td>414.8</td><td>291.0</td><td>430.7</td></tr><tr><td rowspan="4">50/50</td><td>0</td><td>&#8722;17.7</td><td>&#8211;</td><td>170.2</td><td>37.5</td><td>248.2</td><td>259.3</td><td>270.4</td><td>279.1</td><td>437.8</td></tr><tr><td>1</td><td>&#8211;</td><td>60.7</td><td>172.4</td><td>9.1</td><td>266.7</td><td>281.5</td><td>307.4</td><td>313.9</td><td>431.5</td></tr><tr><td>3</td><td>&#8211;</td><td>57.3</td><td>&#8211;</td><td>&#8211;</td><td>274.1</td><td>340.7</td><td>388.9</td><td>300.0</td><td>429.5</td></tr><tr><td>5</td><td>&#8211;</td><td>58.6</td><td>&#8211;</td><td>&#8211;</td><td>285.2</td><td>388.9</td><td>425.9</td><td>294.4</td><td>441.0</td></tr><tr><td rowspan="4">70/30</td><td>0</td><td>&#8722;19.3</td><td>&#8211;</td><td>173.1</td><td>53.7</td><td>235.2</td><td>242.6</td><td>248.2</td><td>276.9</td><td>414.2</td></tr><tr><td>1</td><td>&#8211;</td><td>58.0</td><td>172.8</td><td>18.3</td><td>281.5</td><td>292.6</td><td>300.0</td><td>303.6</td><td>446.7</td></tr><tr><td>3</td><td>&#8211;</td><td>57.4</td><td>170.0</td><td>1.9</td><td>274.1</td><td>296.3</td><td>377.8</td><td>297.9</td><td>438.7</td></tr><tr><td>5</td><td>&#8211;</td><td>54.3</td><td>&#8211;</td><td>&#8211;</td><td>266.7</td><td>355.6</td><td>407.4</td><td>284.1</td><td>429.5</td></tr></table>
59a009a39824d69fde93d6109507b32953d59ca1e1159d7c174a3aa793343de1.png
simple
<table><tr><td>Antibiotics Tested</td><td>No. (%) Resistant <sup>a</sup></td></tr><tr><td>Cefoxitin (CX) </td><td>34 (20.12%)</td></tr><tr><td>Cefotaxime (CTX) </td><td>165 (97.63%)</td></tr><tr><td>Ceftazidime (CAZ) </td><td>154 (91.12%)</td></tr><tr><td>Cefpodoxime (CPD)</td><td>156 (92.30%)</td></tr><tr><td>Imipenem (IPM) </td><td>18 (10.65%)</td></tr><tr><td>Ertapenem (ETP) </td><td>69 (40.82%)</td></tr><tr><td>Meropenem (MRP) </td><td>53 (31.36%)</td></tr><tr><td>Ciprofloxacin (CIP)</td><td>27 (15.98%)</td></tr><tr><td>Aztreonam (AT) </td><td>110 (65.08%)</td></tr><tr><td>Amox/clav (AMC) </td><td>65 (38.46%)</td></tr><tr><td>Piperacillin/Tazobactam (TZP) </td><td>69 (40.82%)</td></tr></table>
e97995388d0d0628221fdc83c85b8dfe611920f71ce5c7f82ddcd27e2063a5ab.png
complex
<table><tr><td rowspan="2">Smoking groups</td><td colspan="4">Women (<i>n</i> = 1741)</td><td colspan="4">Men (<i>n</i> = 1637)</td><td></td></tr><tr><td><i>n</i></td><td>Median</td><td>5th perc.</td><td>95th perc.</td><td><i>n</i></td><td>Median</td><td>5th perc.</td><td>95th perc.</td><td><i>p</i> value<sup>a</sup></td></tr><tr><td>Never smokers</td><td>868</td><td>15.7</td><td>7.8</td><td>35.7</td><td>817</td><td>19.0</td><td>9.0</td><td>44.2</td><td>&lt;0.0001</td></tr><tr><td>Former smokers</td><td>581</td><td>16.3</td><td>7.6</td><td>35.6</td><td>615</td><td>18.9</td><td>9.2</td><td>39.9</td><td>&lt;0.0001</td></tr><tr><td>Current smokers</td><td>292</td><td>10.4<sup>b</sup></td><td>4.4</td><td>29.4</td><td>205</td><td>13.2 <sup>b</sup></td><td>6.2</td><td>34.3</td><td>&lt;0.0001</td></tr><tr><td>All subjects</td><td>1741</td><td>15.0</td><td>6.6</td><td>35.3</td><td>1637</td><td>18.2</td><td>8.2</td><td>41.3</td><td>&lt;0.001.</td></tr></table>
3b5380e1d8fb6db8612cf0514ae257c35f9e01938fe7fbb52c02addaa1077660.png
complex
<table><tr><td> </td><td colspan="2">Changes between years</td><td colspan="3">Difference in the changes</td><td> </td></tr><tr><td> </td><td>EG</td><td>Non EG</td><td>Mean</td><td colspan="2">95% CI</td><td>Sig.</td></tr><tr><td>2003-2005</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>HCE as % of total expenditure (%)</td><td>&#8722;0.528</td><td>0.458</td><td>&#8722;0.987</td><td>&#8722;1.651</td><td>&#8722;0.398</td><td>Yes</td></tr><tr><td>Number of self-treatment (#)</td><td>&#8722;0.991</td><td>&#8722;1.094</td><td>0.103</td><td>&#8722;0.157</td><td>0.359</td><td>No</td></tr><tr><td>Number of go-to-pharmacy (#)</td><td>&#8722;0.030</td><td>&#8722;0.046</td><td>0.016</td><td>&#8722;0.099</td><td>0.101</td><td>No</td></tr><tr><td>Number of private health care utilizations (#)</td><td>&#8722;0.188</td><td>&#8722;0.204</td><td>0.016</td><td>&#8722;0.119</td><td>0.149</td><td>No</td></tr><tr><td>Number of CHS utilizations (#)</td><td>0.005</td><td>&#8722;0.046</td><td>0.052</td><td>&#8722;0.025</td><td>0.102</td><td>No</td></tr><tr><td>Number of DH utilizations (#)</td><td>0.016</td><td>0.019</td><td>&#8722;0.003</td><td>&#8722;0.046</td><td>0.033</td><td>No</td></tr><tr><td>Number of P/CH utilizations (#)</td><td>&#8722;0.010</td><td>0.007</td><td>&#8722;0.017</td><td>&#8722;0.042</td><td>0.012</td><td>No</td></tr><tr><td>Total number of utilizations (#)</td><td>&#8722;1.199</td><td>&#8722;1.365</td><td>0.167</td><td>&#8722;0.249</td><td>0.545</td><td>No</td></tr><tr><td>2005-2007</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>HCE as % of total expenditure (%)</td><td>&#8722;0.065</td><td>0.222</td><td>&#8722;0.287</td><td>&#8722;1.066</td><td>0.560</td><td>No</td></tr><tr><td>Number of self-treatment (#)</td><td>0.196</td><td>&#8722;0.062</td><td>0.258</td><td>&#8722;0.103</td><td>0.484</td><td>No</td></tr><tr><td>Number of go-to-pharmacy (#)</td><td>0.209</td><td>0.182</td><td>0.027</td><td>&#8722;0.083</td><td>0.123</td><td>No</td></tr><tr><td>Number of private health care utilizations (#)</td><td>0.014</td><td>0.021</td><td>&#8722;0.007</td><td>&#8722;0.164</td><td>0.066</td><td>No</td></tr><tr><td>Number of CHS utilizations (#)</td><td>0.016</td><td>0.030</td><td>&#8722;0.013</td><td>&#8722;0.111</td><td>0.053</td><td>No</td></tr><tr><td>Number of DH utilizations (#)</td><td>0.247</td><td>0.269</td><td>&#8722;0.022</td><td>&#8722;0.093</td><td>0.047</td><td>No</td></tr><tr><td>Number of P/CH utilizations (#)</td><td>0.034</td><td>&#8722;0.005</td><td>0.039</td><td>0.016</td><td>0.075</td><td>Yes</td></tr><tr><td>Total number of utilizations (#)</td><td>0.716</td><td>0.434</td><td>0.282</td><td>&#8722;0.350</td><td>0.690</td><td>No</td></tr><tr><td>2003-2007</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>HCE as % of total expenditure (%)</td><td>&#8722;0.588</td><td>0.640</td><td>&#8722;1.227</td><td>&#8722;2.312</td><td>&#8722;0.724</td><td>Yes</td></tr><tr><td>Number of self-treatment (#)</td><td>&#8722;0.797</td><td>&#8722;1.165</td><td>0.368</td><td>0.067</td><td>0.663</td><td>Yes</td></tr><tr><td>Number of go-to-pharmacy (#)</td><td>0.176</td><td>0.143</td><td>0.033</td><td>&#8722;0.070</td><td>0.124</td><td>No</td></tr><tr><td>Number of private health care utilizations (#)</td><td>&#8722;0.176</td><td>&#8722;0.190</td><td>0.014</td><td>&#8722;0.154</td><td>0.115</td><td>No</td></tr><tr><td>Number of CHS utilizations (#)</td><td>0.023</td><td>&#8722;0.015</td><td>0.038</td><td>&#8722;0.030</td><td>0.123</td><td>No</td></tr><tr><td>Number of DH utilizations (#)</td><td>0.262</td><td>0.280</td><td>&#8722;0.018</td><td>&#8722;0.088</td><td>0.043</td><td>No</td></tr><tr><td>Number of P/CH utilizations (#)</td><td>0.023</td><td>0.002</td><td>0.021</td><td>0.001</td><td>0.051</td><td>Yes</td></tr><tr><td>Total number of utilizations (#)</td><td>&#8722;0.488</td><td>&#8722;0.944</td><td>0.456</td><td>&#8722;0.013</td><td>0.825</td><td>No</td></tr></table>
4d921ce63998537e26c9962f01072e82d1295a0a62953479d7525eb59ec3b850.png
simple
<table><tr><td></td><td>Crude model 1OR (95 % CI)</td><td>Model 2OR (95 % CI)</td><td>Model 3OR (95 % CI)</td><td>Mediating effect of maternal burden of care(%)</td><td>Model 4OR (95 % CI)</td><td>Mediating effectof maternal aggressive behavior(%)</td></tr><tr><td>Overall problem score P80</td><td>3.27 (2.11&#8211;5.07)</td><td>2.12 (1.30&#8211;3.46)</td><td>1.98 (1.21&#8211;3.24)</td><td>12.5 %</td><td>1.90 (1.16&#8211;3.1 2)</td><td>9 %</td></tr><tr><td>Conduct problems P80</td><td>2.25 (1.46&#8211;3.48)</td><td>1.75 (1.09&#8211;2.81)</td><td>1.63 (1.00&#8211;2.62)</td><td>16 %</td><td>1.61 (0.99&#8211;2.56)</td><td>6 %</td></tr><tr><td>Emotional symptoms P80</td><td>2.13 (1.37&#8211;3.34)</td><td>1.54 (0.96&#8211;2.47)</td><td>1.42 (0.88&#8211;2.28)</td><td></td><td>1.41 (0.88&#8211;2.28)</td><td></td></tr><tr><td>Hyperactivity P80</td><td>2.28 (1.47&#8211;3.53)</td><td>1.76 (1.10&#8211;2.82)</td><td>1.75 (1.09&#8211;2.82)</td><td>1 %</td><td>1.72 (1.07&#8211;2.78)</td><td>4 %</td></tr><tr><td>Peer problems P80</td><td>2.55 (1.62&#8211;4.01)</td><td>1.63 (0.79&#8211;2.73)</td><td>1.61 (0.96&#8211;2.70)</td><td></td><td>1.60 (0.95&#8211;2.70)</td><td></td></tr><tr><td>Pro-social P20</td><td>1.74 (1.08&#8211;2.80)</td><td>1.45 (0.87&#8211;2.42)</td><td>1.36 (0.81&#8211;2.28)</td><td></td><td>1.32 (0.79&#8211;2.22)</td><td></td></tr><tr><td>SMFQ P80</td><td>2.62 (1.70&#8211;4.05)</td><td>1.84 (1.14&#8211;2.96)</td><td>1.70 (1.05&#8211;2.74)</td><td>17 %</td><td>1.63 (1.01&#8211;2.65)</td><td>10 %</td></tr><tr><td>Generalized anxiety P80</td><td>1.87 (1.19&#8211;2.92)</td><td>1.25 (0.77&#8211;2.02)</td><td>1.19 (0.74&#8211;1.94)</td><td></td><td>1.17 (0.72&#8211;1.90)</td><td></td></tr></table>
9812e39e9aa3816dbd5f3d8d2d81482bcf83a7e2e13e1a966f4bd0871b4e3627.png
complex
<table><tr><td></td><td>ESI</td><td colspan="2">SRM Transition (<i>m/z</i>&#8594;<i>m/z</i>)</td><td>Collision</td><td>~tR</td></tr><tr><td>Mycotoxin</td><td>(+ or -)</td><td>Quantitative</td><td>Qualitative</td><td>Energy</td><td>(min)</td></tr><tr><td>DON</td><td>-</td><td>341.0&#8594;265.0</td><td>341.0&#8594;247.0</td><td>18</td><td>6.1</td></tr><tr><td>HT2</td><td>+</td><td>442.2&#8594;263.0</td><td>442.2&#8594;215.0</td><td>18</td><td>8.9</td></tr><tr><td>T2</td><td>+</td><td>484.2&#8594;185.0</td><td>484.2&#8594;305.0</td><td>18</td><td>9.3</td></tr><tr><td>ZON</td><td>-</td><td>317.0&#8594;174.5</td><td>317.0&#8594;130.5</td><td>25</td><td>10.1</td></tr><tr><td>FB<sub>1</sub></td><td>+</td><td>722.5&#8594;334.4</td><td>722.5&#8594;352.2</td><td>40</td><td>9.2</td></tr><tr><td>OTA</td><td>+</td><td>404.0&#8594;239.0</td><td>404.0&#8594;358.4</td><td>20</td><td>9.9</td></tr><tr><td>FB<sub>2</sub></td><td>+</td><td>706.4&#8594;336.2</td><td>706.4&#8594;354.2</td><td>35</td><td>10.2</td></tr><tr><td>Meloxicam (IS)</td><td>+</td><td>-</td><td>352.0&#8594;115.0</td><td>20</td><td>8.6/9.1</td></tr></table>
84ef94afab7f0d325ceeb3fd44eb6378e67df6f76e73cb1abd3a41c857a604f3.png
complex
<table><tr><td rowspan="2">OTUs</td><td>Mucus</td><td>Seawater</td><td rowspan="2">OTU contribution (%)b</td><td rowspan="2">Cumulative contribution (%)</td></tr><tr><td>Average abundancea</td><td>Average abundancea</td></tr><tr><td>Unclassified Pseudoalteromonadaceae</td><td>2,203.67</td><td>10,112.13</td><td>21.86</td><td>21.86</td></tr><tr><td>Unclassified Desulfovibrionaceae</td><td>2,253.75</td><td>158.88</td><td>6.01</td><td>27.87</td></tr><tr><td>Unclassified Flavobacteriaceae</td><td>1,396.42</td><td>8.13</td><td>3.64</td><td>31.51</td></tr><tr><td><i>Alteromonas</i></td><td>45.83</td><td>1,417.5</td><td>3.58</td><td>35.1</td></tr><tr><td><i>Ruegeria</i>*</td><td>1,189.92</td><td>372.75</td><td>3.28</td><td>38.38</td></tr><tr><td><i>Vibrio</i></td><td>276.67</td><td>1,247.75</td><td>2.83</td><td>41.21</td></tr><tr><td><i>Pseudoalteromonas</i></td><td>1,090.67</td><td>100.63</td><td>2.76</td><td>43.97</td></tr><tr><td><i>Arcobacter</i></td><td>1,010.17</td><td>2.38</td><td>2.64</td><td>46.61</td></tr><tr><td>Unclassified Desulfobulbaceae</td><td>847.92</td><td>1.25</td><td>2.22</td><td>48.82</td></tr><tr><td>Unclassified Desulfovibrionaceae</td><td>825.17</td><td>41.25</td><td>2.19</td><td>51.02</td></tr><tr><td><i>Idiomarina</i></td><td>76.58</td><td>817.13</td><td>2.17</td><td>53.18</td></tr><tr><td>Unclassified Rhodobacteraceae</td><td>910.33</td><td>276.5</td><td>2.15</td><td>55.34</td></tr><tr><td>Unclassified Hyphomonadaceae</td><td>804.17</td><td>2.75</td><td>2.1</td><td>57.44</td></tr><tr><td><i>Halomonas</i></td><td>560.92</td><td>122.13</td><td>1.64</td><td>59.08</td></tr><tr><td><i>Thalassospira</i></td><td>563.33</td><td>69.25</td><td>1.56</td><td>60.64</td></tr><tr><td><i>Alcanivorax</i></td><td>18.42</td><td>600.38</td><td>1.53</td><td>62.16</td></tr><tr><td><i>Marinobacter</i></td><td>10.92</td><td>543.63</td><td>1.41</td><td>63.57</td></tr><tr><td>Unclassified Vibrionaceae</td><td>613.17</td><td>153.75</td><td>1.28</td><td>64.85</td></tr><tr><td>Unclassified Acidaminobacteraceae</td><td>476.67</td><td>0</td><td>1.25</td><td>66.09</td></tr><tr><td>Unclassified Flavobacteriaceae</td><td>398.25</td><td>15.75</td><td>1.03</td><td>67.13</td></tr><tr><td><i>Oceanicaulis</i></td><td>317</td><td>141.38</td><td>0.97</td><td>68.1</td></tr><tr><td><i>Idiomarina</i></td><td>35.08</td><td>389</td><td>0.92</td><td>69.02</td></tr><tr><td><i>Marinobacter</i></td><td>0.17</td><td>334.25</td><td>0.87</td><td>69.9</td></tr><tr><td colspan="5"><i>Phylum</i></td></tr><tr><td>Proteobacteria</td><td></td><td></td><td>63.97</td><td>63.97</td></tr><tr><td>Firmicutes</td><td></td><td></td><td>1.25</td><td>65.22</td></tr><tr><td>Bacteriodetes</td><td></td><td></td><td>4.67</td><td>69.89</td></tr></table>
31511de482299c342adf8e815a372d644123709080b331abaab46833e473818b.png
simple
<table><tr><td><i>Nocardia</i> spp. (no. of strains)</td><td>Agreement between 16S and MALDI-TOF MS</td><td>No. of strains in the Bruker database</td></tr><tr><td>High prevalence (<i>n</i> = 25)</td><td></td><td></td></tr><tr><td><i>Nocardia abscessus</i> (<i>n</i> = 2)</td><td>2/2</td><td>2</td></tr><tr><td><i>N. cyriacigeorgica</i> (<i>n</i> = 6)</td><td>5/6</td><td>16</td></tr><tr><td><i>N. farcinica</i> (<i>n</i> = 8)</td><td>7/8</td><td>12</td></tr><tr><td><i>N. nova</i> (<i>n</i> = 9)</td><td>5/9</td><td>2</td></tr><tr><td>Total (%)</td><td>19/25 (76.0%)</td><td>32</td></tr><tr><td>Intermediate prevalence (<i>n</i> = 20)</td><td></td><td></td></tr><tr><td><i>N. brasiliensis</i> (<i>n</i> = 5)</td><td>3/5</td><td>1</td></tr><tr><td><i>N. carnea</i> (<i>n</i> = 7)</td><td>1/7</td><td>1</td></tr><tr><td><i>N. otitidiscaviarum</i> (<i>n</i> = 5)</td><td>5/5</td><td>6</td></tr><tr><td><i>N. transvalensis</i> complex (<i>n</i> = 3)</td><td>0/3</td><td>1</td></tr><tr><td>Total (%)</td><td>9/20 (45%)</td><td>9</td></tr><tr><td>Low prevalence (<i>n</i> = 55)</td><td></td><td></td></tr><tr><td>22 <i>Nocardia</i> species:</td><td>5/55</td><td>45</td></tr><tr><td>-13 <i>Nocardia</i> species included in Bruker database (<i>n</i> = 28)</td><td>5/23</td><td>45</td></tr><tr><td>-9 <i>Nocardia</i> species not included in Bruker database (<i>n</i> = 27)</td><td>0</td><td>0</td></tr><tr><td>Total (%)</td><td>5/55 (9.1%)</td><td>45</td></tr></table>
ecfd8e38fb12f9ea5eb444d8067e9694527cc39be0a16d9ee491b052e6cf56bc.png
simple
<table><tr><td>Diagnosis</td><td>Indication</td><td>Type of procedure</td></tr><tr><td>HLHS</td><td>Trans-isthmus gradient &gt; 20 mmHg</td><td>Balloon angioplasty</td></tr><tr><td>DILV</td><td>SVC-LPA 2 mmHg gradient</td><td>LPA balloon angioplasty</td></tr><tr><td>TA</td><td>Significant LPA stenosis at X-ray angiography</td><td>LPA balloon angioplasty</td></tr><tr><td>PAIVS</td><td>Veno-venous collateral draining into the CS</td><td>Embolization</td></tr><tr><td>TA</td><td>Veno-venous collateral draining into the atrium</td><td>Embolization</td></tr><tr><td>Complex 2 ventricles</td><td>BTm shunt center opened at previous surgery</td><td>Embolization</td></tr></table>
41baf412fb3ded9de715031eaf1d56cd87dae40be491e5cf583d25e409e0948c.png
complex
<table><tr><td></td><td colspan="4">Likelihood</td></tr><tr><td>Covariate</td><td>WHO</td><td>Int 1</td><td>Int 2</td><td>Exact</td></tr><tr><td>Age (centered at 40 in y)</td><td>0.968 (0.966&#8211;0.970)</td><td>0.969 (0.967&#8211;0.971)</td><td>0.968 (0.967&#8211;0.970)</td><td>0.968 (0.967&#8211;0.970)</td></tr><tr><td>Alcohol intake (g/d)</td><td>1.002 (0.999&#8211;1.004)</td><td>1.003 (1.001&#8211;1.005)</td><td>1.003 (1.001&#8211;1.004)</td><td>1.002 (1.001&#8211;1.004)</td></tr><tr><td>Fruit and vegetables</td><td></td><td></td><td></td><td></td></tr><tr><td>High</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Low</td><td>0.880 (0.824&#8211;0.940)</td><td>0.928 (0.874&#8211;0.986)</td><td>0.929 (0.878&#8211;0.983)</td><td>0.929 (0.878&#8211;0.983)</td></tr><tr><td>Physical activity</td><td></td><td></td><td></td><td></td></tr><tr><td>High</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Moderate</td><td>0.836 (0.774&#8211;0.903)</td><td>0.850 (0.792&#8211;0.912)</td><td>0.863 (0.808&#8211;0.921)</td><td>0.862 (0.808&#8211;0.921)</td></tr><tr><td>Low</td><td>0.695 (0.640&#8211;0.756)</td><td>0.743 (0.688&#8211;0.802)</td><td>0.769 (0.716&#8211;0.827)</td><td>0.769 (0.716&#8211;0.826)</td></tr><tr><td>Education</td><td></td><td></td><td></td><td></td></tr><tr><td>Mandatory</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Secondary</td><td>1.095 (0.992&#8211;1.209)</td><td>1.252 (1.141&#8211;1.373)</td><td>1.256 (1.150&#8211;1.371)</td><td>1.254 (1.149&#8211;1.369)</td></tr><tr><td>Tertiary</td><td>1.604 (1.441&#8211;1.786)</td><td>1.760 (1.594&#8211;1.944)</td><td>1.785 (1.625&#8211;1.961)</td><td>1.781 (1.622&#8211;1.956)</td></tr><tr><td>Nationality</td><td></td><td></td><td></td><td></td></tr><tr><td>Swiss</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Foreign</td><td>0.785 (0.728&#8211;0.848)</td><td>0.832 (0.776&#8211;0.893)</td><td>0.810 (0.758&#8211;0.864)</td><td>0.809 (0.758&#8211;0.864)</td></tr><tr><td>Region</td><td></td><td></td><td></td><td></td></tr><tr><td>German speaking</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>French speaking</td><td>1.175 (1.091&#8211;1.266)</td><td>1.147 (1.071&#8211;1.228)</td><td>1.134 (1.063&#8211;1.208)</td><td>1.133 (1.063&#8211;1.208)</td></tr><tr><td>Italian speaking</td><td>1.190 (1.026&#8211;1.382)</td><td>1.173 (1.024&#8211;1.344)</td><td>1.236 (1.086&#8211;1.405)</td><td>1.234 (1.085&#8211;1.403)</td></tr></table>
33aaaa7b0ae915a951b09a1592282859fcaec3953014b3f6e862f3e89cac8097.png
complex
<table><tr><td></td><td colspan="2">Total</td><td colspan="2">SPM-Free</td><td colspan="2">SPM</td><td>P-values<sup>c</sup></td></tr><tr><td>Variable</td><td>No.</td><td>%</td><td>No.</td><td>%</td><td>No.</td><td>%</td><td></td></tr><tr><td>Total patients</td><td>1,292</td><td>100</td><td>1,172</td><td>100</td><td>120</td><td>100</td><td></td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> &#8804; median (57 years)</td><td>668</td><td>51.7</td><td>629</td><td>53.7</td><td>39</td><td>32.5</td><td>&lt; 0.001</td></tr><tr><td> &gt; median (57 years)</td><td>624</td><td>48.3</td><td>543</td><td>46.3</td><td>81</td><td>67.5</td><td></td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Male</td><td>981</td><td>75.9</td><td>887</td><td>75.7</td><td>94</td><td>78.3</td><td>0.518</td></tr><tr><td> Female</td><td>311</td><td>24.1</td><td>285</td><td>24.3</td><td>26</td><td>21.7</td><td></td></tr><tr><td>Ethnicity</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Non-Hispanic White</td><td>1,093</td><td>84.6</td><td>999</td><td>85.2</td><td>94</td><td>78.3</td><td>0.050</td></tr><tr><td> Other</td><td>199</td><td>15.4</td><td>173</td><td>14.8</td><td>26</td><td>21.7</td><td></td></tr><tr><td>Smoking</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Never</td><td>346</td><td>26.8</td><td>321</td><td>27.4</td><td>25</td><td>20.8</td><td>0.122</td></tr><tr><td> Ever</td><td>946</td><td>73.2</td><td>851</td><td>72.6</td><td>95</td><td>79.2</td><td></td></tr><tr><td>Alcohol</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Never</td><td>337</td><td>26.1</td><td>310</td><td>26.4</td><td>27</td><td>22.5</td><td>0.348</td></tr><tr><td> Ever</td><td>955</td><td>73.9</td><td>862</td><td>73.6</td><td>93</td><td>77.5</td><td></td></tr><tr><td>Index Cancer Site</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Oral cavity</td><td>420</td><td>32.5</td><td>382</td><td>32.6</td><td>38</td><td>31.7</td><td>0.320</td></tr><tr><td> Oropharynx</td><td>575</td><td>44.5</td><td>527</td><td>45.0</td><td>48</td><td>40.0</td><td></td></tr><tr><td> Larynx/Hypopharynx</td><td>297</td><td>23.0</td><td>263</td><td>22.4</td><td>34</td><td>28.3</td><td></td></tr><tr><td>Index Cancer Stage</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I or II</td><td>327</td><td>25.3</td><td>295</td><td>25.0</td><td>32</td><td>26.7</td><td>0.720</td></tr><tr><td> III or IV</td><td>965</td><td>74.7</td><td>877</td><td>75.0</td><td>88</td><td>73.3</td><td></td></tr><tr><td>Treatment</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Surgery only</td><td>230</td><td>17.8</td><td>209</td><td>17.8</td><td>21</td><td>17.5</td><td>0.894</td></tr><tr><td> Surgery + Adjuvant Tx<sup>a</sup></td><td>322</td><td>24.9</td><td>289</td><td>24.7</td><td>33</td><td>27.5</td><td></td></tr><tr><td> XRT<sup>b</sup></td><td>330</td><td>25.6</td><td>302</td><td>25.8</td><td>28</td><td>23.3</td><td></td></tr><tr><td> XRT + Chemotherapy</td><td>410</td><td>31.7</td><td>372</td><td>31.7</td><td>38</td><td>31.7</td><td></td></tr></table>
88356c7da2583e349546c0ff4dd33f71ceb68cf154084b2919e9e9cd7e99ca5a.png
simple
<table><tr><td> </td><td>Equations for lean mass estimation (kg)</td><td>Equation number</td><td><i>r</i><sup><i>2</i></sup></td><td>Cp</td><td>p</td><td>RMSE (kg)</td></tr><tr><td>M (n = 24)</td><td>0.3BW + 3.0PC/TC &#8211; 0.003BW/RTL + 3.51</td><td>13</td><td>0.92</td><td>2.31</td><td>=0.04</td><td>0.16</td></tr><tr><td>F (n = 24)</td><td>&#8722;0.003BW/RTL + 0.11BL<sup>2</sup>/R + 0.40</td><td>14</td><td>0.83</td><td>0.45</td><td>=0.04</td><td>0.17</td></tr><tr><td>M and F (n = 48)</td><td>0.2BW + 0.09BL<sup>2</sup>/R + 0.25</td><td>15</td><td>0.85</td><td>4.72</td><td>=0.0001</td><td>0.21</td></tr><tr><td> </td><td>0.04 BW + 0.07 BL<sup>2</sup>/R &#8211; 3.7SFLT + 0.17</td><td>16</td><td>0.87</td><td>2.65</td><td>=0.05</td><td>0.20</td></tr><tr><td>T0 (n = 16)</td><td>0.4BW + 0.08BL<sup>2</sup>/R - 0.05</td><td>17</td><td>0.86</td><td>4.23</td><td>=0.05</td><td>0.22</td></tr><tr><td>T1 (n = 16)</td><td>0.3BW + 0.08BL<sup>2</sup>/R + 0.20</td><td>18</td><td>0.87</td><td>6.40</td><td>=0.02</td><td>0.17</td></tr><tr><td>T2 (n = 16)</td><td>0.3BW &#8211; 2.71PC/TC &#8211; 0.004BW/RTL + 0.05BL<sup>2</sup>/R + 2.73</td><td>19</td><td>0.97</td><td>3.09</td><td>=0.02</td><td>0.10</td></tr></table>
91eba2bdc3a87cd5e58acd1383285f244a5aadd177187eb2129887423cb1b01f.png
simple
<table><tr><td>Variable</td><td>OR (95% CI)</td><td><i>p</i>-value</td></tr><tr><td>With Shared Epitope</td><td>0.7 (0.3&#8211;1.3)</td><td>0.25</td></tr><tr><td>No Shared Epitope</td><td>0.9 (0.3&#8211;2.6)</td><td>0.90</td></tr><tr><td>Duration &gt; 10</td><td>0.9 (0.4&#8211;1.9)</td><td>0.75</td></tr><tr><td>Duration &lt; 10</td><td>0.8 (0.3&#8211;2.0)</td><td>0.66</td></tr></table>
8b4788bb598d6c5b30eb98b5423311ba33286460f933ca173cf89f0e340ba7c5.png
complex
<table><tr><td>Patient Characteristic</td><td><i>Plasmodium knowlesi</i></td><td><i>Plasmodium vivax</i></td><td><i>Plasmodium falciparum</i></td><td><i>P</i> Value</td></tr><tr><td>Children (age &#8804;12 y), No. (% total)</td><td>44 (9.1)</td><td>71 (41.3)</td><td>31 (32.3)</td><td>&lt;.001</td></tr><tr><td colspan="5">Age, y</td></tr><tr><td> Median (IQR)</td><td>8 (5&#8211;10)</td><td>9 (5&#8211;10)</td><td>7 (3&#8211;10)</td><td>.095</td></tr><tr><td> Range</td><td>0.1&#8211;12</td><td>0.67&#8211;12</td><td>1&#8211;12</td><td></td></tr><tr><td>Male sex, No. (%)</td><td>25 (56.8)</td><td>34 (47.9)</td><td>21 (67.7)</td><td>.170</td></tr><tr><td>Previous malaria (self-reported), No. (%)</td><td>4 (9.1)</td><td>11 (15.5)</td><td>3 (9.7)</td><td>.526</td></tr><tr><td>History of chronic disease, No. (%)</td><td>2 (4.5)</td><td>0</td><td>0</td><td>.095</td></tr><tr><td>Days of fever</td><td>5 (3&#8211;7)</td><td>5 (3&#8211;7)</td><td>4 (3&#8211;5)</td><td>.751</td></tr><tr><td colspan="5">Symptoms on enrollment, No. (%)</td></tr><tr><td> Rigors</td><td>29 (65.9)</td><td>55 (77.5)</td><td>14 (45.2)</td><td>.006</td></tr><tr><td> Headache</td><td>34 (77.3)</td><td>55 (77.5)</td><td>21 (67.7)</td><td>.542</td></tr><tr><td> Vomiting</td><td>14 (31.8)</td><td>37 (52.1)</td><td>11 (35.5)</td><td>.068</td></tr><tr><td> Abdominal pain</td><td>19 (43.2)</td><td>9 (12.7)</td><td>9 (29.0)</td><td>.001</td></tr><tr><td> Diarrhea</td><td>4 (9.1)</td><td>2 (2.8)</td><td>4 (12.9)</td><td>.140</td></tr><tr><td> Cough</td><td>15 (34.1)</td><td>25 (35.2)</td><td>12 (38.7)</td><td>.914</td></tr><tr><td> Shortness of breath</td><td>3 (6.8)</td><td>4 (5.6)</td><td>4 (12.9)</td><td>.431</td></tr><tr><td> Myalgia</td><td>11 (25.0)</td><td>15 (21.1)</td><td>7 (22.6)</td><td>.890</td></tr><tr><td> Arthralgia</td><td>12 (27.3)</td><td>15 (21.1)</td><td>7 (22.6)</td><td>.746</td></tr><tr><td colspan="5">Examination findings on enrollment</td></tr><tr><td> Temperature, &#176;C</td><td>37.1 (36.8&#8211;37.9)</td><td>37.4 (36.8&#8211;37.8)</td><td>37.1 (36.8&#8211;38)</td><td>.647</td></tr><tr><td> Fever (&#8805;37.5&#176;C), No. (%)</td><td>17 (38.6)</td><td>33 (46.5)</td><td>12 (38.7)</td><td>.634</td></tr><tr><td> Systolic blood pressure, mm Hg</td><td>101 (94&#8211;109)</td><td>102 (96&#8211;110)</td><td>106 (98&#8211;112)</td><td>.356</td></tr><tr><td> Heart rate, beats/min</td><td>104 (93&#8211;119)</td><td>105 (94&#8211;118)</td><td>117 (96&#8211;134)</td><td>.688</td></tr><tr><td> Respiratory rate, breaths/min</td><td>24 (22&#8211;27)</td><td>24 (22&#8211;28)</td><td>26 (24&#8211;28)</td><td>.081</td></tr><tr><td> Oxygen saturation, %</td><td>99 (99&#8211;100)</td><td>99 (98&#8211;100)</td><td>100 (99&#8211;100)</td><td>.504</td></tr><tr><td> Palpable liver, No. (%)</td><td>14 (31.8)</td><td>20 (28.2)</td><td>8 (25.8)</td><td>.842</td></tr><tr><td> Palpable spleen, No. (%)</td><td>9 (20.5)</td><td>12 (16.9)</td><td>2 (6.5)</td><td>.244</td></tr><tr><td> Rash, No. (%)</td><td>1 (2.3)</td><td>0 (0)</td><td>1 (3.2)</td><td>.360</td></tr><tr><td>Parasite count/&#956;L</td><td>1722 (386&#8211;4830)</td><td>5967 (1829&#8211;13901)</td><td>7392 (1462&#8211;36546)</td><td>&lt;.001</td></tr><tr><td>Parasite count/&#956;L, range</td><td>36&#8211;74365</td><td>109&#8211;140500</td><td>61&#8211;635415</td><td></td></tr><tr><td>Schizont proportion, mean % (SD)</td><td>3 (7.5)</td><td>1 (4.0)</td><td>0 (0)</td><td>.013</td></tr><tr><td>Schizont proportion &gt;10%, No. (%)</td><td>3 (6.8)</td><td>1 (1.5)</td><td>0 (0)</td><td>.138</td></tr><tr><td>Parasite count &gt;20000/&#956;L, No. (%)</td><td>4 (9)</td><td>8 (11)</td><td>12 (39)</td><td>.001</td></tr><tr><td>Gametocytes present, no./No. (%)</td><td>4/35 (11)</td><td>21/66 (32)</td><td>1/11 (9)</td><td>.035</td></tr><tr><td>Hemoglobin, g/dL</td><td>10.6 (9.7&#8211;11.3)</td><td>10.1 (9.3&#8211;11.2)</td><td>10.3 (9.2&#8211;11.6)</td><td>.726</td></tr><tr><td>Anemia<sup>a</sup> (baseline), No. (%)</td><td>36 (82)</td><td>56 (79)</td><td>21 (68)</td><td>.328</td></tr><tr><td>G6PD deficiency present, no./No. (%)</td><td>1/38 (2.6)</td><td>3/69 (4.3)</td><td>1/18 (5.6)</td><td>.852</td></tr><tr><td>White blood cell count, &#215; 10<sup>3</sup>/&#956;L</td><td>6.1 (5.1&#8211;7.5)</td><td>7.1 (5.1&#8211;8.6)</td><td>9.2 (6.4&#8211;12.7)</td><td>.002</td></tr><tr><td>Neutrophil count, &#215; 10<sup>3</sup>/&#956;L</td><td>2.7 (2.0&#8211;3.5)</td><td>3.3 (2.5&#8211;4.8)</td><td>3.8 (2.5&#8211;6.8)</td><td>.015</td></tr><tr><td>Lymphocyte count, &#215; 10<sup>3</sup>/&#956;L</td><td>2.0 (1.4&#8211;2.7)</td><td>2.2 (1.6&#8211;2.9)</td><td>2.8 (1.7&#8211;5.0)</td><td>.025</td></tr><tr><td>Monocyte count, &#215; 10<sup>3</sup>/&#956;L</td><td>1.1 (0.8&#8211;1.4)</td><td>0.9 (0.6&#8211;1.3)</td><td>1.2 (0.7&#8211;1.4)</td><td>.241</td></tr><tr><td>Platelet count, &#215; 10<sup>3</sup>/&#956;L</td><td>106 (80&#8211;163)</td><td>120 (93&#8211;179)</td><td>159 (83&#8211;282)</td><td>.078</td></tr><tr><td>Platelet nadir, &#215; 10<sup>3</sup>/&#956;L</td><td>78 (60&#8211;134)</td><td>104 (70&#8211;154)</td><td>129 (63&#8211;275)</td><td>&lt;.001</td></tr><tr><td>Platelet nadir, d</td><td>1 (0&#8211;1)</td><td>1 (0&#8211;1)</td><td>1 (0&#8211;1)</td><td>1.000</td></tr><tr><td>Thrombocytopenia (platelets &lt;150 &#215; 10<sup>3</sup>/&#956;L), No. (%)</td><td>30 (68)</td><td>46 (65)</td><td>13 (42)</td><td>.047</td></tr><tr><td>Creatinine, &#956;mol/L</td><td>48 (36&#8211;57)</td><td>48 (34&#8211;58)</td><td>40 (31&#8211;53)</td><td>.267</td></tr><tr><td>Urea, mmol/L</td><td>3.8 (2.8&#8211;4.5)</td><td>3.5 (3.0&#8211;4.6)</td><td>3.2 (2.3&#8211;4.5)</td><td>.167</td></tr><tr><td>Sodium, mmol/L</td><td>137 (135&#8211;139)</td><td>137 (136&#8211;139)</td><td>136 (133&#8211;139)</td><td>.640</td></tr><tr><td>Bilirubin, &#956;mol/L</td><td>11.5 (8.3&#8211;15.8)</td><td>9.8 (6.0&#8211;14.6)</td><td>11.0 (6.8&#8211;19.7)</td><td>.474</td></tr><tr><td>Glucose, mmol/L</td><td>5.8 (5.1&#8211;6.8)</td><td>5.7 (5.0&#8211;6.4)</td><td>6.2 (5.6&#8211;6.6)</td><td>.802</td></tr><tr><td>Albumin, g/dL</td><td>35 (31&#8211;37)</td><td>34 (28&#8211;36)</td><td>32 (29&#8211;37)</td><td>.644</td></tr><tr><td>AST, IU/L</td><td>25 (23&#8211;34)</td><td>24 (15&#8211;28)</td><td>37 (24&#8211;42)</td><td>.268</td></tr><tr><td>ALT, IU/L</td><td>16 (11&#8211;32)</td><td>17 (11&#8211;28)</td><td>24 (14&#8211;32)</td><td>.270</td></tr><tr><td>Bicarbonate, mmol/L</td><td>23 (21&#8211;25)</td><td>22 (20&#8211;26)</td><td>25 (21&#8211;26)</td><td>.418</td></tr><tr><td>Acute kidney injury, No. (%)</td><td>11 (26)</td><td>7 (10)</td><td>10 (32)</td><td>.016</td></tr><tr><td>Blood culture positive<sup>b</sup>, No. (%)</td><td>0/33 (0)</td><td>0/28 (0)</td><td>0/15 (0)</td><td>1.000</td></tr></table>
1ec75d8e9e31853ca030994bb15819c3e366990b4a541a01a35d6d817a8fd2ae.png
complex
<table><tr><td>Correlates<sup>a</sup></td><td>Unadjusted OR</td><td>ORa</td><td>95% CI of the ORa</td><td><i>p</i>-Value</td></tr><tr><td colspan="5">Vegetarian/low calories diet versus mixed diet<sup>b</sup></td></tr><tr><td>Older age</td><td>1.04</td><td>1.04</td><td>0.98&#8211;1.11</td><td>0.168</td></tr><tr><td>Income level</td><td></td><td></td><td></td><td>0.012</td></tr><tr><td> Quartile 1 (reference)</td><td>1.00</td><td></td><td></td><td></td></tr><tr><td> Quartile 2</td><td>0.95</td><td>0.93</td><td>0.69&#8211;1.26</td><td>0.630</td></tr><tr><td> Quartile 3</td><td>1.01</td><td>0.94</td><td>0.68&#8211;1.31</td><td>0.721</td></tr><tr><td> Quartile 4</td><td>1.41</td><td>1.45</td><td>1.06&#8211;1.99</td><td>0.021</td></tr><tr><td>Body mass index</td><td></td><td></td><td></td><td>0.035</td></tr><tr><td> Underweight (reference)</td><td>1.00</td><td></td><td></td><td></td></tr><tr><td> Normal weight</td><td>1.25</td><td>1.41</td><td>0.96&#8211;2.07</td><td>0.076</td></tr><tr><td> Overweight</td><td>1.30</td><td>1.45</td><td>0.90&#8211;2.32</td><td>0.136</td></tr><tr><td> Obese</td><td>1.44</td><td>2.80</td><td>1.40&#8211;5.61</td><td>0.004</td></tr><tr><td>Private versus public university</td><td>1.18</td><td>1.23</td><td>0.96&#8211;1.57</td><td>0.099</td></tr><tr><td>Higher physical activity level</td><td></td><td></td><td></td><td>0.651</td></tr><tr><td> No activity (reference)</td><td>1.00</td><td></td><td></td><td></td></tr><tr><td> Quartile 1</td><td>1.13</td><td>1.21</td><td>0.88&#8211;1.64</td><td>0.237</td></tr><tr><td> Quartile 2</td><td>1.11</td><td>1.19</td><td>0.86&#8211;1.64</td><td>0.304</td></tr><tr><td> Quartile 3</td><td>1.12</td><td>1.05</td><td>0.76&#8211;1.47</td><td>0.759</td></tr><tr><td> Quartile 4</td><td>1.03</td><td>1.23</td><td>0.86&#8211;1.75</td><td>0.260</td></tr><tr><td>Female versus male gender</td><td>1.36</td><td>1.62</td><td>1.24&#8211;2.12</td><td>&lt;0.001</td></tr><tr><td colspan="5">Westernized diet versus mixed diet<sup>c</sup></td></tr><tr><td>Older Age</td><td>0.78</td><td>0.98</td><td>0.93&#8211;1.04</td><td>0.534</td></tr><tr><td>Income level</td><td></td><td></td><td></td><td>0.468</td></tr><tr><td> Quartile 1 (reference)</td><td>1.0</td><td></td><td></td><td></td></tr><tr><td> Quartile 2</td><td>0.95</td><td>0.90</td><td>0.68&#8211;1.17</td><td>0.422</td></tr><tr><td> Quartile 3</td><td>1.21</td><td>1.06</td><td>0.80&#8211;1.41</td><td>0.693</td></tr><tr><td> Quartile 4</td><td>1.23</td><td>1.12</td><td>0.84&#8211;1.49</td><td>0.458</td></tr><tr><td>Body mass index</td><td></td><td></td><td></td><td>0.616</td></tr><tr><td> Underweight (reference)</td><td>1.00</td><td></td><td></td><td></td></tr><tr><td> Normal weight</td><td>1.13</td><td>1.08</td><td>0.78&#8211;1.51</td><td>0.643</td></tr><tr><td> Overweight</td><td>1.25</td><td>0.96</td><td>0.63&#8211;1.45</td><td>0.835</td></tr><tr><td> Obese</td><td>1.35</td><td>1.36</td><td>0.73&#8211;2.53</td><td>0.335</td></tr><tr><td>Private versus public university</td><td>1.22</td><td>1.15</td><td>0.92&#8211;1.43</td><td>0.214</td></tr><tr><td>Higher physical activity level</td><td></td><td></td><td></td><td>0.038</td></tr><tr><td> No activity (reference)</td><td>1.00</td><td></td><td></td><td></td></tr><tr><td> Quartile 1 Low physical activity</td><td>0.73</td><td>0.75</td><td>0.56&#8211;1.00</td><td>0.046</td></tr><tr><td> Quartile 2 moderate Physical activity</td><td>0.74</td><td>0.63</td><td>0.47&#8211;0.86</td><td>0.003</td></tr><tr><td> Quartile 3 high physical activity</td><td>0.96</td><td>0.82</td><td>0.61&#8211;1.09</td><td>0.171</td></tr><tr><td> Quartile 4 very high physical activity</td><td>1.19</td><td>0.86</td><td>0.63&#8211;1.18</td><td>0.359</td></tr><tr><td>Female versus male gender</td><td>0.69</td><td>0.64</td><td>0.50&#8211;0.80</td><td>&lt;0.001</td></tr></table>
ec3e707ee77f1a7bc302a404a010f913945cb06a01a93d1a32288907164b200c.png
simple
<table><tr><td>Species</td><td>Family</td><td>Origin</td><td>Reference</td></tr><tr><td><i>Agrotis hephaestaea</i> (Meyrick)</td><td>Noctuidae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Ethmia nigroapicella</i> (Saalmuller)</td><td>Oecophoridae</td><td>Adventive</td><td>[48]</td></tr><tr><td><i>Eudonia</i> sp.</td><td>Crambidae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Eupithecia monticolens</i> Butler</td><td>Geometridae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Fletcherana leucoxyla</i> Meyrick</td><td>Geometridae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Haliophyle euclidias</i> Meyrick</td><td>Noctuidae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Scotorythra arboricolans</i> Butler</td><td>Geometridae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Scotorytorythra caryopis</i> Meyrick</td><td>Geometridae</td><td>Endemic</td><td>[48]</td></tr><tr><td><i>Scotorythra hecataea</i> Meyrick</td><td>Geometridae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Scotorythra pauludicola</i> (Butler)</td><td>Geometridae</td><td>Endemic</td><td>[48]</td></tr><tr><td><i>Scotorythra rara</i> Butler</td><td>Geometridae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Scotorythra trapezias</i> Meyrick</td><td>Geometridae</td><td>Endemic</td><td>[48]</td></tr><tr><td><i>Scotorythra</i> spp.</td><td>Geometridae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Spodalea recurvalis</i> (Fabricius)</td><td>Crambidae</td><td>Adventive</td><td>[48]</td></tr><tr><td><i>Pseudaletia unipuncta</i> (Haworth)</td><td>Noctuidae</td><td>Adventive</td><td>[48]</td></tr><tr><td><i>Spodoptera exempta</i> (Walker)</td><td>Noctuidae</td><td>Adventive *</td><td>[48]</td></tr><tr><td><i>Spodoptera mauritia</i> (Boisduval)</td><td>Noctuidae</td><td>Adventive</td><td>[48]</td></tr><tr><td><i>Spheretista pleonectes Walsingham</i></td><td>Tortricidae</td><td>Endemic</td><td>[49]</td></tr><tr><td><i>Udea stellata</i> (Butler)</td><td>Crambidae</td><td>Endemic</td><td>[33]</td></tr></table>
4a452a7ca202b86a1900b1a2f5d0e810cf246a5460d58e1064f4aec138efa6b6.png
complex
<table><tr><td>No.</td><td> </td><td>Mean</td><td>SD</td></tr><tr><td colspan="2"><i>Management: General</i></td><td> </td><td> </td></tr><tr><td>11</td><td>Different approaches are used on this ward to manage patient aggression and violence.</td><td>1.7</td><td>0.8</td></tr><tr><td>24</td><td>Patient aggression could be handled more effectively on this ward.</td><td>2.1</td><td>0.8</td></tr><tr><td colspan="4"><i>Management: Use of medication</i></td></tr><tr><td>16</td><td>Medication is a valuable approach for treating aggressive and violent behaviour.</td><td>2.3</td><td>0.9</td></tr><tr><td>25</td><td>Prescribed medication can in some instances lead to patient aggression and violence.</td><td>2.2</td><td>0.6</td></tr><tr><td>28</td><td>Prescribed medication should be used more frequently to help patients who are aggressive and violent.</td><td>2.4</td><td>0.9</td></tr><tr><td colspan="4"><i>Management: Use of seclusion</i></td></tr><tr><td>13</td><td>When a patient is violent, seclusion is one of the most effective approaches to use.</td><td>2.7</td><td>0.9</td></tr><tr><td>15</td><td>The practice of secluding violent patients should be discontinued.</td><td>3.0</td><td>0.8</td></tr><tr><td>27</td><td>Seclusion is sometimes used more than necessary.</td><td>2.5</td><td>0.9</td></tr><tr><td colspan="4"><i>Management: Restraint</i></td></tr><tr><td>14</td><td>Patients who are violent are often restrained for their own safety.</td><td>2.5</td><td>0.9</td></tr><tr><td>21</td><td>Physical restraint is sometimes used more than necessary.</td><td>2.4</td><td>0.9</td></tr><tr><td colspan="4"><i>Management: Non-physical methods</i></td></tr><tr><td>18</td><td>Negotiation could be used more effectively when managing aggression and violence.</td><td>1.9</td><td>0.7</td></tr><tr><td>20</td><td>Expressions of aggression do not always require staff intervention.</td><td>2.5</td><td>0.8</td></tr><tr><td>22</td><td>Alternatives to the use of containment and sedation to manage patient violence could be used more frequently.</td><td>2.1</td><td>0.7</td></tr><tr><td>29</td><td>The use of de-escalation is successful in preventing violence.</td><td>1.7</td><td>0.6</td></tr></table>
43e7a6c353e122c5430a393b9ccb14a76ecb0136fbdca0edfbc014ea9fd98b7f.png
simple
<table><tr><td>Step</td><td>Push node</td><td>flow</td><td>Received node</td></tr><tr><td>1</td><td>S</td><td>&#8734;</td><td>G1</td></tr><tr><td>2</td><td>G1</td><td>1.83</td><td>G6</td></tr><tr><td>3</td><td>G1</td><td>0.69</td><td>G3</td></tr><tr><td>4</td><td>G3</td><td>0.69</td><td>G7</td></tr><tr><td>5</td><td>G6</td><td>1.83</td><td>T</td></tr><tr><td>6</td><td>G7</td><td>0.69</td><td>T</td></tr></table>
1dc189b64826957e90c78224b82a52d2280cbdbfbe2391f29733cc1dac783821.png
simple
<table><tr><td>VITBRK2</td><td>Growth characteristics</td></tr><tr><td>Growth under anaerobic conditions</td><td>Negative</td></tr><tr><td>Gram stain</td><td>Positive</td></tr><tr><td>Shape and growth</td><td>Long filamentous</td></tr><tr><td>Motility</td><td>Non-motile</td></tr><tr><td>Temperature range for growth</td><td>25-37&#176;C</td></tr><tr><td>Optimum temperature</td><td>28&#176;C</td></tr><tr><td>Range of pH for growth</td><td>6-8</td></tr><tr><td>Growth on MacConky plates</td><td>Negative</td></tr><tr><td>Growth in the presence of NaCl</td><td>2-12 %</td></tr><tr><td>2%</td><td>Positive</td></tr><tr><td>5%</td><td>Positive</td></tr><tr><td>7%</td><td>Positive</td></tr><tr><td>9%</td><td>Positive</td></tr><tr><td>12%</td><td>Positive</td></tr><tr><td>Aerial mass colour</td><td>Whitish grey</td></tr><tr><td>Melanoid pigments</td><td>Negative</td></tr><tr><td>Reverse side pigments</td><td>Negative</td></tr><tr><td>Soluble pigments</td><td>Negative</td></tr><tr><td>Spore chain</td><td>Spiral</td></tr><tr><td>Spore surface</td><td>Smooth</td></tr><tr><td>Arabinose</td><td>Positive</td></tr><tr><td>Xylose</td><td>Positive</td></tr><tr><td>Inositol</td><td>Positive</td></tr><tr><td>Mannitol</td><td>Positive</td></tr><tr><td>Fructose</td><td>Positive</td></tr><tr><td>Rhamnose</td><td>Negative</td></tr><tr><td>Sucrose</td><td>Positive</td></tr><tr><td>Raffinose</td><td>Positive</td></tr></table>
21f187bf7bc5603e776d5436871c1a6dbe7055442047c7dc9c2a0d5a644618bf.png
simple
<table><tr><td>Spot no.</td><td>Mascot score</td><td>ID</td><td>Accession no.</td><td>Protein name</td><td>Mr/PI</td><td>SC</td><td>Description</td></tr><tr><td>H3(872)</td><td>88</td><td>FIBB</td><td>P02675</td><td>Fibrinogen beta chain</td><td>55/8.5</td><td>35</td><td>N&gt;P</td></tr><tr><td>H4(867)</td><td>62</td><td>FIBB</td><td>P02675</td><td>Fibrinogen beta chain</td><td>55/8.5</td><td>26</td><td>N&gt;P</td></tr><tr><td>H6(1026)</td><td>72</td><td>FIBB</td><td>P02675</td><td>Fibrinogen beta chain</td><td>55/8.5</td><td>29</td><td>N&gt;P</td></tr><tr><td>H7(1023)</td><td>114</td><td>TCPB</td><td>P78371</td><td>T-complex protein 1 subunit beta</td><td>57/6.0</td><td>41</td><td>N&gt;P</td></tr><tr><td>G11(1014)</td><td>57</td><td>FIBG</td><td>P02679</td><td>Fibrinogen gamma chain</td><td>51/5.3</td><td>18</td><td>N&gt;P</td></tr><tr><td>G13(1534)</td><td>63</td><td>SH319</td><td>Q5HYK7</td><td>SH3 domain-containing protein 19</td><td>86/8.5</td><td>11</td><td>N&gt;P</td></tr><tr><td>G15(812)</td><td>61</td><td>RARB</td><td>P10826</td><td>Retinoic acid receptor beta</td><td>50/8.0</td><td>11</td><td>N&gt;P</td></tr><tr><td>H16(1572)</td><td>57</td><td>GPX1</td><td>P07203</td><td>Glutathione peroxidase 1</td><td>21/6.1</td><td>23</td><td>N&gt;P</td></tr><tr><td>G1(791)</td><td>86</td><td>PDIA3</td><td>P30101</td><td>Protein disulfdte-isomerase A3</td><td>56/5.9</td><td>25</td><td>P&gt;N</td></tr><tr><td>H2(786)</td><td>94</td><td>PDIA3</td><td>P30101</td><td>Protein disulfide-isomerase A3</td><td>56/5.9</td><td>30</td><td>P&gt;N</td></tr><tr><td>G14(1317)</td><td>70</td><td>CAPZB</td><td>P47756</td><td>F-actin-capping protein subunit beta</td><td>31/5.3</td><td>26</td><td>P&gt;N</td></tr></table>
bb07493cb033bcb7361874c03c35168ed23eb145e8f56681ea9dc620d3cdbe91.png
simple
<table><tr><td></td><td>Components and processes</td></tr><tr><td>National Performance Indicators</td><td>52 National indicators spanning government priorities</td></tr><tr><td></td><td> &#8226; Governance</td></tr><tr><td></td><td> &#8226; Prevention and early intervention,</td></tr><tr><td></td><td> &#8226; Access</td></tr><tr><td></td><td> &#8226; Integration</td></tr><tr><td></td><td> &#8226; Chronic disease management</td></tr><tr><td></td><td>Compulsory reporting against a subset of national indicators and choice in reporting against local programs</td></tr><tr><td></td><td>PIs underpinned by a conceptual framework and technical details 4 levels of indicators from processes through to client outcomes</td></tr><tr><td>Accreditation</td><td>Requirement for all Divisions to become accredited by June 2008</td></tr><tr><td></td><td>Once accredited, Divisions no longer required to report on governance indicators</td></tr><tr><td>Performance Assessment</td><td>Performance against indicators is to feed into individual performance appraisal</td></tr><tr><td></td><td>At the national level, analysis and benchmarking support comparison and provide an aggregated picture of performance</td></tr><tr><td></td><td>Links to rewards (still to be determined) to reward high performance and support improvement</td></tr></table>
f06799a010b329dd9a59ce25b1d52b939ccc688f6cc0bfb039b2dff049644a77.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">lncRNABLACAT1</td></tr><tr><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>PTC diagnosis</td><td>0.887</td><td>0.833&#8211;0.982</td><td>0.013*</td></tr><tr><td>Model 1</td><td></td><td></td><td></td></tr><tr><td>Lymph node metastasis</td><td></td><td></td><td></td></tr><tr><td>Model 1</td><td>0.596</td><td>0.459&#8211;0.805</td><td>&lt; 0.001**</td></tr><tr><td>Model 2</td><td>0.504</td><td>0.341&#8211;0.798</td><td>0.005*</td></tr></table>
9d683df61e7e7003bd86716d4d2a06eeabd2b9671bc379364b05c86b30d82cc3.png
simple
<table><tr><td></td><td>Naive group</td><td>Treated patients</td><td>STI patients</td></tr><tr><td>Number</td><td>10</td><td>20</td><td>15</td></tr><tr><td>Genders</td><td></td><td></td><td></td></tr><tr><td>Males</td><td>5</td><td>8</td><td>8</td></tr><tr><td>Females</td><td>5</td><td>12</td><td>6</td></tr><tr><td>Transsexuals</td><td></td><td></td><td>1</td></tr><tr><td>Mean years old</td><td>42</td><td>42</td><td>43</td></tr><tr><td>Geographic origin</td><td></td><td></td><td></td></tr><tr><td>Europeans</td><td>5</td><td>12</td><td>12</td></tr><tr><td>Other/Unknown</td><td>5</td><td>8</td><td>3</td></tr><tr><td>Mean range follow up</td><td></td><td></td><td></td></tr><tr><td>Years<sup>a</sup></td><td>4 (range 1 &#8211; 11) <sup>a</sup></td><td>7.5 (range 1 &#8211; 15)<sup>a</sup></td><td>6 (range 2 &#8211; 7) <sup>a</sup></td></tr><tr><td>CD4+ count</td><td></td><td></td><td></td></tr><tr><td>cells &#215; 10<sup>6</sup>/l</td><td>Median 391 (range 109&#8211;805)</td><td>Median 338 (range 1 &#8211; 790)</td><td>Median 717 (range 216 &#8211; 1356)</td></tr><tr><td>&lt;200 cells &#215; 10<sup>6</sup>/l (Number) <sup>b</sup></td><td>1</td><td>6</td><td>0</td></tr><tr><td>Plasma HIV-RNA</td><td></td><td></td><td></td></tr><tr><td>Log<sub>10 </sub>copies/ml</td><td>Median 4.8 (range 2.7 &#8211; 5.4)</td><td>Median 4.4 (range 1.7 &#8211; 5.9)</td><td>Median 3.2 (range 1.7 &#8211; 4.7) <sup>c</sup></td></tr><tr><td>&lt;50 copies/ml (Number)<sup>b</sup></td><td>0</td><td>5</td><td>3</td></tr><tr><td>HIV1-DNA</td><td></td><td></td><td></td></tr><tr><td>Log<sub>10 </sub>copies/10<sup>6 </sup>CD4 cells</td><td>Median 3.0 (range 2.6 &#8211; 3.7)</td><td>Median 3.3 (range 2.2 &#8211; 4.6)</td><td>Median 2.9 (range 2.1 &#8211; 4.0)</td></tr><tr><td>&lt;5 copies/PCR (Number) <sup>b</sup></td><td>6</td><td>12</td><td>5</td></tr></table>